data_1q01_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q01 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.7 p -57.65 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 111.08 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -50.89 164.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.123 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.53 -178.07 0.25 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.634 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -65.03 175.44 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -90.81 49.3 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.02 -32.99 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.9 138.27 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.63 143.58 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mt 54.51 173.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.65 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -67.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -64.51 -67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.8 p -73.16 172.07 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.88 69.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.5 mt -60.78 169.06 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 59.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -31.37 56.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.82 151.0 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 t 60.65 156.67 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -54.65 157.27 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.21 157.88 17.52 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.046 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' ' ND2' ' A' ' 31' ' ' ASN . 5.1 m-70 -65.9 176.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.64 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp 74.9 96.18 0.07 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.284 1.04 . . . . 0.0 110.951 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.405 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 32.3 mt -50.07 -35.89 11.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.229 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 58.46 160.82 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.335 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -82.28 163.7 21.63 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.071 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 22' ' ' ILE . 1.3 mt 54.58 173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 125.132 1.52 . . . . 0.0 110.934 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.02 45.9 0.25 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.332 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -66.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.177 0.513 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -108.72 -51.87 2.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.272 0.558 . . . . 0.0 111.168 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -59.14 167.0 1.88 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.277 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -157.68 64.34 0.31 Allowed Glycine 0 C--O 1.206 -1.628 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.601 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.1 -178.32 7.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.961 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 100.72 70.62 0.91 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.369 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 t -111.85 -63.33 1.43 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.475 ' ND2' ' CE1' ' A' ' 17' ' ' HIS . 1.5 m-80 -56.57 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.81 164.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 20.9 m-85 -59.07 -178.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.369 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -171.04 0.95 Allowed Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.654 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.06 -178.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.55 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 48.82 1.69 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.5 mt -89.4 -31.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.994 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HA ' HD23 ' A' ' 28' ' ' LEU . 6.3 t70 54.82 105.31 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.599 0.714 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.86 166.05 21.71 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.927 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -46.58 142.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.413 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 93.76 0.24 Allowed Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.773 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -46.78 -56.72 5.77 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.937 0.433 . . . . 0.0 111.554 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -44.85 -51.97 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.373 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.8 m -44.08 145.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.572 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -140.63 56.21 0.61 Allowed Glycine 0 C--O 1.221 -0.711 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.347 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -47.17 170.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.983 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.72 -32.86 2.96 Favored Glycine 0 C--N 1.311 -0.857 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.512 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.3 t -61.54 -37.41 83.68 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.344 -0.504 . . . . 0.0 111.24 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -58.05 149.29 23.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.183 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? . . . . . 0 N--CA 1.451 -0.38 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.503 0 N-CA-C 112.649 -0.18 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -166.93 176.24 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -59.69 171.96 0.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.55 173.76 2.37 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.95 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -61.3 175.93 0.51 Allowed 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.73 48.68 1.56 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 124.597 1.186 . . . . 0.0 110.653 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.27 -46.47 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 120.927 0.394 . . . . 0.0 111.108 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 144.73 51.97 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 72.79 3.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.024 0.828 . . . . 0.0 111.118 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 22' ' ' ILE . 1.2 mt -131.19 173.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 O-C-N 125.005 1.441 . . . . 0.0 110.732 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.67 -40.69 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.519 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -59.74 -74.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -66.8 -66.53 0.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.416 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -90.14 172.11 9.05 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.243 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -152.07 53.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.507 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 0.2 OUTLIER -52.43 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.124 0.488 . . . . 0.0 111.087 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 66.9 0.85 Allowed Glycine 0 C--N 1.286 -2.234 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.781 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -126.33 -53.38 1.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 110.848 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -58.78 128.02 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.581 -0.207 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.83 -170.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 0.0 110.717 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -52.67 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.007 179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.96 169.16 0.33 Allowed Glycine 0 CA--C 1.494 -1.262 0 CA-C-O 122.117 0.843 . . . . 0.0 111.839 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.13 176.91 1.14 Allowed 'General case' 0 C--O 1.208 -1.09 0 O-C-N 122.346 -0.502 . . . . 0.0 110.835 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 48.95 1.58 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.908 1.38 . . . . 0.0 110.731 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.52 -35.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -88.22 123.68 33.08 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.187 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.41 73.01 1.84 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.663 0.602 . . . . 0.0 110.948 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 22' ' ' ILE . 1.1 mt -131.95 172.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.893 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.05 27.78 0.9 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.408 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -69.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.818 0.342 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -124.35 -61.67 1.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -61.34 172.11 1.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.136 0.174 . . . . 0.0 111.413 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.86 64.36 0.3 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.734 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.8 mt -55.25 170.78 0.19 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 111.044 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.27 83.91 0.93 Allowed Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.275 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.09 -53.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.057 0.456 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -59.09 131.63 51.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.977 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 52.63 177.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 2.6 p90 -48.68 140.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.787 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.99 177.69 0.92 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.518 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -93.11 131.72 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.215 0.531 . . . . 0.0 110.52 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER 166.92 99.26 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.997 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -34.68 -52.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 56.36 162.78 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.1 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 169.21 18.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.259 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -42.2 161.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.263 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.74 91.36 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.511 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.8 p -43.88 -58.45 2.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.632 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.69 -59.06 4.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.141 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 m -65.99 152.8 43.8 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -159.31 62.6 0.3 Allowed Glycine 0 C--O 1.211 -1.287 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.816 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.35 -174.75 0.41 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.41 72.46 1.16 Allowed Glycine 0 C--N 1.288 -2.087 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.63 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.3 t -71.03 -33.23 70.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.39 151.12 24.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 pttt . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.093 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.628 -0.189 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -70.23 -176.55 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.539 0.209 . . . . 0.0 111.186 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.429 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER -47.39 151.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.973 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.11 -167.49 43.41 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.641 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -59.04 178.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.36 0.6 . . . . 0.0 110.997 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt 74.82 84.18 0.1 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.47 -32.59 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.371 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 59.5 159.96 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.114 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.98 163.17 18.15 Favored 'General case' 0 C--O 1.199 -1.566 0 C-N-CA 123.522 0.729 . . . . 0.0 111.273 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mt 54.67 173.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.009 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.25 46.56 0.66 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.664 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.1 p -58.67 -58.61 7.82 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.725 0.297 . . . . 0.0 110.933 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -123.07 -59.08 1.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 m -59.83 150.76 27.4 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.049 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -141.37 54.32 0.63 Allowed Glycine 0 N--CA 1.424 -2.14 0 O-C-N 124.071 0.857 . . . . 0.0 112.637 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.56 179.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.981 0.419 . . . . 0.0 110.733 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 38.18 2.01 Favored Glycine 0 C--N 1.28 -2.528 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.644 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -102.05 -74.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.71 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -75.51 157.35 34.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.016 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 176.04 0.53 Allowed 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -55.27 166.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.2 157.51 9.78 Favored Glycine 0 CA--C 1.497 -1.062 0 CA-C-O 121.891 0.717 . . . . 0.0 112.018 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -64.64 177.27 0.94 Allowed 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 tptp 75.57 96.82 0.07 Allowed 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.997 0.903 . . . . 0.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 mt -48.41 -31.42 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.32 99.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.765 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -52.32 149.34 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 22' ' ' ILE . 1.4 mt 54.6 173.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.09 93.33 2.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.334 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.13 -57.85 10.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -59.27 133.15 55.83 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.584 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -135.45 53.04 0.78 Allowed Glycine 0 C--O 1.204 -1.733 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.941 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 2.6 mm? -73.5 -177.38 2.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.899 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.02 72.02 1.29 Allowed Glycine 0 C--N 1.284 -2.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.413 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -129.99 -75.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.639 0.257 . . . . 0.0 110.723 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.36 -179.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.208 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 -174.25 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -55.84 164.16 1.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.725 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.79 161.92 5.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.793 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -61.58 178.49 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.749 0.309 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 77.04 97.33 0.07 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 19' ' ' ILE . 31.3 mt -47.08 -42.36 6.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.711 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 46.71 94.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.436 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -56.3 89.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 22' ' ' ILE . 1.2 mt 54.34 173.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.216 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.78 -82.28 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -82.18 0.65 Allowed 'General case' 0 C--O 1.213 -0.837 0 O-C-N 122.634 -0.333 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -120.22 -52.23 2.18 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 122.407 0.283 . . . . 0.0 110.772 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 172.78 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.585 0.354 . . . . 0.0 111.376 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -151.61 61.63 0.4 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.195 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 mt -52.66 170.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 15' ' ' PHE . . . 130.71 70.9 0.11 Allowed Glycine 0 C--N 1.289 -2.054 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.534 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 -47.26 2.68 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.701 0.286 . . . . 0.0 111.068 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -56.37 -179.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t 60.26 157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.421 ' CE1' ' O ' ' A' ' 27' ' ' GLY . 4.2 p90 -51.67 161.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.145 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.22 -165.16 23.35 Favored Glycine 0 N--CA 1.418 -2.535 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.535 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -58.14 172.82 0.4 Allowed 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.527 0.203 . . . . 0.0 111.024 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 49.34 1.53 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 123.9 0.75 . . . . 0.0 111.017 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.89 -43.88 79.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.43 136.11 37.56 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.97 153.57 22.08 Favored 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 124.13 0.893 . . . . 0.0 111.172 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.78 173.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.435 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.6 92.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -67.67 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.21 -56.56 5.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.1 p -61.53 172.08 1.3 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 15' ' ' PHE . . . -166.2 68.3 0.19 Allowed Glycine 0 C--O 1.217 -0.956 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.45 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.4 mt -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.914 0.387 . . . . 0.0 110.845 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.61 55.48 0.58 Allowed Glycine 0 C--N 1.283 -2.393 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.55 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -109.02 -71.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.693 0.283 . . . . 0.0 110.791 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -66.24 152.38 45.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.879 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.11 172.1 7.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 9.8 m-85 -59.85 141.11 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.16 -151.71 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.59 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -56.57 173.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -91.56 49.63 1.61 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.585 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.42 -52.28 38.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.93 137.94 57.95 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -79.26 162.75 25.46 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.716 0.635 . . . . 0.0 110.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mt 54.55 174.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 O-C-N 123.969 0.793 . . . . 0.0 110.558 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.02 32.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.553 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -67.38 0.4 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.637 0.256 . . . . 0.0 110.88 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -88.78 -53.28 4.69 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.069 0.462 . . . . 0.0 111.225 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 t -70.08 172.45 7.94 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.514 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -151.15 60.4 0.41 Allowed Glycine 0 C--O 1.2 -1.978 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.623 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -174.94 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.375 0.607 . . . . 0.0 110.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 68.38 0.92 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.767 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.91 -47.21 0.27 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 117.407 0.604 . . . . 0.0 112.425 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.21 -179.08 1.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.097 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.597 -179.562 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.208 0 N-CA-C 112.4 -0.28 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -122.65 -95.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.34 0.114 . . . . 0.0 110.721 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -122.07 144.55 48.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.98 -155.86 0.14 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -56.46 173.13 0.19 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 119.847 -0.12 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 3.4 ptmt -103.76 39.03 1.69 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 125.349 1.656 . . . . 0.0 111.135 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.3 mt -81.24 -46.24 20.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.31 138.03 58.03 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.06 119.73 9.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.318 0.58 . . . . 0.0 111.029 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -102.18 173.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.37 44.51 0.84 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.81 -68.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -125.9 -59.16 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -59.62 167.83 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.425 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.36 61.81 0.38 Allowed Glycine 0 C--O 1.2 -2.025 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.418 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 18.8 mt -61.21 176.34 0.46 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.181 0.991 . . . . 0.0 110.233 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 27.23 3.25 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.572 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 15' ' ' PHE . 0.5 OUTLIER -102.34 -57.92 1.97 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.045 0.45 . . . . 0.0 111.542 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.35 -179.14 2.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t 60.78 156.7 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.4 p90 -55.27 -179.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.021 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.88 156.42 47.17 Favored Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.195 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -74.69 179.13 4.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.792 0.329 . . . . 0.0 111.131 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tttt 77.53 98.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.445 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.0 mt -40.15 -49.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.563 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 58.26 161.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.53 10.97 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -41.3 161.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 125.105 1.503 . . . . 0.0 111.512 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.36 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.117 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 p -40.61 -58.69 1.54 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.811 0.339 . . . . 0.0 111.821 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -50.06 -57.66 7.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.374 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 p -72.58 171.9 11.57 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -157.77 39.56 0.53 Allowed Glycine 0 C--O 1.216 -1.011 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.781 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -64.26 177.35 0.85 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.61 51.46 0.91 Allowed Glycine 0 C--N 1.283 -2.378 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.729 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -30.85 11.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -60.93 154.24 22.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 111.081 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.121 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.6 p -57.88 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -51.07 164.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.45 -178.0 0.23 Allowed Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -65.4 176.54 1.37 Allowed 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 119.859 -0.115 . . . . 0.0 110.782 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -92.08 48.96 1.47 Allowed 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 124.179 0.924 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.14 -32.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 138.62 35.2 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.69 143.48 27.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.929 0.768 . . . . 0.0 111.177 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.92 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.544 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.17 91.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.407 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -67.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -64.46 -66.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.8 p -75.27 171.95 13.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -170.05 69.78 0.14 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.354 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -60.31 169.48 1.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 59.09 0.13 Allowed Glycine 0 C--N 1.295 -1.738 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.849 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -31.51 54.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -97.04 151.08 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.001 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.966 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.46 -95.44 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.858 -0.201 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.45 152.76 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.0 110.695 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.36 179.22 1.31 Allowed Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.549 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -59.32 175.53 0.31 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.354 0.121 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 39.58 1.08 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.489 1.118 . . . . 0.0 110.962 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.1 -20.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.221 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.19 109.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -68.34 152.59 45.22 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.5 174.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 O-C-N 124.289 0.993 . . . . 0.0 110.401 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.62 94.75 0.54 Allowed Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.552 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 p -46.01 -59.9 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.616 0.208 . . . . 0.0 110.957 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.09 -73.6 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.942 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 t 55.6 171.61 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.184 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -160.54 29.38 0.34 Allowed Glycine 0 C--O 1.21 -1.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.198 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.9 mt -73.39 172.46 11.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.775 0.798 . . . . 0.0 110.631 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.28 27.42 4.49 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.876 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -31.35 59.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.566 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -81.79 -179.14 7.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 mttm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 -179.841 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.41 -170.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CZ ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -53.17 -178.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 163.95 0.62 Allowed Glycine 0 CA--C 1.496 -1.101 0 CA-C-O 122.162 0.868 . . . . 0.0 111.871 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -62.28 177.15 0.52 Allowed 'General case' 0 C--O 1.208 -1.106 0 O-C-N 122.418 -0.46 . . . . 0.0 111.143 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -91.04 48.63 1.54 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.564 1.165 . . . . 0.0 110.521 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.68 -37.7 9.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.8 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.64 144.65 41.59 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -93.04 162.72 13.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 123.564 0.54 . . . . 0.0 111.055 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.68 173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.61 65.82 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.62 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -66.96 0.45 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.634 0.73 . . . . 0.0 110.842 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -104.41 -56.85 2.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 m -76.44 172.81 12.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -148.19 59.32 0.46 Allowed Glycine 0 C--O 1.224 -0.497 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.308 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -56.07 170.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.864 0.364 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.03 80.6 0.69 Allowed Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.77 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -57.11 0.24 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.177 0.988 . . . . 0.0 110.968 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.92 172.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 -179.834 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.133 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 51.04 179.22 0.02 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.528 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -64.18 179.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.72 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.1 -163.85 0.07 OUTLIER Glycine 0 CA--C 1.492 -1.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.87 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 8.4 m-70 -56.56 -179.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.475 . . . . 0.0 111.013 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.64 48.23 1.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.835 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.41 -56.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 46.31 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.34 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.0 106.3 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.957 0.884 . . . . 0.0 111.824 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mt 54.85 173.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.125 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 42.55 1.95 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.451 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -79.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -126.83 -57.4 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -57.83 172.69 0.37 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.458 0.171 . . . . 0.0 111.397 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -164.95 67.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.328 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.45 ' HA ' ' CG ' ' A' ' 15' ' ' PHE . 0.4 OUTLIER -80.19 170.1 16.89 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 110.617 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.05 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.574 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -58.53 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.831 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.99 154.88 14.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tptm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.44 0 CA-C-O 120.333 -0.148 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.23 179.95 6.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -112.51 -179.41 3.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -172.85 0.17 Allowed Glycine 0 CA--C 1.499 -0.958 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.363 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 5.4 m-70 -57.47 -177.75 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.05 0.453 . . . . 0.0 111.108 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -85.35 46.55 1.3 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.266 -178.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.23 -64.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 t70 42.7 92.74 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 115.39 3.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.54 0.209 . . . . 0.0 111.19 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mt 54.81 173.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.11 43.62 1.75 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.347 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -56.92 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.528 0.204 . . . . 0.0 110.982 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -137.83 -64.11 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -49.43 172.67 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.64 64.09 0.31 Allowed Glycine 0 C--O 1.218 -0.852 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.142 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' HIS . 6.3 mt -60.48 168.31 2.19 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.919 0.866 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 18' ' ' LYS . . . 124.46 66.57 0.19 Allowed Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.094 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -66.52 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 0.0 110.812 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -65.09 135.71 55.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.201 -1.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.228 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.5 -164.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.93 166.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 110.991 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.02 -173.02 0.09 OUTLIER Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.224 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 9.2 m-70 -56.52 -178.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.301 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . 15.9 pttt -92.54 40.19 1.05 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.734 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.04 -52.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.46 95.07 0.05 OUTLIER 'General case' 0 C--O 1.188 -2.181 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.28 152.79 3.17 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 124.342 1.026 . . . . 0.0 111.708 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.96 173.03 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.941 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.42 -24.36 1.86 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.411 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.2 -79.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.152 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -139.87 -65.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.33 172.17 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 122.532 0.333 . . . . 0.0 111.753 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.77 69.78 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.445 ' HA ' ' CG ' ' A' ' 15' ' ' PHE . 9.1 mt -62.35 169.39 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.932 0.396 . . . . 0.0 111.077 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' CA ' ' A' ' 18' ' ' LYS . . . 134.96 64.25 0.07 OUTLIER Glycine 0 C--N 1.296 -1.641 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.921 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -29.25 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.4 175.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.257 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -61.34 172.36 1.14 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 10.8 m-85 -60.01 -179.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.32 -152.81 0.02 OUTLIER Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.718 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -61.59 176.37 0.51 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 110.888 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.02 41.12 1.12 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.09 -66.27 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 120.787 0.327 . . . . 0.0 111.043 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.72 111.23 10.84 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -74.87 76.07 2.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.96 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 22' ' ' ILE . 1.3 mt 54.48 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.34 -85.0 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.406 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -81.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.625 0.25 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.71 -50.76 5.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.081 0.467 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -59.9 172.03 0.83 Allowed 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.62 70.03 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 15' ' ' PHE . 53.0 mt -59.59 178.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.3 42.6 0.18 Allowed Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.724 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.72 -58.64 2.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.85 150.19 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.692 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.4 tptt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.837 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.275 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.62 169.03 13.53 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 122.667 -0.314 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 1.7 m-85 -77.52 -179.74 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.49 -166.4 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.18 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 15.9 m-70 -59.72 178.9 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.866 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 47.19 1.47 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.606 1.192 . . . . 0.0 110.731 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.64 -71.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.013 0.435 . . . . 0.0 110.821 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 12.4 t0 40.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.077 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -59.57 89.96 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mt 57.0 173.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.261 0.351 . . . . 0.0 110.586 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.44 94.7 1.66 Allowed Glycine 0 CA--C 1.489 -1.535 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.354 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.8 p -50.36 -57.89 6.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.286 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -47.52 -55.4 9.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.8 m -48.56 156.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.344 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -168.26 69.43 0.17 Allowed Glycine 0 C--O 1.201 -1.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD2' ' CB ' ' A' ' 15' ' ' PHE . 1.3 mt -78.32 -171.63 2.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.67 0.748 . . . . 0.0 110.972 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 74.49 0.59 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.954 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.54 -56.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 111.048 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -54.85 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.983 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.187 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.2 t 61.37 157.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.3 p90 -54.88 142.91 27.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.948 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.89 -167.21 0.17 Allowed Glycine 0 N--CA 1.419 -2.462 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.667 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 31' ' ' ASN . 60.3 m-70 -60.67 173.03 0.79 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 121.658 0.742 . . . . 0.0 110.104 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.69 38.58 1.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.157 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.83 -27.69 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.36 147.8 16.36 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 170.01 0.95 Allowed 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -44.89 164.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.671 0 O-C-N 124.498 1.124 . . . . 0.0 111.024 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.05 88.49 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.553 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 p -43.97 -59.02 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 111.327 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.17 -58.85 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -60.02 171.97 0.87 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.056 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.02 67.46 0.21 Allowed Glycine 0 C--O 1.198 -2.131 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.659 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.2 mt -83.38 167.82 17.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.12 49.43 0.45 Allowed Glycine 0 C--N 1.291 -1.962 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.532 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.03 -63.98 1.27 Allowed 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.738 -0.272 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 12.6 m-80 -58.98 144.48 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 179.942 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -1.148 0 CA-C-O 120.975 0.208 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' CZ ' ' A' ' 15' ' ' PHE . 27.1 p -56.21 -48.76 75.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.451 -0.441 . . . . 0.0 111.048 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -125.21 -178.8 4.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 110.378 178.37 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.47 168.22 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.134 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.19 177.94 0.76 Allowed 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.641 -0.279 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 49.17 1.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 124.947 1.404 . . . . 0.0 110.872 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.77 -45.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -82.57 123.32 29.11 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.21 77.67 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.861 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -130.04 172.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.54 72.83 0.23 Allowed Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -68.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.62 -66.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.091 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -76.42 172.23 13.29 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.244 -0.285 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.28 64.03 0.31 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.398 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.0 mt -57.21 167.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 47.07 1.04 Allowed Glycine 0 C--N 1.283 -2.416 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.675 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -93.92 -37.54 11.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.275 0.559 . . . . 0.0 111.705 179.197 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.24 127.19 30.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.025 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.007 179.997 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.1 m -60.28 174.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.31 -178.88 1.82 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.015 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.13 -177.76 1.04 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.94 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -61.7 177.06 0.45 Allowed 'General case' 0 C--O 1.211 -0.935 0 O-C-N 122.701 -0.294 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -96.73 38.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.585 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.37 -26.31 3.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.3 144.6 19.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.065 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -58.87 170.88 0.75 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 pt -46.27 166.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.704 0 O-C-N 124.591 1.182 . . . . 0.0 110.729 -178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.11 88.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.41 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 p -42.44 -58.47 2.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.754 0.312 . . . . 0.0 111.721 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -50.71 -58.41 5.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.043 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.9 m -61.25 172.19 1.15 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.076 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.09 68.81 0.17 Allowed Glycine 0 C--O 1.198 -2.105 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.732 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -76.0 168.88 19.23 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 122.663 1.22 . . . . 0.0 110.01 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 83.1 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.332 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.9 t -158.29 -46.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.475 0.637 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -59.99 -179.55 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.523 -0.231 . . . . 1.0 112.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 68.49 -68.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -33.45 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.24 87.15 2.38 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.48 110.13 2.63 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.28 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.54 168.13 22.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.427 2.085 . . . . 0.0 112.279 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.39 163.39 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 178.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 111.369 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.06 109.22 1.76 Allowed Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.545 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.43 170.91 15.1 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.428 2.086 . . . . 0.0 112.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.98 63.34 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.139 . . . . 0.0 112.305 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.24 112.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.35 174.05 21.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.7 p -57.65 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 111.08 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -50.89 164.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.123 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.53 -178.07 0.25 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.634 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -65.03 175.44 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -90.81 49.3 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.02 -32.99 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.9 138.27 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.63 143.58 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mt 54.51 173.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.65 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -67.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -64.51 -67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.8 p -73.16 172.07 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.88 69.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.5 mt -60.78 169.06 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 59.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -31.37 56.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.82 151.0 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -93.11 161.99 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.64 -177.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -86.91 54.01 3.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.93 -175.69 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -50.66 147.76 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -176.7 6.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.462 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 CA-C-O 120.984 0.214 . . . . 1.0 112.761 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.96 -31.59 70.02 Favored 'General case' 0 C--O 1.196 -1.725 0 CA-C-O 121.15 0.5 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -88.76 -31.11 18.56 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.983 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.4 77.01 0.69 Allowed Pre-proline 0 C--O 1.217 -0.644 0 CA-C-O 122.739 1.257 . . . . 0.0 110.643 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.92 110.12 2.71 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.717 2.278 . . . . 0.0 111.988 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.76 149.27 72.9 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.962 1.775 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tptm 59.7 161.53 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.071 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -85.92 172.39 10.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.582 0.551 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.04 108.78 0.93 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.902 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.11 110.83 3.15 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 121.693 1.595 . . . . 0.0 112.473 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.68 62.13 3.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.314 2.009 . . . . 0.0 112.44 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -165.48 -168.29 1.32 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.94 -63.51 5.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.695 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 t 60.65 156.67 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -54.65 157.27 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.21 157.88 17.52 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.046 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' ' ND2' ' A' ' 31' ' ' ASN . 5.1 m-70 -65.9 176.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.64 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp 74.9 96.18 0.07 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.284 1.04 . . . . 0.0 110.951 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.405 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 32.3 mt -50.07 -35.89 11.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.229 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 58.46 160.82 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.335 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -82.28 163.7 21.63 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.071 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 22' ' ' ILE . 1.3 mt 54.58 173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 125.132 1.52 . . . . 0.0 110.934 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.02 45.9 0.25 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.332 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -66.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.177 0.513 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -108.72 -51.87 2.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.272 0.558 . . . . 0.0 111.168 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -59.14 167.0 1.88 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.277 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -157.68 64.34 0.31 Allowed Glycine 0 C--O 1.206 -1.628 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.601 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.1 -178.32 7.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.961 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 100.72 70.62 0.91 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.369 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 t -111.85 -63.33 1.43 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.475 ' ND2' ' CE1' ' A' ' 17' ' ' HIS . 1.5 m-80 -56.57 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt 59.87 73.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.12 135.95 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -105.36 56.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -64.83 109.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 66.1 -73.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.045 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -175.15 -41.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.149 -1.361 . . . . 0.0 112.479 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 112.4 -0.28 . . . . 1.0 112.4 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -153.9 80.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.37 . . . . 0.0 111.055 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.27 -31.61 70.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -106.35 86.92 2.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.39 110.25 2.64 Favored 'Trans proline' 0 C--O 1.202 -1.288 0 C-N-CA 122.835 2.357 . . . . 0.0 112.111 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.91 164.95 32.78 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.349 2.032 . . . . 0.0 112.304 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HG3' ' CE1' ' A' ' 17' ' ' HIS . 3.0 mmmm -60.99 163.18 6.13 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 123.659 0.599 . . . . 0.0 110.922 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -96.79 170.14 9.38 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.65 -89.31 0.28 Allowed Glycine 0 N--CA 1.446 -0.633 0 O-C-N 125.064 1.477 . . . . 0.0 112.668 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.01 151.38 67.6 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 122.021 1.814 . . . . 0.0 112.426 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.6 60.87 4.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.907 2.405 . . . . 0.0 112.364 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -179.62 -178.48 0.47 Allowed 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.691 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.43 76.16 0.24 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.482 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.81 164.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 20.9 m-85 -59.07 -178.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.369 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -171.04 0.95 Allowed Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.654 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.414 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 3.6 m-70 -56.06 -178.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.55 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 48.82 1.69 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.5 mt -89.4 -31.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.994 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HA ' HD23 ' A' ' 28' ' ' LEU . 6.3 t70 54.82 105.31 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.599 0.714 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.86 166.05 21.71 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.927 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -46.58 142.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.413 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 93.76 0.24 Allowed Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.773 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -46.78 -56.72 5.77 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.937 0.433 . . . . 0.0 111.554 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -44.85 -51.97 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.373 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.8 m -44.08 145.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.572 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -140.63 56.21 0.61 Allowed Glycine 0 C--O 1.221 -0.711 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.347 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -47.17 170.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.983 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.72 -32.86 2.96 Favored Glycine 0 C--N 1.311 -0.857 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.512 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.3 t -61.54 -37.41 83.68 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.344 -0.504 . . . . 0.0 111.24 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -58.05 149.29 23.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.183 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -58.97 127.56 32.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.46 -176.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.94 61.76 0.19 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.091 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.27 -61.79 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -50.74 97.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -31.27 21.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.88 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.918 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.608 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 112.674 -0.17 . . . . 1.0 112.674 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.93 159.65 40.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -162.92 93.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -59.13 109.25 1.75 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.09 110.22 2.76 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.586 2.191 . . . . 0.0 112.364 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 157.29 60.09 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.394 2.063 . . . . 0.0 112.184 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 164.17 3.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.86 174.52 5.84 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 124.61 1.194 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.14 -60.78 0.61 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.554 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.5 160.29 49.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.591 2.194 . . . . 0.0 112.401 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.09 122.39 8.98 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 C-N-CA 122.627 2.218 . . . . 0.0 111.532 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 p30 43.41 91.97 0.01 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.641 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.46 -143.41 44.3 Favored Glycine 0 C--O 1.208 -1.503 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.649 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -166.93 176.24 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -59.69 171.96 0.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.55 173.76 2.37 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.95 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -61.3 175.93 0.51 Allowed 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.73 48.68 1.56 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 124.597 1.186 . . . . 0.0 110.653 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.27 -46.47 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 120.927 0.394 . . . . 0.0 111.108 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 144.73 51.97 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 72.79 3.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.024 0.828 . . . . 0.0 111.118 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 22' ' ' ILE . 1.2 mt -131.19 173.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 O-C-N 125.005 1.441 . . . . 0.0 110.732 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.67 -40.69 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.519 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -59.74 -74.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -66.8 -66.53 0.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.416 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -90.14 172.11 9.05 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.243 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -152.07 53.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.507 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 0.2 OUTLIER -52.43 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.124 0.488 . . . . 0.0 111.087 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 66.9 0.85 Allowed Glycine 0 C--N 1.286 -2.234 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.781 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -126.33 -53.38 1.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 110.848 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -58.78 128.02 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -60.04 92.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.11 -175.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.083 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.4 61.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.39 118.6 31.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -51.09 -44.86 61.32 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.395 0.278 . . . . 0.0 111.393 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -31.46 71.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.932 0.396 . . . . 0.0 110.149 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.353 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.395 -0.282 . . . . 1.0 112.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -132.86 93.99 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.92 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -89.75 -36.02 15.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -106.65 86.56 2.31 Favored Pre-proline 0 CA--C 1.516 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.517 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.35 110.14 2.6 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.223 1.949 . . . . 0.0 112.371 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.57 167.92 22.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.401 2.068 . . . . 0.0 112.329 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -60.63 163.18 5.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -76.73 170.1 17.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.096 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.56 -90.68 0.22 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.44 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.96 157.77 58.91 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.434 2.089 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 84.17 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.999 2.466 . . . . 0.0 112.323 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.54 31.21 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.11 162.2 28.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.581 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.83 -170.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 0.0 110.717 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -52.67 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.007 179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.96 169.16 0.33 Allowed Glycine 0 CA--C 1.494 -1.262 0 CA-C-O 122.117 0.843 . . . . 0.0 111.839 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.13 176.91 1.14 Allowed 'General case' 0 C--O 1.208 -1.09 0 O-C-N 122.346 -0.502 . . . . 0.0 110.835 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 48.95 1.58 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.908 1.38 . . . . 0.0 110.731 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.52 -35.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -88.22 123.68 33.08 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.187 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.41 73.01 1.84 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.663 0.602 . . . . 0.0 110.948 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 22' ' ' ILE . 1.1 mt -131.95 172.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.893 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.05 27.78 0.9 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.408 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -69.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.818 0.342 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -124.35 -61.67 1.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -61.34 172.11 1.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.136 0.174 . . . . 0.0 111.413 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.86 64.36 0.3 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.734 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.8 mt -55.25 170.78 0.19 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 111.044 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.27 83.91 0.93 Allowed Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.275 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.09 -53.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.057 0.456 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -59.09 131.63 51.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 132.06 52.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.977 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.13 -176.41 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.76 61.61 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.82 -172.25 2.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.631 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 65.83 -73.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.217 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.35 130.13 35.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.614 0 CA-C-O 117.659 -1.634 . . . . 0.0 112.355 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.52 -0.232 . . . . 1.0 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.62 150.23 38.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.74 -31.36 16.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.33 87.14 2.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 110.06 2.6 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.523 2.149 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 161.73 44.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.684 2.256 . . . . 0.0 112.293 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -62.07 163.33 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 172.34 12.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.763 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.62 -154.88 31.55 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.274 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.66 170.68 17.07 Favored 'Trans proline' 0 C--O 1.205 -1.164 0 C-N-CA 122.74 2.293 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.91 84.25 0.69 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.028 2.485 . . . . 0.0 111.938 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.75 130.41 34.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.756 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.9 -129.17 11.59 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 52.63 177.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 2.6 p90 -48.68 140.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.787 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.99 177.69 0.92 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.518 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.407 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -93.11 131.72 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.215 0.531 . . . . 0.0 110.52 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 17' ' ' HIS . 0.7 OUTLIER 166.92 99.26 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.997 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -34.68 -52.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 56.36 162.78 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.1 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 169.21 18.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.259 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -42.2 161.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.263 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.74 91.36 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.511 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.8 p -43.88 -58.45 2.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.632 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.69 -59.06 4.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.141 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 m -65.99 152.8 43.8 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -159.31 62.6 0.3 Allowed Glycine 0 C--O 1.211 -1.287 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.816 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.35 -174.75 0.41 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.41 72.46 1.16 Allowed Glycine 0 C--N 1.288 -2.087 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.63 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.3 t -71.03 -33.23 70.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.39 151.12 24.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -59.08 124.29 19.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.093 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -116.5 134.54 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -112.27 54.13 0.71 Allowed 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.243 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.89 -65.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.488 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.5 p30 -43.75 -52.23 6.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.732 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.39 -40.6 19.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.602 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.478 -0.249 . . . . 1.0 112.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -103.04 -65.77 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.98 -46.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -107.03 87.98 3.38 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.69 110.56 2.92 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 123.019 2.479 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.08 150.42 66.25 Favored 'Trans proline' 0 C--O 1.202 -1.305 0 C-N-CA 121.956 1.771 . . . . 0.0 112.332 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.6 tptt 61.3 111.52 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.707 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.73 169.42 9.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.04 -95.67 0.2 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.116 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.85 111.32 3.26 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.663 2.242 . . . . 0.0 111.842 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.98 56.35 5.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.494 2.129 . . . . 0.0 112.41 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 179.91 158.74 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.13 -177.03 2.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -70.23 -176.55 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.539 0.209 . . . . 0.0 111.186 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.429 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER -47.39 151.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.973 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.11 -167.49 43.41 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.641 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -59.04 178.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.36 0.6 . . . . 0.0 110.997 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt 74.82 84.18 0.1 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.47 -32.59 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.371 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 59.5 159.96 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.114 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.98 163.17 18.15 Favored 'General case' 0 C--O 1.199 -1.566 0 C-N-CA 123.522 0.729 . . . . 0.0 111.273 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mt 54.67 173.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.009 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.25 46.56 0.66 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.664 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.1 p -58.67 -58.61 7.82 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.725 0.297 . . . . 0.0 110.933 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -123.07 -59.08 1.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 m -59.83 150.76 27.4 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.049 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -141.37 54.32 0.63 Allowed Glycine 0 N--CA 1.424 -2.14 0 O-C-N 124.071 0.857 . . . . 0.0 112.637 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.56 179.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.981 0.419 . . . . 0.0 110.733 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 38.18 2.01 Favored Glycine 0 C--N 1.28 -2.528 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.644 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -102.05 -74.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.71 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -75.51 157.35 34.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.016 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -102.04 152.58 20.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.72 134.83 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.04 61.82 3.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.548 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.41 97.57 0.58 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.041 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -50.72 155.0 1.22 Allowed 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? 59.99 85.69 0.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.82 0.343 . . . . 0.0 110.675 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.381 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.124 0 N-CA-C 112.337 -0.305 . . . . 1.0 112.337 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.2 83.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -99.27 -48.59 4.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -106.71 81.2 0.84 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.257 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 110.01 2.57 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.583 2.189 . . . . 0.0 112.481 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.45 168.08 22.19 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.535 2.157 . . . . 0.0 112.394 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.12 163.29 39.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -80.66 172.22 14.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.242 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.24 -61.49 0.15 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.5 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.86 110.39 2.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.421 2.081 . . . . 0.0 112.437 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.75 62.11 3.02 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.61 2.206 . . . . 0.0 112.247 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 178.53 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.51 112.11 1.05 Allowed Glycine 0 C--N 1.321 -0.255 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.653 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 176.04 0.53 Allowed 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -55.27 166.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.2 157.51 9.78 Favored Glycine 0 CA--C 1.497 -1.062 0 CA-C-O 121.891 0.717 . . . . 0.0 112.018 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -64.64 177.27 0.94 Allowed 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 tptp 75.57 96.82 0.07 Allowed 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.997 0.903 . . . . 0.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 mt -48.41 -31.42 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.32 99.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.765 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -52.32 149.34 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 22' ' ' ILE . 1.4 mt 54.6 173.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.09 93.33 2.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.419 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.334 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.13 -57.85 10.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -59.27 133.15 55.83 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.584 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -135.45 53.04 0.78 Allowed Glycine 0 C--O 1.204 -1.733 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.941 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 2.6 mm? -73.5 -177.38 2.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.899 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.02 72.02 1.29 Allowed Glycine 0 C--N 1.284 -2.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.413 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -129.99 -75.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.639 0.257 . . . . 0.0 110.723 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.36 -179.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 155.04 40.14 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.18 134.8 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.713 0.768 . . . . 0.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.09 61.07 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.67 -65.75 0.98 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -50.93 104.0 0.07 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.906 0.384 . . . . 0.0 111.491 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.06 135.78 52.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.671 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.796 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.427 -0.269 . . . . 1.0 112.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -175.94 -53.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.0 110.834 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.48 93.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.771 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 109.58 2.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.415 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.65 110.35 2.51 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.272 1.982 . . . . 0.0 112.074 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.2 150.04 71.19 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.477 2.118 . . . . 0.0 112.365 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -58.91 165.25 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.631 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 172.67 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.31 109.36 1.89 Allowed Glycine 0 C--N 1.317 -0.481 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.67 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.76 3.08 Favored 'Trans proline' 0 C--N 1.329 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.01 67.98 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.215 1.943 . . . . 0.0 112.286 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -177.48 116.81 0.09 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.687 0.755 . . . . 0.0 110.147 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.56 -112.42 4.02 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.413 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 -174.25 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -55.84 164.16 1.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.725 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.79 161.92 5.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.793 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -61.58 178.49 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.749 0.309 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 77.04 97.33 0.07 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 19' ' ' ILE . 31.3 mt -47.08 -42.36 6.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.711 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 46.71 94.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.436 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -56.3 89.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 22' ' ' ILE . 1.2 mt 54.34 173.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.216 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.78 -82.28 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -82.18 0.65 Allowed 'General case' 0 C--O 1.213 -0.837 0 O-C-N 122.634 -0.333 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -120.22 -52.23 2.18 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 122.407 0.283 . . . . 0.0 110.772 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 172.78 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.585 0.354 . . . . 0.0 111.376 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -151.61 61.63 0.4 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.195 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 mt -52.66 170.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 15' ' ' PHE . . . 130.71 70.9 0.11 Allowed Glycine 0 C--N 1.289 -2.054 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.534 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 -47.26 2.68 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.701 0.286 . . . . 0.0 111.068 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -56.37 -179.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 148.01 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.7 m -119.1 134.4 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.984 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.87 61.67 6.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -151.05 -47.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.01 151.35 1.96 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tttp 60.47 80.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.716 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 112.514 -0.234 . . . . 1.0 112.514 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.37 -78.76 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.55 -54.14 0.67 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.372 1.069 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.79 87.33 2.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.275 0.56 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.61 110.04 2.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.502 2.135 . . . . 0.0 112.403 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.31 168.24 21.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 112.201 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 151.75 25.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.802 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -94.06 172.28 8.32 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.633 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.71 150.4 20.53 Favored Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.064 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 163.8 36.36 Favored 'Trans proline' 0 C--O 1.204 -1.223 0 C-N-CA 122.995 2.463 . . . . 0.0 112.249 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.71 92.18 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.36 2.04 . . . . 0.0 112.412 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 p30 176.41 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.26 -178.73 16.0 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t 60.26 157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.421 ' CE1' ' O ' ' A' ' 27' ' ' GLY . 4.2 p90 -51.67 161.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.145 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.22 -165.16 23.35 Favored Glycine 0 N--CA 1.418 -2.535 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.535 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -58.14 172.82 0.4 Allowed 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.527 0.203 . . . . 0.0 111.024 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 49.34 1.53 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 123.9 0.75 . . . . 0.0 111.017 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.89 -43.88 79.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.43 136.11 37.56 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.97 153.57 22.08 Favored 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 124.13 0.893 . . . . 0.0 111.172 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.78 173.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.435 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.6 92.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -67.67 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.21 -56.56 5.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.1 p -61.53 172.08 1.3 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 15' ' ' PHE . . . -166.2 68.3 0.19 Allowed Glycine 0 C--O 1.217 -0.956 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.45 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.4 mt -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.914 0.387 . . . . 0.0 110.845 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.61 55.48 0.58 Allowed Glycine 0 C--N 1.283 -2.393 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.55 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -109.02 -71.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.693 0.283 . . . . 0.0 110.791 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -66.24 152.38 45.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.81 161.58 32.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 m -118.96 134.6 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.406 . . . . 0.0 111.128 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.89 59.81 1.48 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.809 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.69 -45.99 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -50.68 176.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.76 71.09 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.888 0.475 . . . . 0.0 110.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.204 -1.331 . . . . 0.0 112.519 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 112.539 -0.224 . . . . 1.0 112.539 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.15 -33.78 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.692 0.282 . . . . 0.0 110.743 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -63.24 -49.57 73.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 110.688 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -59.51 109.98 2.38 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.949 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.15 110.71 2.7 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.103 1.869 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 168.33 21.77 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.392 2.061 . . . . 0.0 112.3 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -60.64 162.48 6.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -79.27 170.37 16.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.402 0.62 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.08 90.92 0.73 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.452 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.05 154.42 66.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.725 2.283 . . . . 0.0 112.55 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 83.79 0.7 Allowed 'Trans proline' 0 C--O 1.212 -0.788 0 C-N-CA 122.549 2.166 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -165.6 32.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.6 -87.34 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.11 172.1 7.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 9.8 m-85 -59.85 141.11 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.16 -151.71 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.59 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -56.57 173.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -91.56 49.63 1.61 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.585 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.42 -52.28 38.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -59.93 137.94 57.95 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -79.26 162.75 25.46 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.716 0.635 . . . . 0.0 110.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mt 54.55 174.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 O-C-N 123.969 0.793 . . . . 0.0 110.558 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.02 32.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.553 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -67.38 0.4 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.637 0.256 . . . . 0.0 110.88 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -88.78 -53.28 4.69 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.069 0.462 . . . . 0.0 111.225 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 t -70.08 172.45 7.94 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.514 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -151.15 60.4 0.41 Allowed Glycine 0 C--O 1.2 -1.978 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.623 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -174.94 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.375 0.607 . . . . 0.0 110.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 68.38 0.92 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.767 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.91 -47.21 0.27 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 117.407 0.604 . . . . 0.0 112.425 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.21 -179.08 1.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.097 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -60.46 95.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.597 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -119.25 135.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -79.32 61.98 3.55 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.677 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.73 113.98 20.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -50.57 111.68 0.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.764 0.316 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -60.21 -33.0 71.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.014 -179.743 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.662 -0.175 . . . . 1.0 112.662 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.83 118.26 3.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.0 0.429 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -176.64 -55.5 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.75 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 86.89 2.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.811 0.339 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.34 110.17 2.6 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.538 2.159 . . . . 0.0 112.358 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.61 153.06 70.08 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.804 1.67 . . . . 0.0 113.54 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -150.78 76.69 1.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.935 0.398 . . . . 0.0 111.148 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -101.92 172.36 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.843 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.22 90.81 0.75 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 153.27 67.99 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.73 2.287 . . . . 0.0 112.268 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.01 62.39 2.48 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 122.526 2.15 . . . . 0.0 112.028 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.89 109.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.82 118.27 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.4 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -122.65 -95.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.34 0.114 . . . . 0.0 110.721 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -122.07 144.55 48.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.98 -155.86 0.14 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -56.46 173.13 0.19 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 119.847 -0.12 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 3.4 ptmt -103.76 39.03 1.69 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 125.349 1.656 . . . . 0.0 111.135 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.3 mt -81.24 -46.24 20.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.31 138.03 58.03 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.06 119.73 9.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.318 0.58 . . . . 0.0 111.029 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -102.18 173.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.37 44.51 0.84 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.81 -68.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -125.9 -59.16 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -59.62 167.83 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.425 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.36 61.81 0.38 Allowed Glycine 0 C--O 1.2 -2.025 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.418 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 18.8 mt -61.21 176.34 0.46 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.181 0.991 . . . . 0.0 110.233 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 27.23 3.25 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.572 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 15' ' ' PHE . 0.5 OUTLIER -102.34 -57.92 1.97 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.045 0.45 . . . . 0.0 111.542 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.35 -179.14 2.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -176.16 79.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.14 135.67 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.238 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -106.59 56.58 0.65 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -172.22 2.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.752 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 t30 65.8 -73.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -176.16 -59.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.421 -179.838 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.421 -0.271 . . . . 1.0 112.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -175.85 174.49 2.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 110.714 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.47 -48.24 82.61 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -59.35 109.63 2.07 Favored Pre-proline 0 C--N 1.318 -0.801 0 O-C-N 124.834 1.334 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.14 110.46 2.64 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.257 1.971 . . . . 0.0 112.223 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.61 150.52 69.23 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.589 2.193 . . . . 0.0 112.285 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.72 163.4 17.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 170.37 15.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.41 158.22 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.66 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.38 110.23 2.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 63.49 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.354 2.036 . . . . 0.0 112.147 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 60.26 109.61 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.69 -61.71 1.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t 60.78 156.7 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.4 p90 -55.27 -179.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.021 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.88 156.42 47.17 Favored Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.195 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -74.69 179.13 4.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.792 0.329 . . . . 0.0 111.131 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tttt 77.53 98.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.445 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.0 mt -40.15 -49.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.563 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 58.26 161.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.53 10.97 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -41.3 161.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 125.105 1.503 . . . . 0.0 111.512 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.36 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.117 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 p -40.61 -58.69 1.54 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.811 0.339 . . . . 0.0 111.821 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -50.06 -57.66 7.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.374 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 p -72.58 171.9 11.57 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -157.77 39.56 0.53 Allowed Glycine 0 C--O 1.216 -1.011 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.781 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -64.26 177.35 0.85 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.61 51.46 0.91 Allowed Glycine 0 C--N 1.283 -2.378 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.729 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -30.85 11.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -60.93 154.24 22.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -176.78 79.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.74 -179.03 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.186 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.16 61.63 0.3 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.39 118.86 31.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.39 101.54 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.745 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt 60.59 95.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.653 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.478 -0.249 . . . . 1.0 112.478 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 68.49 -68.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.91 -33.39 59.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -106.08 86.96 2.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.49 110.19 2.64 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.517 2.144 . . . . 0.0 112.243 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 167.91 22.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.429 2.086 . . . . 0.0 112.409 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -61.04 163.74 5.7 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.093 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 178.7 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.187 0.518 . . . . 0.0 111.52 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 109.08 1.7 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.538 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.28 171.51 13.81 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.318 2.012 . . . . 0.0 112.487 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.64 63.17 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.161 2.574 . . . . 0.0 112.293 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.25 112.97 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.781 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.15 172.09 19.15 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.461 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.6 p -57.88 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -51.07 164.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.45 -178.0 0.23 Allowed Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -65.4 176.54 1.37 Allowed 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 119.859 -0.115 . . . . 0.0 110.782 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -92.08 48.96 1.47 Allowed 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 124.179 0.924 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.14 -32.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 138.62 35.2 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.69 143.48 27.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.929 0.768 . . . . 0.0 111.177 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.92 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.544 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.17 91.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.407 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -67.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -64.46 -66.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.8 p -75.27 171.95 13.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -170.05 69.78 0.14 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.354 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -60.31 169.48 1.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 59.09 0.13 Allowed Glycine 0 C--N 1.295 -1.738 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.849 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -31.51 54.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -97.04 151.08 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.001 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -93.82 161.99 14.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -108.77 -177.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -86.83 53.93 3.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.8 -175.85 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -50.68 146.67 5.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.236 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 -175.0 5.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.629 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.659 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -61.07 108.45 0.89 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.184 0.516 . . . . 0.0 110.847 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.83 71.58 0.82 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.35 109.57 2.03 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 122.308 0.243 . . . . 0.0 110.62 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.02 110.08 2.52 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.557 2.171 . . . . 0.0 112.355 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.39 168.02 22.27 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.269 1.979 . . . . 0.0 112.356 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.54 130.71 34.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 172.14 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.1 62.97 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.415 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.0 154.27 66.94 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.834 2.356 . . . . 0.0 111.963 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.97 63.59 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.145 1.897 . . . . 0.0 112.032 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 60.1 31.3 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 127.94 2.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.46 -95.44 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.858 -0.201 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.45 152.76 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.0 110.695 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.36 179.22 1.31 Allowed Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.549 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -59.32 175.53 0.31 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.354 0.121 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 39.58 1.08 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.489 1.118 . . . . 0.0 110.962 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.1 -20.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.221 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.19 109.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -68.34 152.59 45.22 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.5 174.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 O-C-N 124.289 0.993 . . . . 0.0 110.401 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.62 94.75 0.54 Allowed Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.552 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 p -46.01 -59.9 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.616 0.208 . . . . 0.0 110.957 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.09 -73.6 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.942 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 t 55.6 171.61 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.184 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -160.54 29.38 0.34 Allowed Glycine 0 C--O 1.21 -1.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.198 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.9 mt -73.39 172.46 11.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.775 0.798 . . . . 0.0 110.631 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.28 27.42 4.49 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.876 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -31.35 59.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.566 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -81.79 -179.14 7.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -60.72 118.13 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.81 134.73 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.98 62.49 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.99 173.98 8.8 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 122.724 0.409 . . . . 0.0 111.928 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.2 t30 66.1 -73.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.629 0.581 . . . . 0.0 110.831 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -80.54 121.76 26.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.741 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.491 -0.244 . . . . 1.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.64 88.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.94 -31.89 66.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -106.05 86.81 2.13 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.884 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.51 110.17 2.64 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.748 2.299 . . . . 0.0 112.311 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.49 168.23 21.81 Favored 'Trans proline' 0 C--O 1.208 -1.007 0 C-N-CA 122.553 2.169 . . . . 0.0 112.106 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -61.0 91.33 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 124.043 0.84 . . . . 0.0 110.011 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -75.42 172.11 13.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 52.34 7.46 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.596 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.9 158.65 56.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 112.288 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.22 63.81 2.06 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 122.199 1.933 . . . . 0.0 112.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 60.26 84.33 0.12 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.67 -165.0 36.64 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.602 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.41 -170.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CZ ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -53.17 -178.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 163.95 0.62 Allowed Glycine 0 CA--C 1.496 -1.101 0 CA-C-O 122.162 0.868 . . . . 0.0 111.871 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -62.28 177.15 0.52 Allowed 'General case' 0 C--O 1.208 -1.106 0 O-C-N 122.418 -0.46 . . . . 0.0 111.143 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -91.04 48.63 1.54 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.564 1.165 . . . . 0.0 110.521 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.68 -37.7 9.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.8 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.64 144.65 41.59 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -93.04 162.72 13.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 123.564 0.54 . . . . 0.0 111.055 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt 54.68 173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.61 65.82 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.62 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -66.96 0.45 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.634 0.73 . . . . 0.0 110.842 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -104.41 -56.85 2.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 m -76.44 172.81 12.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -148.19 59.32 0.46 Allowed Glycine 0 C--O 1.224 -0.497 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.308 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -56.07 170.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.864 0.364 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.03 80.6 0.69 Allowed Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.77 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -57.11 0.24 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.177 0.988 . . . . 0.0 110.968 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.92 172.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.0 tttm 56.4 79.23 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.39 -179.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.14 61.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.36 -72.13 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.34 158.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.84 143.71 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.445 -1.197 . . . . 0.0 112.247 179.652 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.088 -0.405 . . . . 1.0 112.088 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.07 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.853 0.359 . . . . 0.0 111.043 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -33.02 72.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.629 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.14 86.87 2.19 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.765 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.38 110.17 2.62 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.37 167.97 22.4 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.639 2.226 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -61.21 163.02 6.72 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.008 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -76.25 170.45 16.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 124.258 0.974 . . . . 0.0 110.731 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.19 169.62 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.616 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 110.31 2.68 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.462 2.108 . . . . 0.0 112.336 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.98 152.32 68.14 Favored 'Trans proline' 0 CA--C 1.497 -1.371 0 C-N-CA 122.437 2.091 . . . . 0.0 111.948 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.58 -20.89 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.188 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.21 -129.82 3.69 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.443 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 51.04 179.22 0.02 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.528 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -64.18 179.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.72 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.1 -163.85 0.07 OUTLIER Glycine 0 CA--C 1.492 -1.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.87 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 8.4 m-70 -56.56 -179.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.475 . . . . 0.0 111.013 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.64 48.23 1.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.835 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.41 -56.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 46.31 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.34 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.0 106.3 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.957 0.884 . . . . 0.0 111.824 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mt 54.85 173.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.125 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 42.55 1.95 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.451 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -79.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -126.83 -57.4 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -57.83 172.69 0.37 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.458 0.171 . . . . 0.0 111.397 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -164.95 67.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.328 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.45 ' HA ' ' CG ' ' A' ' 15' ' ' PHE . 0.4 OUTLIER -80.19 170.1 16.89 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 110.617 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.05 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.574 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -58.53 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.831 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.99 154.88 14.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -176.48 110.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -101.16 -173.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.8 62.79 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.78 112.46 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -49.65 175.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.103 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -176.53 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.999 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.495 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.662 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.633 -0.187 . . . . 1.0 112.633 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -156.04 -175.59 5.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 110.934 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -109.77 -31.27 7.5 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 87.49 2.39 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.944 0.402 . . . . 0.0 110.321 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.54 110.03 2.41 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.588 2.192 . . . . 0.0 112.317 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.36 168.42 21.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.202 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -60.1 164.15 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -59.78 173.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.06 108.73 1.04 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.467 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 110.81 3.14 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.294 1.996 . . . . 0.0 111.867 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.31 62.99 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.739 2.293 . . . . 0.0 112.603 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -168.71 -177.38 3.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.52 112.45 4.31 Favored Glycine 0 C--O 1.209 -1.44 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.23 179.95 6.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -112.51 -179.41 3.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -172.85 0.17 Allowed Glycine 0 CA--C 1.499 -0.958 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.363 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 5.4 m-70 -57.47 -177.75 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.05 0.453 . . . . 0.0 111.108 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -85.35 46.55 1.3 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.266 -178.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.23 -64.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 t70 42.7 92.74 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 115.39 3.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.54 0.209 . . . . 0.0 111.19 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mt 54.81 173.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.11 43.62 1.75 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.347 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -56.92 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.528 0.204 . . . . 0.0 110.982 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -137.83 -64.11 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -49.43 172.67 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.64 64.09 0.31 Allowed Glycine 0 C--O 1.218 -0.852 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.142 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' HIS . 6.3 mt -60.48 168.31 2.19 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.919 0.866 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 18' ' ' LYS . . . 124.46 66.57 0.19 Allowed Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.094 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -66.52 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 0.0 110.812 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -65.09 135.71 55.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 161.75 4.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.9 -179.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.269 0.557 . . . . 0.0 111.073 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.85 61.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.182 0.515 . . . . 0.0 111.323 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -145.25 -47.26 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.941 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -49.97 158.45 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.283 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.72 -79.43 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.027 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.328 0 CA-C-O 118.196 -1.336 . . . . 0.0 112.652 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.63 -0.188 . . . . 1.0 112.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.24 -69.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.729 0.3 . . . . 0.0 111.186 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.7 -31.56 71.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.09 87.23 2.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.44 109.94 2.57 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.621 2.214 . . . . 0.0 112.274 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.66 168.24 22.0 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.37 2.046 . . . . 0.0 112.223 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 129.05 37.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.844 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -75.11 172.05 13.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.69 -83.24 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.276 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 168.45 21.92 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.35 77.92 0.9 Allowed 'Trans proline' 0 CA--C 1.498 -1.282 0 C-N-CA 122.586 2.191 . . . . 0.0 111.929 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.47 112.93 0.08 Allowed 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.922 0.391 . . . . 0.0 110.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.72 -88.04 0.21 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.52 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.5 -164.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.93 166.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 110.991 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.02 -173.02 0.09 OUTLIER Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.224 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 9.2 m-70 -56.52 -178.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.301 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . 15.9 pttt -92.54 40.19 1.05 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.734 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.04 -52.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.46 95.07 0.05 OUTLIER 'General case' 0 C--O 1.188 -2.181 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.28 152.79 3.17 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 124.342 1.026 . . . . 0.0 111.708 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.96 173.03 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.941 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.42 -24.36 1.86 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.411 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.2 -79.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.152 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -139.87 -65.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.33 172.17 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 122.532 0.333 . . . . 0.0 111.753 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.77 69.78 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.445 ' HA ' ' CG ' ' A' ' 15' ' ' PHE . 9.1 mt -62.35 169.39 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.932 0.396 . . . . 0.0 111.077 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' CA ' ' A' ' 18' ' ' LYS . . . 134.96 64.25 0.07 OUTLIER Glycine 0 C--N 1.296 -1.641 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.921 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -29.25 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.4 175.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.257 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 161.65 7.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.06 135.0 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.22 59.98 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -32.89 14.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.828 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.76 172.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 132.93 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.301 0 CA-C-O 118.551 -1.138 . . . . 0.0 112.696 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.454 -0.259 . . . . 1.0 112.454 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.1 -69.81 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.076 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -118.04 71.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -59.21 109.89 2.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 110.27 2.54 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.196 1.93 . . . . 0.0 112.279 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.45 152.23 70.91 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.491 2.127 . . . . 0.0 112.345 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -70.99 148.0 48.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.739 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -75.55 172.31 12.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.036 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.71 -87.41 0.45 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.25 154.59 65.65 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.463 2.109 . . . . 0.0 112.334 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.8 84.48 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.196 . . . . 0.0 112.433 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 45.44 -168.74 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.284 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.77 -151.97 36.42 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -61.34 172.36 1.14 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 10.8 m-85 -60.01 -179.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.32 -152.81 0.02 OUTLIER Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.718 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -61.59 176.37 0.51 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 110.888 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.02 41.12 1.12 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.09 -66.27 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 120.787 0.327 . . . . 0.0 111.043 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.72 111.23 10.84 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -74.87 76.07 2.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.96 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 22' ' ' ILE . 1.3 mt 54.48 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.34 -85.0 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.406 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -81.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.625 0.25 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.71 -50.76 5.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.081 0.467 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -59.9 172.03 0.83 Allowed 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.62 70.03 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 15' ' ' PHE . 53.0 mt -59.59 178.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.3 42.6 0.18 Allowed Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.724 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.72 -58.64 2.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.85 150.19 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.692 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -172.73 89.5 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.33 -179.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -70.95 61.65 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.972 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -92.13 -55.66 3.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.646 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 65.66 -73.39 0.07 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER 44.12 31.41 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.35 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.322 -1.265 . . . . 0.0 112.576 179.93 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.454 -0.258 . . . . 1.0 112.454 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.63 163.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.985 0.421 . . . . 0.0 110.758 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -90.33 -45.5 8.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.06 127.19 50.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.015 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.33 110.22 2.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.218 . . . . 0.0 112.456 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.27 168.21 21.56 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.544 2.163 . . . . 0.0 112.291 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.59 142.87 54.98 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.98 0.419 . . . . 0.0 110.162 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -78.5 168.75 19.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.032 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.13 51.84 56.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.505 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.93 162.07 42.99 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.63 2.22 . . . . 0.0 112.312 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.65 124.01 10.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.718 2.279 . . . . 0.0 112.442 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -60.11 88.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.202 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.95 -52.38 0.45 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.243 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.62 169.03 13.53 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 122.667 -0.314 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 1.7 m-85 -77.52 -179.74 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.49 -166.4 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.18 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 15.9 m-70 -59.72 178.9 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.866 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 47.19 1.47 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.606 1.192 . . . . 0.0 110.731 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.64 -71.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.013 0.435 . . . . 0.0 110.821 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 12.4 t0 40.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.077 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -59.57 89.96 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mt 57.0 173.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.261 0.351 . . . . 0.0 110.586 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.44 94.7 1.66 Allowed Glycine 0 CA--C 1.489 -1.535 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.354 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.8 p -50.36 -57.89 6.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.286 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -47.52 -55.4 9.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.8 m -48.56 156.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.344 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -168.26 69.43 0.17 Allowed Glycine 0 C--O 1.201 -1.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD2' ' CB ' ' A' ' 15' ' ' PHE . 1.3 mt -78.32 -171.63 2.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.67 0.748 . . . . 0.0 110.972 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 74.49 0.59 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.954 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.54 -56.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 111.048 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -54.85 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.95 101.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.983 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.7 m -113.25 133.61 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.336 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.74 63.5 0.29 Allowed 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.929 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.72 108.88 2.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -51.2 101.34 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.289 0.566 . . . . 0.0 111.401 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -76.07 82.26 2.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.8 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.263 179.89 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 112.375 -0.29 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -83.64 100.82 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.525 0.202 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -117.89 71.18 0.81 Allowed 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 83.81 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.63 0 O-C-N 124.199 0.937 . . . . 0.0 110.473 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.24 110.13 2.58 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.345 2.03 . . . . 0.0 112.464 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.57 168.07 22.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.277 1.984 . . . . 0.0 112.352 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -80.22 160.91 25.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -85.31 170.18 13.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.023 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.75 90.76 1.61 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.054 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 110.03 2.5 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 122.989 2.459 . . . . 0.0 112.023 179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.44 100.95 0.95 Allowed 'Trans proline' 0 CA--C 1.497 -1.365 0 C-N-CA 122.255 1.97 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.49 31.29 20.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.942 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.97 -64.06 0.28 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.2 t 61.37 157.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.3 p90 -54.88 142.91 27.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.948 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.89 -167.21 0.17 Allowed Glycine 0 N--CA 1.419 -2.462 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.667 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 31' ' ' ASN . 60.3 m-70 -60.67 173.03 0.79 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 121.658 0.742 . . . . 0.0 110.104 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.69 38.58 1.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.157 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.83 -27.69 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -55.36 147.8 16.36 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 170.01 0.95 Allowed 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -44.89 164.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.671 0 O-C-N 124.498 1.124 . . . . 0.0 111.024 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.05 88.49 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.553 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 p -43.97 -59.02 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 111.327 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.17 -58.85 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -60.02 171.97 0.87 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.056 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.02 67.46 0.21 Allowed Glycine 0 C--O 1.198 -2.131 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.659 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.2 mt -83.38 167.82 17.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.12 49.43 0.45 Allowed Glycine 0 C--N 1.291 -1.962 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.532 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.03 -63.98 1.27 Allowed 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.738 -0.272 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 12.6 m-80 -58.98 144.48 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -60.56 142.36 55.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.73 -179.78 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.98 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t0 56.3 75.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -151.64 -46.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.696 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.7 -30.95 15.07 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.234 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -86.19 145.36 27.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.823 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.351 179.943 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.024 0 N-CA-C 112.016 -0.434 . . . . 1.0 112.016 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 t0 60.45 104.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.98 -31.92 19.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.8 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.11 87.08 2.28 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.33 110.11 2.59 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.677 2.251 . . . . 0.0 112.353 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.95 150.61 67.29 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.361 2.041 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -86.32 77.2 9.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.99 172.24 7.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 110.385 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.19 -61.03 7.78 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.555 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.39 158.82 56.04 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.845 2.363 . . . . 0.0 111.981 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.99 92.8 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.528 2.152 . . . . 0.0 112.053 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.59 30.91 20.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.996 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.07 65.81 0.24 Allowed Glycine 0 C--O 1.214 -1.148 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.582 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' CZ ' ' A' ' 15' ' ' PHE . 27.1 p -56.21 -48.76 75.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.451 -0.441 . . . . 0.0 111.048 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -125.21 -178.8 4.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 110.378 178.37 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.47 168.22 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.134 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.19 177.94 0.76 Allowed 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.641 -0.279 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 49.17 1.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 124.947 1.404 . . . . 0.0 110.872 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.77 -45.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -82.57 123.32 29.11 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.21 77.67 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.861 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -130.04 172.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.54 72.83 0.23 Allowed Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.387 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -68.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.62 -66.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.091 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -76.42 172.23 13.29 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.244 -0.285 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.28 64.03 0.31 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.398 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.0 mt -57.21 167.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 47.07 1.04 Allowed Glycine 0 C--N 1.283 -2.416 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.675 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -93.92 -37.54 11.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.275 0.559 . . . . 0.0 111.705 179.197 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.24 127.19 30.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.025 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -58.94 126.91 29.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -118.86 134.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.97 56.45 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.69 -171.94 2.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.466 0.65 . . . . 0.0 110.41 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -51.17 -30.41 16.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.373 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttm 60.5 110.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.016 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 CA-C-O 118.268 -1.295 . . . . 0.0 112.475 -179.767 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 112.573 -0.211 . . . . 1.0 112.573 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -176.42 146.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.477 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.88 31.79 2.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.46 109.82 2.24 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.637 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.82 110.0 2.46 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.36 168.21 21.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -60.3 161.61 7.01 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -75.98 172.1 13.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.031 0.832 . . . . 0.0 110.474 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.42 90.77 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.222 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 159.17 54.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.555 2.17 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.11 63.45 2.0 Allowed 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 122.638 2.225 . . . . 0.0 112.157 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -164.89 31.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.1 -83.11 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.586 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.1 m -60.28 174.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.31 -178.88 1.82 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.015 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.13 -177.76 1.04 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.94 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -61.7 177.06 0.45 Allowed 'General case' 0 C--O 1.211 -0.935 0 O-C-N 122.701 -0.294 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -96.73 38.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.585 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.37 -26.31 3.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.3 144.6 19.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.065 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -58.87 170.88 0.75 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 pt -46.27 166.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.704 0 O-C-N 124.591 1.182 . . . . 0.0 110.729 -178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.11 88.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.41 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 p -42.44 -58.47 2.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.754 0.312 . . . . 0.0 111.721 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -50.71 -58.41 5.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.043 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.9 m -61.25 172.19 1.15 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.076 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.09 68.81 0.17 Allowed Glycine 0 C--O 1.198 -2.105 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.732 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -76.0 168.88 19.23 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 122.663 1.22 . . . . 0.0 110.01 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 83.1 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.332 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.9 t -158.29 -46.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.475 0.637 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -59.99 -179.55 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 98.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.81 134.64 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 111.265 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.08 61.84 3.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.234 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -86.48 111.97 21.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.773 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -50.65 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.37 135.16 57.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.386 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.7 p -57.65 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 111.08 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -50.89 164.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.123 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.53 -178.07 0.25 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.634 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -65.03 175.44 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -90.81 49.3 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.02 -32.99 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.9 138.27 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.63 143.58 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.51 173.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.65 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -67.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -64.51 -67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.8 p -73.16 172.07 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.88 69.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.5 mt -60.78 169.06 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 59.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -31.37 56.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -96.82 151.0 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 t 60.65 156.67 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -54.65 157.27 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.21 157.88 17.52 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.046 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -65.9 176.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp 74.9 96.18 0.07 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.284 1.04 . . . . 0.0 110.951 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 32.3 mt -50.07 -35.89 11.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.229 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 58.46 160.82 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.335 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -82.28 163.7 21.63 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.071 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.58 173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 125.132 1.52 . . . . 0.0 110.934 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -167.02 45.9 0.25 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.332 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -66.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.177 0.513 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -108.72 -51.87 2.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.272 0.558 . . . . 0.0 111.168 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -59.14 167.0 1.88 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.277 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -157.68 64.34 0.31 Allowed Glycine 0 C--O 1.206 -1.628 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.601 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 28' ' ' LEU . 2.4 mm? -83.1 -178.32 7.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.961 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 100.72 70.62 0.91 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.369 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 t -111.85 -63.33 1.43 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -56.57 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.021 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.81 164.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 20.9 m-85 -59.07 -178.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.369 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -171.04 0.95 Allowed Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.654 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.06 -178.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.55 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 48.82 1.69 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.5 mt -89.4 -31.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.994 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 t70 54.82 105.31 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.599 0.714 . . . . 0.0 112.427 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.86 166.05 21.71 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.927 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -46.58 142.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.413 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 93.76 0.24 Allowed Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.773 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -46.78 -56.72 5.77 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.937 0.433 . . . . 0.0 111.554 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -44.85 -51.97 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.373 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.8 m -44.08 145.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.572 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -140.63 56.21 0.61 Allowed Glycine 0 C--O 1.221 -0.711 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.347 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.17 170.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.983 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.72 -32.86 2.96 Favored Glycine 0 C--N 1.311 -0.857 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.512 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.3 t -61.54 -37.41 83.68 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.344 -0.504 . . . . 0.0 111.24 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -58.05 149.29 23.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.183 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? . . . . . 0 N--CA 1.451 -0.38 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.503 0 N-CA-C 112.649 -0.18 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -166.93 176.24 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -59.69 171.96 0.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.55 173.76 2.37 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.95 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 28' ' ' LEU . 5.8 m-70 -61.3 175.93 0.51 Allowed 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HA ' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -90.73 48.68 1.56 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 124.597 1.186 . . . . 0.0 110.653 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.27 -46.47 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 120.927 0.394 . . . . 0.0 111.108 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 144.73 51.97 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 72.79 3.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.024 0.828 . . . . 0.0 111.118 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -131.19 173.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 O-C-N 125.005 1.441 . . . . 0.0 110.732 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.592 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -168.67 -40.69 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.519 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -59.74 -74.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -66.8 -66.53 0.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.416 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -90.14 172.11 9.05 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.243 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -152.07 53.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.507 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -52.43 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.124 0.488 . . . . 0.0 111.087 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 66.9 0.85 Allowed Glycine 0 C--N 1.286 -2.234 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.781 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -126.33 -53.38 1.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 110.848 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -58.78 128.02 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.581 -0.207 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.83 -170.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 0.0 110.717 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -52.67 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.007 179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.96 169.16 0.33 Allowed Glycine 0 CA--C 1.494 -1.262 0 CA-C-O 122.117 0.843 . . . . 0.0 111.839 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.413 ' O ' HD13 ' A' ' 28' ' ' LEU . 31.0 m-70 -65.13 176.91 1.14 Allowed 'General case' 0 C--O 1.208 -1.09 0 O-C-N 122.346 -0.502 . . . . 0.0 110.835 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 48.95 1.58 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.908 1.38 . . . . 0.0 110.731 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.52 -35.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' OD1' HD11 ' A' ' 22' ' ' ILE . 2.1 t0 -88.22 123.68 33.08 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.187 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.41 73.01 1.84 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.663 0.602 . . . . 0.0 110.948 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.1 mt -131.95 172.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.893 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -152.05 27.78 0.9 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.408 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -69.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.818 0.342 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -124.35 -61.67 1.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -61.34 172.11 1.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.136 0.174 . . . . 0.0 111.413 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.86 64.36 0.3 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.734 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.8 mt -55.25 170.78 0.19 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 111.044 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.27 83.91 0.93 Allowed Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.275 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.09 -53.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.057 0.456 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -59.09 131.63 51.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.977 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 52.63 177.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.508 ' HB2' HD23 ' A' ' 28' ' ' LEU . 2.6 p90 -48.68 140.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.787 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.99 177.69 0.92 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.518 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -93.11 131.72 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.215 0.531 . . . . 0.0 110.52 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' CB ' HD13 ' A' ' 28' ' ' LEU . 0.7 OUTLIER 166.92 99.26 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.997 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -34.68 -52.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 56.36 162.78 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.1 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 169.21 18.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.259 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -42.2 161.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.263 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.74 91.36 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.511 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.8 p -43.88 -58.45 2.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.632 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.69 -59.06 4.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.141 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 m -65.99 152.8 43.8 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -159.31 62.6 0.3 Allowed Glycine 0 C--O 1.211 -1.287 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.816 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 15' ' ' PHE . 56.3 mt -67.35 -174.75 0.41 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.41 72.46 1.16 Allowed Glycine 0 C--N 1.288 -2.087 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.63 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.3 t -71.03 -33.23 70.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.39 151.12 24.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 pttt . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.093 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.628 -0.189 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -70.23 -176.55 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.539 0.209 . . . . 0.0 111.186 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -47.39 151.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.973 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.11 -167.49 43.41 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.641 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -59.04 178.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.36 0.6 . . . . 0.0 110.997 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt 74.82 84.18 0.1 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.47 -32.59 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.371 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 28' ' ' LEU . 6.5 t70 59.5 159.96 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.114 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.98 163.17 18.15 Favored 'General case' 0 C--O 1.199 -1.566 0 C-N-CA 123.522 0.729 . . . . 0.0 111.273 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.67 173.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -149.25 46.56 0.66 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.664 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.1 p -58.67 -58.61 7.82 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.725 0.297 . . . . 0.0 110.933 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -123.07 -59.08 1.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 m -59.83 150.76 27.4 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.049 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -141.37 54.32 0.63 Allowed Glycine 0 N--CA 1.424 -2.14 0 O-C-N 124.071 0.857 . . . . 0.0 112.637 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.679 ' H ' HD22 ' A' ' 28' ' ' LEU . 1.1 mm? -60.56 179.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.981 0.419 . . . . 0.0 110.733 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 38.18 2.01 Favored Glycine 0 C--N 1.28 -2.528 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.644 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -74.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -75.51 157.35 34.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.016 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 176.04 0.53 Allowed 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -55.27 166.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -56.2 157.51 9.78 Favored Glycine 0 CA--C 1.497 -1.062 0 CA-C-O 121.891 0.717 . . . . 0.0 112.018 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -64.64 177.27 0.94 Allowed 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 tptp 75.57 96.82 0.07 Allowed 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.997 0.903 . . . . 0.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 20.0 mt -48.41 -31.42 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.302 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.32 99.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.765 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -52.32 149.34 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.6 173.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 109.09 93.33 2.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.419 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.334 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.13 -57.85 10.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -59.27 133.15 55.83 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.584 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -135.45 53.04 0.78 Allowed Glycine 0 C--O 1.204 -1.733 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.941 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 15' ' ' PHE . 2.6 mm? -73.5 -177.38 2.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.899 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 87.02 72.02 1.29 Allowed Glycine 0 C--N 1.284 -2.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.618 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.99 -75.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.639 0.257 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.36 -179.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.208 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 -174.25 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -55.84 164.16 1.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.725 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.79 161.92 5.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.793 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -61.58 178.49 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.749 0.309 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 77.04 97.33 0.07 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.3 mt -47.08 -42.36 6.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.711 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 46.71 94.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.436 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -56.3 89.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt 54.34 173.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.216 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -179.78 -82.28 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -82.18 0.65 Allowed 'General case' 0 C--O 1.213 -0.837 0 O-C-N 122.634 -0.333 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -120.22 -52.23 2.18 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 122.407 0.283 . . . . 0.0 110.772 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 172.78 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.585 0.354 . . . . 0.0 111.376 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -151.61 61.63 0.4 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.195 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 11.4 mt -52.66 170.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 15' ' ' PHE . . . 130.71 70.9 0.11 Allowed Glycine 0 C--N 1.289 -2.054 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.534 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 -47.26 2.68 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.701 0.286 . . . . 0.0 111.068 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -56.37 -179.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t 60.26 157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 4.2 p90 -51.67 161.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.145 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.22 -165.16 23.35 Favored Glycine 0 N--CA 1.418 -2.535 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.535 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 19' ' ' ILE . 32.8 m-70 -58.14 172.82 0.4 Allowed 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.527 0.203 . . . . 0.0 111.024 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 49.34 1.53 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 123.9 0.75 . . . . 0.0 111.017 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 17' ' ' HIS . 20.1 mt -69.89 -43.88 79.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.43 136.11 37.56 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.97 153.57 22.08 Favored 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 124.13 0.893 . . . . 0.0 111.172 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.78 173.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.435 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 149.6 92.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -67.67 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.21 -56.56 5.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.1 p -61.53 172.08 1.3 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 15' ' ' PHE . . . -166.2 68.3 0.19 Allowed Glycine 0 C--O 1.217 -0.956 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.45 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.4 mt -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.914 0.387 . . . . 0.0 110.845 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.61 55.48 0.58 Allowed Glycine 0 C--N 1.283 -2.393 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.55 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -109.02 -71.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.693 0.283 . . . . 0.0 110.791 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -66.24 152.38 45.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.879 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.11 172.1 7.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 9.8 m-85 -59.85 141.11 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.16 -151.71 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.59 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -56.57 173.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 13.3 pttp -91.56 49.63 1.61 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.585 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.42 -52.28 38.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.1 t70 -59.93 137.94 57.95 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -79.26 162.75 25.46 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.716 0.635 . . . . 0.0 110.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.55 174.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 O-C-N 123.969 0.793 . . . . 0.0 110.558 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -147.02 32.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.553 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -67.38 0.4 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.637 0.256 . . . . 0.0 110.88 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -88.78 -53.28 4.69 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.069 0.462 . . . . 0.0 111.225 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 t -70.08 172.45 7.94 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.514 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -151.15 60.4 0.41 Allowed Glycine 0 C--O 1.2 -1.978 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.623 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -60.26 -174.94 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.375 0.607 . . . . 0.0 110.406 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 68.38 0.92 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.767 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.91 -47.21 0.27 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 117.407 0.604 . . . . 0.0 112.425 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -69.21 -179.08 1.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.097 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.597 -179.562 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.208 0 N-CA-C 112.4 -0.28 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -122.65 -95.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.34 0.114 . . . . 0.0 110.721 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -122.07 144.55 48.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.98 -155.86 0.14 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 28' ' ' LEU . 7.4 m-70 -56.46 173.13 0.19 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 119.847 -0.12 . . . . 0.0 111.052 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 3.4 ptmt -103.76 39.03 1.69 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 125.349 1.656 . . . . 0.0 111.135 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 17' ' ' HIS . 10.3 mt -81.24 -46.24 20.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -60.31 138.03 58.03 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.06 119.73 9.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.318 0.58 . . . . 0.0 111.029 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mt -102.18 173.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 112.37 44.51 0.84 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.492 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.81 -68.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -125.9 -59.16 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -59.62 167.83 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.425 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.36 61.81 0.38 Allowed Glycine 0 C--O 1.2 -2.025 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.418 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 17' ' ' HIS . 18.8 mt -61.21 176.34 0.46 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.181 0.991 . . . . 0.0 110.233 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 27.23 3.25 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.572 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 15' ' ' PHE . 0.5 OUTLIER -102.34 -57.92 1.97 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.045 0.45 . . . . 0.0 111.542 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.35 -179.14 2.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t 60.78 156.7 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.4 p90 -55.27 -179.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.021 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.88 156.42 47.17 Favored Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.195 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -74.69 179.13 4.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.792 0.329 . . . . 0.0 111.131 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tttt 77.53 98.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.445 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.407 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 62.0 mt -40.15 -49.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.563 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CB ' HD12 ' A' ' 28' ' ' LEU . 5.4 t70 58.26 161.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 110.786 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.53 10.97 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -41.3 161.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 125.105 1.503 . . . . 0.0 111.512 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.36 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.117 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 p -40.61 -58.69 1.54 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.811 0.339 . . . . 0.0 111.821 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -50.06 -57.66 7.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.374 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 p -72.58 171.9 11.57 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -157.77 39.56 0.53 Allowed Glycine 0 C--O 1.216 -1.011 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.781 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -64.26 177.35 0.85 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 104.61 51.46 0.91 Allowed Glycine 0 C--N 1.283 -2.378 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.729 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -30.85 11.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.93 154.24 22.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 111.081 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.121 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.6 p -57.88 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -51.07 164.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.45 -178.0 0.23 Allowed Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.4 176.54 1.37 Allowed 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 119.859 -0.115 . . . . 0.0 110.782 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -92.08 48.96 1.47 Allowed 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 124.179 0.924 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.14 -32.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 138.62 35.2 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.69 143.48 27.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.929 0.768 . . . . 0.0 111.177 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.92 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.544 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.59 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.17 91.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.407 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -67.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -64.46 -66.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.8 p -75.27 171.95 13.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -170.05 69.78 0.14 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.354 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -60.31 169.48 1.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 59.09 0.13 Allowed Glycine 0 C--N 1.295 -1.738 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.849 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -31.51 54.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.04 151.08 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.001 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.966 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.46 -95.44 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.858 -0.201 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.45 152.76 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.0 110.695 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.36 179.22 1.31 Allowed Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.549 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.502 ' O ' HD13 ' A' ' 28' ' ' LEU . 37.9 m-70 -59.32 175.53 0.31 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.354 0.121 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 39.58 1.08 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.489 1.118 . . . . 0.0 110.962 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.568 HG22 HH12 ' A' ' 21' ' ' ARG . 1.7 mt -106.1 -20.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.221 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.19 109.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.568 HH12 HG22 ' A' ' 19' ' ' ILE . 3.0 mtm-85 -68.34 152.59 45.22 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.479 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.5 174.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 O-C-N 124.289 0.993 . . . . 0.0 110.401 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 133.62 94.75 0.54 Allowed Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.552 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 p -46.01 -59.9 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.616 0.208 . . . . 0.0 110.957 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.09 -73.6 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.942 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 t 55.6 171.61 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.184 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -160.54 29.38 0.34 Allowed Glycine 0 C--O 1.21 -1.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.198 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 17' ' ' HIS . 6.9 mt -73.39 172.46 11.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.775 0.798 . . . . 0.0 110.631 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.28 27.42 4.49 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.876 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -31.35 59.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.566 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -81.79 -179.14 7.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 mttm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 -179.841 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.41 -170.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -53.17 -178.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 163.95 0.62 Allowed Glycine 0 CA--C 1.496 -1.101 0 CA-C-O 122.162 0.868 . . . . 0.0 111.871 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.5 ' O ' HD13 ' A' ' 28' ' ' LEU . 34.2 m-70 -62.28 177.15 0.52 Allowed 'General case' 0 C--O 1.208 -1.106 0 O-C-N 122.418 -0.46 . . . . 0.0 111.143 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -91.04 48.63 1.54 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.564 1.165 . . . . 0.0 110.521 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.68 -37.7 9.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.8 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.64 144.65 41.59 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -93.04 162.72 13.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 123.564 0.54 . . . . 0.0 111.055 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.68 173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -144.61 65.82 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.62 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -66.96 0.45 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.634 0.73 . . . . 0.0 110.842 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -104.41 -56.85 2.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 m -76.44 172.81 12.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -148.19 59.32 0.46 Allowed Glycine 0 C--O 1.224 -0.497 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.308 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 17' ' ' HIS . 8.7 mt -56.07 170.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.864 0.364 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.03 80.6 0.69 Allowed Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.77 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -57.11 0.24 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.177 0.988 . . . . 0.0 110.968 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.92 172.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 -179.834 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.133 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 51.04 179.22 0.02 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.528 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.815 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -64.18 179.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.72 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.1 -163.85 0.07 OUTLIER Glycine 0 CA--C 1.492 -1.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.87 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 8.4 m-70 -56.56 -179.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.475 . . . . 0.0 111.013 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.64 48.23 1.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.835 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.41 -56.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 46.31 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.34 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.0 106.3 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.957 0.884 . . . . 0.0 111.824 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.85 173.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.125 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -99.9 42.55 1.95 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.451 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -79.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -126.83 -57.4 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -57.83 172.69 0.37 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.458 0.171 . . . . 0.0 111.397 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -164.95 67.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.328 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER -80.19 170.1 16.89 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 110.617 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.05 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.574 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -58.53 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.831 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.99 154.88 14.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tptm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.44 0 CA-C-O 120.333 -0.148 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.23 179.95 6.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -112.51 -179.41 3.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -172.85 0.17 Allowed Glycine 0 CA--C 1.499 -0.958 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.363 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 5.4 m-70 -57.47 -177.75 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.05 0.453 . . . . 0.0 111.108 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -85.35 46.55 1.3 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.266 -178.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.23 -64.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 t70 42.7 92.74 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 115.39 3.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.54 0.209 . . . . 0.0 111.19 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.81 173.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -100.11 43.62 1.75 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.347 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -56.92 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.528 0.204 . . . . 0.0 110.982 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -137.83 -64.11 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -49.43 172.67 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.64 64.09 0.31 Allowed Glycine 0 C--O 1.218 -0.852 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.142 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -60.48 168.31 2.19 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.919 0.866 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 18' ' ' LYS . . . 124.46 66.57 0.19 Allowed Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.094 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -66.52 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 0.0 110.812 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -65.09 135.71 55.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.201 -1.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.228 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.5 -164.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.93 166.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 110.991 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.02 -173.02 0.09 OUTLIER Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.224 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 9.2 m-70 -56.52 -178.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.301 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.439 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . 15.9 pttt -92.54 40.19 1.05 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.734 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.04 -52.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.1 t0 -61.46 95.07 0.05 OUTLIER 'General case' 0 C--O 1.188 -2.181 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.687 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.28 152.79 3.17 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 124.342 1.026 . . . . 0.0 111.708 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -92.96 173.03 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 145.42 -24.36 1.86 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.411 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.2 -79.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.152 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -139.87 -65.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.33 172.17 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 122.532 0.333 . . . . 0.0 111.753 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.77 69.78 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 20' ' ' ASP . 9.1 mt -62.35 169.39 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.932 0.396 . . . . 0.0 111.077 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' HA2' ' CA ' ' A' ' 18' ' ' LYS . . . 134.96 64.25 0.07 OUTLIER Glycine 0 C--N 1.296 -1.641 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.921 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -29.25 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.42 HD22 ' HD3' ' A' ' 18' ' ' LYS . 4.5 p-10 -50.4 175.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.257 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -61.34 172.36 1.14 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.541 ' CB ' HD23 ' A' ' 28' ' ' LEU . 10.8 m-85 -60.01 -179.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.32 -152.81 0.02 OUTLIER Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.718 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.772 ' O ' HD13 ' A' ' 28' ' ' LEU . 36.1 m-70 -61.59 176.37 0.51 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 110.888 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.02 41.12 1.12 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.09 -66.27 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 120.787 0.327 . . . . 0.0 111.043 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.72 111.23 10.84 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -74.87 76.07 2.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.96 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.48 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -173.34 -85.0 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.406 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -81.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.625 0.25 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.71 -50.76 5.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.081 0.467 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -59.9 172.03 0.83 Allowed 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.62 70.03 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 17' ' ' HIS . 53.0 mt -59.59 178.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.3 42.6 0.18 Allowed Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.724 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.72 -58.64 2.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.85 150.19 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.692 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.4 tptt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.837 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.275 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.62 169.03 13.53 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 122.667 -0.314 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.681 ' CB ' HD22 ' A' ' 28' ' ' LEU . 1.7 m-85 -77.52 -179.74 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.49 -166.4 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.18 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 15.9 m-70 -59.72 178.9 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.866 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 47.19 1.47 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.606 1.192 . . . . 0.0 110.731 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.64 -71.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.013 0.435 . . . . 0.0 110.821 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 12.4 t0 40.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.077 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -59.57 89.96 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 57.0 173.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.261 0.351 . . . . 0.0 110.586 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 118.44 94.7 1.66 Allowed Glycine 0 CA--C 1.489 -1.535 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.354 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.8 p -50.36 -57.89 6.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.286 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -47.52 -55.4 9.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.8 m -48.56 156.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.344 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -168.26 69.43 0.17 Allowed Glycine 0 C--O 1.201 -1.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 15' ' ' PHE . 1.3 mt -78.32 -171.63 2.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.67 0.748 . . . . 0.0 110.972 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 74.49 0.59 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.954 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.54 -56.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 111.048 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -54.85 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.983 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.187 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.2 t 61.37 157.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.3 p90 -54.88 142.91 27.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.948 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.89 -167.21 0.17 Allowed Glycine 0 N--CA 1.419 -2.462 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.667 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 31' ' ' ASN . 31.9 m170 -60.67 173.03 0.79 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 121.658 0.742 . . . . 0.0 110.104 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.69 38.58 1.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.157 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.83 -27.69 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 28' ' ' LEU . 18.9 t70 -55.36 147.8 16.36 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 170.01 0.95 Allowed 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -44.89 164.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.671 0 O-C-N 124.498 1.124 . . . . 0.0 111.024 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.05 88.49 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.553 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 p -43.97 -59.02 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 111.327 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.17 -58.85 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -60.02 171.97 0.87 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.056 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.02 67.46 0.21 Allowed Glycine 0 C--O 1.198 -2.131 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.659 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 20' ' ' ASP . 6.2 mt -83.38 167.82 17.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.12 49.43 0.45 Allowed Glycine 0 C--N 1.291 -1.962 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.532 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.03 -63.98 1.27 Allowed 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.738 -0.272 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' HB2' ' CD2' ' A' ' 17' ' ' HIS . 8.8 m120 -58.98 144.48 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 179.942 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . . . . . . 0 C--O 1.214 -1.148 0 CA-C-O 120.975 0.208 . . . . 0.0 112.582 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' CZ ' ' A' ' 15' ' ' PHE . 27.1 p -56.21 -48.76 75.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.451 -0.441 . . . . 0.0 111.048 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -125.21 -178.8 4.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 110.378 178.37 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.47 168.22 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.134 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.19 177.94 0.76 Allowed 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.641 -0.279 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 49.17 1.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 124.947 1.404 . . . . 0.0 110.872 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.77 -45.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' HD11 ' A' ' 22' ' ' ILE . 5.0 t0 -82.57 123.32 29.11 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.21 77.67 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.861 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -130.04 172.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -158.54 72.83 0.23 Allowed Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.387 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -68.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.62 -66.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.091 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -76.42 172.23 13.29 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.244 -0.285 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.28 64.03 0.31 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.398 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.0 mt -57.21 167.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 47.07 1.04 Allowed Glycine 0 C--N 1.283 -2.416 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.675 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -93.92 -37.54 11.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.275 0.559 . . . . 0.0 111.705 179.197 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.24 127.19 30.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.025 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.007 179.997 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.1 m -60.28 174.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.31 -178.88 1.82 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.015 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.13 -177.76 1.04 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.94 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -61.7 177.06 0.45 Allowed 'General case' 0 C--O 1.211 -0.935 0 O-C-N 122.701 -0.294 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -96.73 38.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.585 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.37 -26.31 3.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.3 144.6 19.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.065 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -58.87 170.88 0.75 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 pt -46.27 166.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.704 0 O-C-N 124.591 1.182 . . . . 0.0 110.729 -178.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.11 88.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.41 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 p -42.44 -58.47 2.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.754 0.312 . . . . 0.0 111.721 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -50.71 -58.41 5.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.043 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.9 m -61.25 172.19 1.15 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.076 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.09 68.81 0.17 Allowed Glycine 0 C--O 1.198 -2.105 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.732 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -76.0 168.88 19.23 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 122.663 1.22 . . . . 0.0 110.01 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 83.1 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.332 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.9 t -158.29 -46.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.475 0.637 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -59.99 -179.55 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 68.49 -68.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -33.45 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.733 ' NZ ' HD11 ' A' ' 28' ' ' LEU . 0.7 OUTLIER -106.24 87.15 2.38 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.48 110.13 2.63 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.28 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.54 168.13 22.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.427 2.085 . . . . 0.0 112.279 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.39 163.39 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 178.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 111.369 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.06 109.22 1.76 Allowed Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.545 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.43 170.91 15.1 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.428 2.086 . . . . 0.0 112.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.98 63.34 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.139 . . . . 0.0 112.305 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.24 112.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.35 174.05 21.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.7 p -57.65 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 111.08 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -50.89 164.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.123 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.53 -178.07 0.25 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.634 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -65.03 175.44 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.766 ' NZ ' HG11 ' A' ' 33' ' ' VAL . 4.5 pttt -90.81 49.3 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.02 -32.99 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.9 138.27 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.63 143.58 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.51 173.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.65 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -67.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -64.51 -67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.8 p -73.16 172.07 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.88 69.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.733 HD11 ' NZ ' ' A' ' 4' ' ' LYS . 8.5 mt -60.78 169.06 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 59.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -31.37 56.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -96.82 151.0 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -93.11 161.99 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG11 ' NZ ' ' A' ' 18' ' ' LYS . 30.4 m -108.64 -177.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -86.91 54.01 3.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.93 -175.69 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -50.66 147.76 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -176.7 6.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.462 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 CA-C-O 120.984 0.214 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.96 -31.59 70.02 Favored 'General case' 0 C--O 1.196 -1.725 0 CA-C-O 121.15 0.5 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -88.76 -31.11 18.56 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.983 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.4 77.01 0.69 Allowed Pre-proline 0 C--O 1.217 -0.644 0 CA-C-O 122.739 1.257 . . . . 0.0 110.643 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' HB2' HG12 ' A' ' 33' ' ' VAL . 55.9 Cg_endo -70.92 110.12 2.71 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.717 2.278 . . . . 0.0 111.988 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 45.1 Cg_endo -68.76 149.27 72.9 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.962 1.775 . . . . 0.0 111.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tptm 59.7 161.53 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.071 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -85.92 172.39 10.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.582 0.551 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.04 108.78 0.93 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.902 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.11 110.83 3.15 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 121.693 1.595 . . . . 0.0 112.473 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.68 62.13 3.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.314 2.009 . . . . 0.0 112.44 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -165.48 -168.29 1.32 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.94 -63.51 5.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.695 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 t 60.65 156.67 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -54.65 157.27 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.21 157.88 17.52 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.046 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -65.9 176.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.64 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp 74.9 96.18 0.07 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.284 1.04 . . . . 0.0 110.951 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 32.3 mt -50.07 -35.89 11.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.229 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 58.46 160.82 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.335 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -82.28 163.7 21.63 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.071 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.58 173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 125.132 1.52 . . . . 0.0 110.934 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -167.02 45.9 0.25 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.332 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -66.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.177 0.513 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -108.72 -51.87 2.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.272 0.558 . . . . 0.0 111.168 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -59.14 167.0 1.88 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.277 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -157.68 64.34 0.31 Allowed Glycine 0 C--O 1.206 -1.628 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.601 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 28' ' ' LEU . 2.4 mm? -83.1 -178.32 7.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.961 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 100.72 70.62 0.91 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.369 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 t -111.85 -63.33 1.43 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -56.57 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.021 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt 59.87 73.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 5' ' ' PRO . 3.9 m -121.12 135.95 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.18 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -105.36 56.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -64.83 109.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 66.1 -73.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.045 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -175.15 -41.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.149 -1.361 . . . . 0.0 112.479 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 112.4 -0.28 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -153.9 80.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.37 . . . . 0.0 111.055 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.27 -31.61 70.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -106.35 86.92 2.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.39 110.25 2.64 Favored 'Trans proline' 0 C--O 1.202 -1.288 0 C-N-CA 122.835 2.357 . . . . 0.0 112.111 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.91 164.95 32.78 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.349 2.032 . . . . 0.0 112.304 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -60.99 163.18 6.13 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 123.659 0.599 . . . . 0.0 110.922 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -96.79 170.14 9.38 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.65 -89.31 0.28 Allowed Glycine 0 N--CA 1.446 -0.633 0 O-C-N 125.064 1.477 . . . . 0.0 112.668 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.01 151.38 67.6 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 122.021 1.814 . . . . 0.0 112.426 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.6 60.87 4.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.907 2.405 . . . . 0.0 112.364 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -179.62 -178.48 0.47 Allowed 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.691 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.43 76.16 0.24 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.482 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.81 164.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 20.9 m-85 -59.07 -178.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.369 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -171.04 0.95 Allowed Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.654 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.06 -178.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.55 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 48.82 1.69 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.5 mt -89.4 -31.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.994 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 t70 54.82 105.31 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.599 0.714 . . . . 0.0 112.427 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.86 166.05 21.71 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.927 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -46.58 142.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.413 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 93.76 0.24 Allowed Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.773 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -46.78 -56.72 5.77 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.937 0.433 . . . . 0.0 111.554 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -44.85 -51.97 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.373 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.8 m -44.08 145.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.572 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -140.63 56.21 0.61 Allowed Glycine 0 C--O 1.221 -0.711 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.347 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.17 170.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.983 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.72 -32.86 2.96 Favored Glycine 0 C--N 1.311 -0.857 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.512 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.3 t -61.54 -37.41 83.68 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.344 -0.504 . . . . 0.0 111.24 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -58.05 149.29 23.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.183 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -58.97 127.56 32.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.46 -176.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.94 61.76 0.19 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.091 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.27 -61.79 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -50.74 97.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -31.27 21.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.88 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.918 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.608 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.93 159.65 40.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -162.92 93.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -59.13 109.25 1.75 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.09 110.22 2.76 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.586 2.191 . . . . 0.0 112.364 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 157.29 60.09 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.394 2.063 . . . . 0.0 112.184 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 164.17 3.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.86 174.52 5.84 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 124.61 1.194 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.14 -60.78 0.61 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.554 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.5 160.29 49.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.591 2.194 . . . . 0.0 112.401 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.09 122.39 8.98 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 C-N-CA 122.627 2.218 . . . . 0.0 111.532 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 p30 43.41 91.97 0.01 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.641 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.46 -143.41 44.3 Favored Glycine 0 C--O 1.208 -1.503 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.649 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -166.93 176.24 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -59.69 171.96 0.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.55 173.76 2.37 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.95 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 28' ' ' LEU . 5.8 m-70 -61.3 175.93 0.51 Allowed 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HA ' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -90.73 48.68 1.56 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 124.597 1.186 . . . . 0.0 110.653 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.27 -46.47 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 120.927 0.394 . . . . 0.0 111.108 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 144.73 51.97 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 72.79 3.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.024 0.828 . . . . 0.0 111.118 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -131.19 173.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 O-C-N 125.005 1.441 . . . . 0.0 110.732 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.592 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -168.67 -40.69 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.519 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -59.74 -74.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -66.8 -66.53 0.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.416 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -90.14 172.11 9.05 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.243 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -152.07 53.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.507 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -52.43 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.124 0.488 . . . . 0.0 111.087 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 66.9 0.85 Allowed Glycine 0 C--N 1.286 -2.234 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.781 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -126.33 -53.38 1.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 110.848 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -58.78 128.02 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -60.04 92.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.11 -175.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.083 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.4 61.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.39 118.6 31.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -51.09 -44.86 61.32 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.395 0.278 . . . . 0.0 111.393 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -31.46 71.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.932 0.396 . . . . 0.0 110.149 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.353 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -132.86 93.99 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.92 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -89.75 -36.02 15.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -106.65 86.56 2.31 Favored Pre-proline 0 CA--C 1.516 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.517 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.35 110.14 2.6 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.223 1.949 . . . . 0.0 112.371 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.57 167.92 22.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.401 2.068 . . . . 0.0 112.329 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -60.63 163.18 5.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -76.73 170.1 17.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.096 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.56 -90.68 0.22 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.44 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.96 157.77 58.91 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.434 2.089 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 84.17 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.999 2.466 . . . . 0.0 112.323 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.54 31.21 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.11 162.2 28.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.581 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.83 -170.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 0.0 110.717 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -52.67 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.007 179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.96 169.16 0.33 Allowed Glycine 0 CA--C 1.494 -1.262 0 CA-C-O 122.117 0.843 . . . . 0.0 111.839 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.413 ' O ' HD13 ' A' ' 28' ' ' LEU . 31.0 m-70 -65.13 176.91 1.14 Allowed 'General case' 0 C--O 1.208 -1.09 0 O-C-N 122.346 -0.502 . . . . 0.0 110.835 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.718 ' HD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -90.9 48.95 1.58 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.908 1.38 . . . . 0.0 110.731 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.52 -35.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' OD1' HD11 ' A' ' 22' ' ' ILE . 2.1 t0 -88.22 123.68 33.08 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.187 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.41 73.01 1.84 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.663 0.602 . . . . 0.0 110.948 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.1 mt -131.95 172.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.893 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -152.05 27.78 0.9 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.408 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -69.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.818 0.342 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -124.35 -61.67 1.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -61.34 172.11 1.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.136 0.174 . . . . 0.0 111.413 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.86 64.36 0.3 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.734 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.8 mt -55.25 170.78 0.19 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 111.044 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.27 83.91 0.93 Allowed Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.275 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.09 -53.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.057 0.456 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -59.09 131.63 51.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 132.06 52.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.977 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.718 HG11 ' HD2' ' A' ' 18' ' ' LYS . 27.8 m -107.13 -176.41 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.76 61.61 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.82 -172.25 2.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.631 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 65.83 -73.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.217 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.35 130.13 35.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.614 0 CA-C-O 117.659 -1.634 . . . . 0.0 112.355 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.62 150.23 38.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.74 -31.36 16.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.33 87.14 2.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 110.06 2.6 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.523 2.149 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 161.73 44.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.684 2.256 . . . . 0.0 112.293 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -62.07 163.33 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 172.34 12.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.763 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.62 -154.88 31.55 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.274 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.66 170.68 17.07 Favored 'Trans proline' 0 C--O 1.205 -1.164 0 C-N-CA 122.74 2.293 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.91 84.25 0.69 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.028 2.485 . . . . 0.0 111.938 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.75 130.41 34.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.756 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.9 -129.17 11.59 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 52.63 177.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.508 ' HB2' HD23 ' A' ' 28' ' ' LEU . 2.6 p90 -48.68 140.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.787 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.99 177.69 0.92 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.518 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.407 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -93.11 131.72 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.215 0.531 . . . . 0.0 110.52 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' CB ' HD13 ' A' ' 28' ' ' LEU . 0.7 OUTLIER 166.92 99.26 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.997 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -34.68 -52.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 56.36 162.78 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.1 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 169.21 18.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.259 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -42.2 161.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.263 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.74 91.36 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.511 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.8 p -43.88 -58.45 2.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.632 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.69 -59.06 4.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.141 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 m -65.99 152.8 43.8 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -159.31 62.6 0.3 Allowed Glycine 0 C--O 1.211 -1.287 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.816 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 15' ' ' PHE . 56.3 mt -67.35 -174.75 0.41 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.41 72.46 1.16 Allowed Glycine 0 C--N 1.288 -2.087 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.63 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.3 t -71.03 -33.23 70.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.39 151.12 24.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -59.08 124.29 19.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.093 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.52 HG11 ' C ' ' A' ' 38' ' ' GLY . 12.3 m -116.5 134.54 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -112.27 54.13 0.71 Allowed 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.243 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.89 -65.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.488 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.5 p30 -43.75 -52.23 6.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.732 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.39 -40.6 19.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.52 ' C ' HG11 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.602 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -103.04 -65.77 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.98 -46.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -107.03 87.98 3.38 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 55.9 Cg_endo -71.69 110.56 2.92 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 123.019 2.479 . . . . 0.0 112.477 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.9 Cg_endo -70.08 150.42 66.25 Favored 'Trans proline' 0 C--O 1.202 -1.305 0 C-N-CA 121.956 1.771 . . . . 0.0 112.332 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' CG ' HD11 ' A' ' 28' ' ' LEU . 7.6 tptt 61.3 111.52 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.707 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.73 169.42 9.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.04 -95.67 0.2 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.116 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.85 111.32 3.26 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.663 2.242 . . . . 0.0 111.842 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.98 56.35 5.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.494 2.129 . . . . 0.0 112.41 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 179.91 158.74 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.13 -177.03 2.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -70.23 -176.55 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.539 0.209 . . . . 0.0 111.186 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -47.39 151.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.973 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.11 -167.49 43.41 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.641 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -59.04 178.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.36 0.6 . . . . 0.0 110.997 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt 74.82 84.18 0.1 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.47 -32.59 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.371 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 28' ' ' LEU . 6.5 t70 59.5 159.96 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.114 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.98 163.17 18.15 Favored 'General case' 0 C--O 1.199 -1.566 0 C-N-CA 123.522 0.729 . . . . 0.0 111.273 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.67 173.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -149.25 46.56 0.66 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.664 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.1 p -58.67 -58.61 7.82 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.725 0.297 . . . . 0.0 110.933 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -123.07 -59.08 1.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 m -59.83 150.76 27.4 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.049 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -141.37 54.32 0.63 Allowed Glycine 0 N--CA 1.424 -2.14 0 O-C-N 124.071 0.857 . . . . 0.0 112.637 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.679 ' H ' HD22 ' A' ' 28' ' ' LEU . 1.1 mm? -60.56 179.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.981 0.419 . . . . 0.0 110.733 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 38.18 2.01 Favored Glycine 0 C--N 1.28 -2.528 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.644 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -74.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -75.51 157.35 34.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.016 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -102.04 152.58 20.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.72 134.83 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.04 61.82 3.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.548 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.41 97.57 0.58 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.041 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -50.72 155.0 1.22 Allowed 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? 59.99 85.69 0.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.82 0.343 . . . . 0.0 110.675 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.381 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.124 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.2 83.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -99.27 -48.59 4.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -106.71 81.2 0.84 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.257 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 110.01 2.57 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.583 2.189 . . . . 0.0 112.481 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.45 168.08 22.19 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.535 2.157 . . . . 0.0 112.394 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.12 163.29 39.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -80.66 172.22 14.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.242 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.24 -61.49 0.15 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.5 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.86 110.39 2.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.421 2.081 . . . . 0.0 112.437 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.75 62.11 3.02 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.61 2.206 . . . . 0.0 112.247 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 178.53 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.51 112.11 1.05 Allowed Glycine 0 C--N 1.321 -0.255 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.653 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 176.04 0.53 Allowed 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -55.27 166.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -56.2 157.51 9.78 Favored Glycine 0 CA--C 1.497 -1.062 0 CA-C-O 121.891 0.717 . . . . 0.0 112.018 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -64.64 177.27 0.94 Allowed 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 tptp 75.57 96.82 0.07 Allowed 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.997 0.903 . . . . 0.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 20.0 mt -48.41 -31.42 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.302 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.32 99.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.765 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -52.32 149.34 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.6 173.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 109.09 93.33 2.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.419 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.334 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.13 -57.85 10.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -59.27 133.15 55.83 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.584 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -135.45 53.04 0.78 Allowed Glycine 0 C--O 1.204 -1.733 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.941 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 15' ' ' PHE . 2.6 mm? -73.5 -177.38 2.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.899 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 87.02 72.02 1.29 Allowed Glycine 0 C--N 1.284 -2.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.618 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.99 -75.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.639 0.257 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.36 -179.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 155.04 40.14 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.18 134.8 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.713 0.768 . . . . 0.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.09 61.07 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.67 -65.75 0.98 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -50.93 104.0 0.07 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.906 0.384 . . . . 0.0 111.491 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.06 135.78 52.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.671 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.796 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -175.94 -53.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.0 110.834 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.48 93.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.771 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 109.58 2.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.415 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 51.3 Cg_endo -69.65 110.35 2.51 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.272 1.982 . . . . 0.0 112.074 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.4 Cg_endo -69.2 150.04 71.19 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.477 2.118 . . . . 0.0 112.365 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -58.91 165.25 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.631 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 172.67 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.31 109.36 1.89 Allowed Glycine 0 C--N 1.317 -0.481 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.67 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.76 3.08 Favored 'Trans proline' 0 C--N 1.329 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.01 67.98 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.215 1.943 . . . . 0.0 112.286 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -177.48 116.81 0.09 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.687 0.755 . . . . 0.0 110.147 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.56 -112.42 4.02 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.413 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 -174.25 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -55.84 164.16 1.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.725 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.79 161.92 5.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.793 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -61.58 178.49 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.749 0.309 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 77.04 97.33 0.07 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.705 HD13 HG12 ' A' ' 33' ' ' VAL . 31.3 mt -47.08 -42.36 6.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.711 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 46.71 94.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.436 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -56.3 89.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt 54.34 173.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.216 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -179.78 -82.28 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -82.18 0.65 Allowed 'General case' 0 C--O 1.213 -0.837 0 O-C-N 122.634 -0.333 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -120.22 -52.23 2.18 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 122.407 0.283 . . . . 0.0 110.772 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 172.78 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.585 0.354 . . . . 0.0 111.376 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -151.61 61.63 0.4 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.195 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 11.4 mt -52.66 170.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 15' ' ' PHE . . . 130.71 70.9 0.11 Allowed Glycine 0 C--N 1.289 -2.054 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.534 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 -47.26 2.68 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.701 0.286 . . . . 0.0 111.068 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -56.37 -179.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 148.01 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.705 HG12 HD13 ' A' ' 19' ' ' ILE . 4.7 m -119.1 134.4 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.87 61.67 6.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -151.05 -47.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.01 151.35 1.96 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tttp 60.47 80.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.716 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.37 -78.76 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.55 -54.14 0.67 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.372 1.069 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.79 87.33 2.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.275 0.56 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.61 110.04 2.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.502 2.135 . . . . 0.0 112.403 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.31 168.24 21.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 112.201 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 151.75 25.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.802 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -94.06 172.28 8.32 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.633 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.71 150.4 20.53 Favored Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.064 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 163.8 36.36 Favored 'Trans proline' 0 C--O 1.204 -1.223 0 C-N-CA 122.995 2.463 . . . . 0.0 112.249 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.71 92.18 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.36 2.04 . . . . 0.0 112.412 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 p30 176.41 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.26 -178.73 16.0 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t 60.26 157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 4.2 p90 -51.67 161.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.145 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.22 -165.16 23.35 Favored Glycine 0 N--CA 1.418 -2.535 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.535 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 19' ' ' ILE . 32.8 m-70 -58.14 172.82 0.4 Allowed 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.527 0.203 . . . . 0.0 111.024 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 49.34 1.53 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 123.9 0.75 . . . . 0.0 111.017 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 17' ' ' HIS . 20.1 mt -69.89 -43.88 79.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.43 136.11 37.56 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.97 153.57 22.08 Favored 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 124.13 0.893 . . . . 0.0 111.172 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.78 173.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.435 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 149.6 92.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -67.67 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.21 -56.56 5.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.1 p -61.53 172.08 1.3 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 15' ' ' PHE . . . -166.2 68.3 0.19 Allowed Glycine 0 C--O 1.217 -0.956 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.45 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.4 mt -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.914 0.387 . . . . 0.0 110.845 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.61 55.48 0.58 Allowed Glycine 0 C--N 1.283 -2.393 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.55 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -109.02 -71.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.693 0.283 . . . . 0.0 110.791 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -66.24 152.38 45.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.81 161.58 32.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 m -118.96 134.6 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.406 . . . . 0.0 111.128 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.89 59.81 1.48 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.809 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.69 -45.99 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -50.68 176.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.76 71.09 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.888 0.475 . . . . 0.0 110.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.204 -1.331 . . . . 0.0 112.519 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.15 -33.78 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.692 0.282 . . . . 0.0 110.743 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -63.24 -49.57 73.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 110.688 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -59.51 109.98 2.38 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.949 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.15 110.71 2.7 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.103 1.869 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 168.33 21.77 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.392 2.061 . . . . 0.0 112.3 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HE2' HD12 ' A' ' 19' ' ' ILE . 43.5 tttm -60.64 162.48 6.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -79.27 170.37 16.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.402 0.62 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.08 90.92 0.73 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.452 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.05 154.42 66.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.725 2.283 . . . . 0.0 112.55 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 83.79 0.7 Allowed 'Trans proline' 0 C--O 1.212 -0.788 0 C-N-CA 122.549 2.166 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -165.6 32.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.6 -87.34 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.11 172.1 7.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 9.8 m-85 -59.85 141.11 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.16 -151.71 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.59 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -56.57 173.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HD3' HG11 ' A' ' 33' ' ' VAL . 13.3 pttp -91.56 49.63 1.61 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.585 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.433 HD12 ' HE2' ' A' ' 7' ' ' LYS . 22.4 mt -68.42 -52.28 38.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.1 t70 -59.93 137.94 57.95 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -79.26 162.75 25.46 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.716 0.635 . . . . 0.0 110.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.55 174.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 O-C-N 123.969 0.793 . . . . 0.0 110.558 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -147.02 32.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.553 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -67.38 0.4 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.637 0.256 . . . . 0.0 110.88 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -88.78 -53.28 4.69 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.069 0.462 . . . . 0.0 111.225 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 t -70.08 172.45 7.94 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.514 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -151.15 60.4 0.41 Allowed Glycine 0 C--O 1.2 -1.978 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.623 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -60.26 -174.94 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.375 0.607 . . . . 0.0 110.406 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 68.38 0.92 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.767 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.91 -47.21 0.27 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 117.407 0.604 . . . . 0.0 112.425 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -69.21 -179.08 1.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.097 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -60.46 95.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.597 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG11 ' HD3' ' A' ' 18' ' ' LYS . 4.6 m -119.25 135.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -79.32 61.98 3.55 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.677 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.73 113.98 20.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -50.57 111.68 0.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.764 0.316 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -60.21 -33.0 71.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.014 -179.743 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.83 118.26 3.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.0 0.429 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -176.64 -55.5 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.75 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 86.89 2.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.811 0.339 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.4 Cg_endo -70.34 110.17 2.6 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.538 2.159 . . . . 0.0 112.358 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 56.0 Cg_endo -69.61 153.06 70.08 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.804 1.67 . . . . 0.0 113.54 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -150.78 76.69 1.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.935 0.398 . . . . 0.0 111.148 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -101.92 172.36 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.843 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.22 90.81 0.75 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 153.27 67.99 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.73 2.287 . . . . 0.0 112.268 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.01 62.39 2.48 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 122.526 2.15 . . . . 0.0 112.028 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.89 109.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.82 118.27 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.4 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -122.65 -95.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.34 0.114 . . . . 0.0 110.721 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -122.07 144.55 48.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.98 -155.86 0.14 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 28' ' ' LEU . 7.4 m-70 -56.46 173.13 0.19 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 119.847 -0.12 . . . . 0.0 111.052 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 3.4 ptmt -103.76 39.03 1.69 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 125.349 1.656 . . . . 0.0 111.135 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 17' ' ' HIS . 10.3 mt -81.24 -46.24 20.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -60.31 138.03 58.03 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.06 119.73 9.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.318 0.58 . . . . 0.0 111.029 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mt -102.18 173.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 112.37 44.51 0.84 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.492 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.81 -68.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -125.9 -59.16 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -59.62 167.83 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.425 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.36 61.81 0.38 Allowed Glycine 0 C--O 1.2 -2.025 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.418 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 17' ' ' HIS . 18.8 mt -61.21 176.34 0.46 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.181 0.991 . . . . 0.0 110.233 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 27.23 3.25 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.572 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 15' ' ' PHE . 0.5 OUTLIER -102.34 -57.92 1.97 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.045 0.45 . . . . 0.0 111.542 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.35 -179.14 2.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -176.16 79.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.14 135.67 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.238 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -106.59 56.58 0.65 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -172.22 2.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.752 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 t30 65.8 -73.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -176.16 -59.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.421 -179.838 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.421 -0.271 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -175.85 174.49 2.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 110.714 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.47 -48.24 82.61 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -59.35 109.63 2.07 Favored Pre-proline 0 C--N 1.318 -0.801 0 O-C-N 124.834 1.334 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 53.8 Cg_endo -70.14 110.46 2.64 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.257 1.971 . . . . 0.0 112.223 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 55.4 Cg_endo -69.61 150.52 69.23 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.589 2.193 . . . . 0.0 112.285 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.72 163.4 17.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 170.37 15.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.41 158.22 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.66 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.38 110.23 2.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 63.49 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.354 2.036 . . . . 0.0 112.147 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 60.26 109.61 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.69 -61.71 1.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t 60.78 156.7 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.4 p90 -55.27 -179.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.021 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.88 156.42 47.17 Favored Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.195 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -74.69 179.13 4.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.792 0.329 . . . . 0.0 111.131 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tttt 77.53 98.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.445 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.407 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 62.0 mt -40.15 -49.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.563 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CB ' HD12 ' A' ' 28' ' ' LEU . 5.4 t70 58.26 161.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 110.786 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.53 10.97 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -41.3 161.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 125.105 1.503 . . . . 0.0 111.512 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.36 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.117 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 p -40.61 -58.69 1.54 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.811 0.339 . . . . 0.0 111.821 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -50.06 -57.66 7.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.374 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 p -72.58 171.9 11.57 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -157.77 39.56 0.53 Allowed Glycine 0 C--O 1.216 -1.011 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.781 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -64.26 177.35 0.85 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 104.61 51.46 0.91 Allowed Glycine 0 C--N 1.283 -2.378 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.729 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -30.85 11.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.93 154.24 22.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -176.78 79.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.74 -179.03 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.186 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.16 61.63 0.3 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.39 118.86 31.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.39 101.54 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.745 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt 60.59 95.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.653 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 68.49 -68.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.91 -33.39 59.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' NZ ' HD11 ' A' ' 28' ' ' LEU . 1.4 tmtt? -106.08 86.96 2.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.49 110.19 2.64 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.517 2.144 . . . . 0.0 112.243 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 167.91 22.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.429 2.086 . . . . 0.0 112.409 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -61.04 163.74 5.7 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.093 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 178.7 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.187 0.518 . . . . 0.0 111.52 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 109.08 1.7 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.538 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.28 171.51 13.81 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.318 2.012 . . . . 0.0 112.487 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.64 63.17 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.161 2.574 . . . . 0.0 112.293 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.25 112.97 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.781 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.15 172.09 19.15 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.461 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.6 p -57.88 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -51.07 164.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.45 -178.0 0.23 Allowed Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.4 176.54 1.37 Allowed 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 119.859 -0.115 . . . . 0.0 110.782 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.788 ' NZ ' HG11 ' A' ' 33' ' ' VAL . 4.4 pttt -92.08 48.96 1.47 Allowed 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 124.179 0.924 . . . . 0.0 110.479 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.14 -32.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 138.62 35.2 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.69 143.48 27.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.929 0.768 . . . . 0.0 111.177 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.92 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.544 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.59 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.17 91.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.407 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -67.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -64.46 -66.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.8 p -75.27 171.95 13.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -170.05 69.78 0.14 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.354 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -60.31 169.48 1.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 59.09 0.13 Allowed Glycine 0 C--N 1.295 -1.738 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.849 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -31.51 54.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.04 151.08 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.001 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -93.82 161.99 14.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.788 HG11 ' NZ ' ' A' ' 18' ' ' LYS . 30.8 m -108.77 -177.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -86.83 53.93 3.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.8 -175.85 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -50.68 146.67 5.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.236 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 -175.0 5.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.629 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.659 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -61.07 108.45 0.89 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.184 0.516 . . . . 0.0 110.847 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.83 71.58 0.82 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.35 109.57 2.03 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 122.308 0.243 . . . . 0.0 110.62 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 55.8 Cg_endo -70.02 110.08 2.52 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.557 2.171 . . . . 0.0 112.355 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 53.4 Cg_endo -69.39 168.02 22.27 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.269 1.979 . . . . 0.0 112.356 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.54 130.71 34.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 172.14 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.1 62.97 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.415 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.0 154.27 66.94 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.834 2.356 . . . . 0.0 111.963 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.97 63.59 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.145 1.897 . . . . 0.0 112.032 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 60.1 31.3 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 127.94 2.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.46 -95.44 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.858 -0.201 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.45 152.76 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.0 110.695 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.36 179.22 1.31 Allowed Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.549 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.502 ' O ' HD13 ' A' ' 28' ' ' LEU . 37.9 m-70 -59.32 175.53 0.31 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.354 0.121 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.77 ' HG2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.25 39.58 1.08 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.489 1.118 . . . . 0.0 110.962 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.568 HG22 HH12 ' A' ' 21' ' ' ARG . 1.7 mt -106.1 -20.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.221 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.19 109.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.568 HH12 HG22 ' A' ' 19' ' ' ILE . 3.0 mtm-85 -68.34 152.59 45.22 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.479 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.5 174.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 O-C-N 124.289 0.993 . . . . 0.0 110.401 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 133.62 94.75 0.54 Allowed Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.552 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 p -46.01 -59.9 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.616 0.208 . . . . 0.0 110.957 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.09 -73.6 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.942 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 t 55.6 171.61 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.184 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -160.54 29.38 0.34 Allowed Glycine 0 C--O 1.21 -1.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.198 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 17' ' ' HIS . 6.9 mt -73.39 172.46 11.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.775 0.798 . . . . 0.0 110.631 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.28 27.42 4.49 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.876 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -31.35 59.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.566 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -81.79 -179.14 7.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -60.72 118.13 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.77 HG12 ' HG2' ' A' ' 18' ' ' LYS . 4.9 m -118.81 134.73 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.98 62.49 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.99 173.98 8.8 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 122.724 0.409 . . . . 0.0 111.928 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.2 t30 66.1 -73.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.629 0.581 . . . . 0.0 110.831 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -80.54 121.76 26.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.741 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.64 88.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.94 -31.89 66.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -106.05 86.81 2.13 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.884 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.2 Cg_endo -70.51 110.17 2.64 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.748 2.299 . . . . 0.0 112.311 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.9 Cg_endo -69.49 168.23 21.81 Favored 'Trans proline' 0 C--O 1.208 -1.007 0 C-N-CA 122.553 2.169 . . . . 0.0 112.106 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -61.0 91.33 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 124.043 0.84 . . . . 0.0 110.011 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -75.42 172.11 13.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 52.34 7.46 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.596 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.9 158.65 56.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 112.288 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.22 63.81 2.06 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 122.199 1.933 . . . . 0.0 112.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 60.26 84.33 0.12 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.67 -165.0 36.64 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.602 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.41 -170.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -53.17 -178.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 163.95 0.62 Allowed Glycine 0 CA--C 1.496 -1.101 0 CA-C-O 122.162 0.868 . . . . 0.0 111.871 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.5 ' O ' HD13 ' A' ' 28' ' ' LEU . 34.2 m-70 -62.28 177.15 0.52 Allowed 'General case' 0 C--O 1.208 -1.106 0 O-C-N 122.418 -0.46 . . . . 0.0 111.143 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -91.04 48.63 1.54 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.564 1.165 . . . . 0.0 110.521 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.68 -37.7 9.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.8 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.64 144.65 41.59 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -93.04 162.72 13.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 123.564 0.54 . . . . 0.0 111.055 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.68 173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -144.61 65.82 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.62 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -66.96 0.45 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.634 0.73 . . . . 0.0 110.842 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -104.41 -56.85 2.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 m -76.44 172.81 12.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -148.19 59.32 0.46 Allowed Glycine 0 C--O 1.224 -0.497 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.308 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 17' ' ' HIS . 8.7 mt -56.07 170.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.864 0.364 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.03 80.6 0.69 Allowed Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.77 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -57.11 0.24 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.177 0.988 . . . . 0.0 110.968 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.92 172.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.0 tttm 56.4 79.23 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.39 -179.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.14 61.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.36 -72.13 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.34 158.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.84 143.71 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.445 -1.197 . . . . 0.0 112.247 179.652 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.07 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.853 0.359 . . . . 0.0 111.043 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -33.02 72.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.629 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.14 86.87 2.19 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.765 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.38 110.17 2.62 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.37 167.97 22.4 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.639 2.226 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -61.21 163.02 6.72 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.008 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -76.25 170.45 16.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 124.258 0.974 . . . . 0.0 110.731 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.19 169.62 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.616 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 56.1 Cg_endo -70.54 110.31 2.68 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.462 2.108 . . . . 0.0 112.336 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 54.1 Cg_endo -69.98 152.32 68.14 Favored 'Trans proline' 0 CA--C 1.497 -1.371 0 C-N-CA 122.437 2.091 . . . . 0.0 111.948 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.58 -20.89 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.188 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.21 -129.82 3.69 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.443 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 51.04 179.22 0.02 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.528 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.815 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -64.18 179.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.72 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.1 -163.85 0.07 OUTLIER Glycine 0 CA--C 1.492 -1.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.87 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 8.4 m-70 -56.56 -179.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.475 . . . . 0.0 111.013 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.64 48.23 1.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.835 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.41 -56.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 46.31 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.34 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.0 106.3 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.957 0.884 . . . . 0.0 111.824 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.85 173.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.125 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -99.9 42.55 1.95 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.451 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -79.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -126.83 -57.4 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -57.83 172.69 0.37 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.458 0.171 . . . . 0.0 111.397 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -164.95 67.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.328 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER -80.19 170.1 16.89 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 110.617 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.05 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.574 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -58.53 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.831 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.99 154.88 14.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -176.48 110.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -101.16 -173.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.8 62.79 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.78 112.46 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -49.65 175.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.103 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -176.53 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.999 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.495 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.662 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -156.04 -175.59 5.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 110.934 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -109.77 -31.27 7.5 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 87.49 2.39 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.944 0.402 . . . . 0.0 110.321 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 52.7 Cg_endo -69.54 110.03 2.41 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.588 2.192 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.5 Cg_endo -69.36 168.42 21.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -60.1 164.15 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -59.78 173.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.06 108.73 1.04 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.467 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 73.2 Cg_endo -73.25 110.81 3.14 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.294 1.996 . . . . 0.0 111.867 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 57.2 Cg_endo -69.31 62.99 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.739 2.293 . . . . 0.0 112.603 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -168.71 -177.38 3.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.52 112.45 4.31 Favored Glycine 0 C--O 1.209 -1.44 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.23 179.95 6.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -112.51 -179.41 3.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -172.85 0.17 Allowed Glycine 0 CA--C 1.499 -0.958 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.363 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 5.4 m-70 -57.47 -177.75 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.05 0.453 . . . . 0.0 111.108 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -85.35 46.55 1.3 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.266 -178.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.23 -64.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 t70 42.7 92.74 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 115.39 3.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.54 0.209 . . . . 0.0 111.19 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.81 173.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -100.11 43.62 1.75 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.347 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -56.92 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.528 0.204 . . . . 0.0 110.982 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -137.83 -64.11 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -49.43 172.67 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.64 64.09 0.31 Allowed Glycine 0 C--O 1.218 -0.852 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.142 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -60.48 168.31 2.19 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.919 0.866 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 18' ' ' LYS . . . 124.46 66.57 0.19 Allowed Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.094 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -66.52 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 0.0 110.812 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -65.09 135.71 55.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 161.75 4.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.9 -179.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.269 0.557 . . . . 0.0 111.073 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.85 61.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.182 0.515 . . . . 0.0 111.323 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -145.25 -47.26 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.941 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -49.97 158.45 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.283 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.72 -79.43 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.027 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.328 0 CA-C-O 118.196 -1.336 . . . . 0.0 112.652 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.63 -0.188 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.24 -69.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.729 0.3 . . . . 0.0 111.186 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.7 -31.56 71.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.09 87.23 2.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.0 Cg_endo -70.44 109.94 2.57 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.621 2.214 . . . . 0.0 112.274 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.7 Cg_endo -69.66 168.24 22.0 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.37 2.046 . . . . 0.0 112.223 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 129.05 37.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.844 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -75.11 172.05 13.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.69 -83.24 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.276 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 168.45 21.92 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.35 77.92 0.9 Allowed 'Trans proline' 0 CA--C 1.498 -1.282 0 C-N-CA 122.586 2.191 . . . . 0.0 111.929 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.47 112.93 0.08 Allowed 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.922 0.391 . . . . 0.0 110.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.72 -88.04 0.21 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.52 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.5 -164.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.93 166.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 110.991 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.02 -173.02 0.09 OUTLIER Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.224 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 9.2 m-70 -56.52 -178.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.301 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.439 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . 15.9 pttt -92.54 40.19 1.05 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.734 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.04 -52.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.1 t0 -61.46 95.07 0.05 OUTLIER 'General case' 0 C--O 1.188 -2.181 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.687 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.28 152.79 3.17 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 124.342 1.026 . . . . 0.0 111.708 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -92.96 173.03 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 145.42 -24.36 1.86 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.411 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.2 -79.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.152 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -139.87 -65.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.33 172.17 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 122.532 0.333 . . . . 0.0 111.753 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.77 69.78 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 20' ' ' ASP . 9.1 mt -62.35 169.39 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.932 0.396 . . . . 0.0 111.077 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' HA2' ' CA ' ' A' ' 18' ' ' LYS . . . 134.96 64.25 0.07 OUTLIER Glycine 0 C--N 1.296 -1.641 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.921 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -29.25 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.42 HD22 ' HD3' ' A' ' 18' ' ' LYS . 4.5 p-10 -50.4 175.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.257 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 161.65 7.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.06 135.0 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.22 59.98 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -32.89 14.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.828 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.76 172.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 132.93 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.301 0 CA-C-O 118.551 -1.138 . . . . 0.0 112.696 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.1 -69.81 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.076 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -118.04 71.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -59.21 109.89 2.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 110.27 2.54 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.196 1.93 . . . . 0.0 112.279 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.45 152.23 70.91 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.491 2.127 . . . . 0.0 112.345 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -70.99 148.0 48.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.739 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -75.55 172.31 12.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.036 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.71 -87.41 0.45 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.25 154.59 65.65 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.463 2.109 . . . . 0.0 112.334 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.8 84.48 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.196 . . . . 0.0 112.433 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 45.44 -168.74 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.284 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.77 -151.97 36.42 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -61.34 172.36 1.14 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.541 ' CB ' HD23 ' A' ' 28' ' ' LEU . 10.8 m-85 -60.01 -179.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.32 -152.81 0.02 OUTLIER Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.718 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.772 ' O ' HD13 ' A' ' 28' ' ' LEU . 36.1 m-70 -61.59 176.37 0.51 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 110.888 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.02 41.12 1.12 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.09 -66.27 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 120.787 0.327 . . . . 0.0 111.043 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.72 111.23 10.84 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -74.87 76.07 2.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.96 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.48 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -173.34 -85.0 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.406 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -81.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.625 0.25 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.71 -50.76 5.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.081 0.467 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -59.9 172.03 0.83 Allowed 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.62 70.03 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 17' ' ' HIS . 53.0 mt -59.59 178.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.3 42.6 0.18 Allowed Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.724 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.72 -58.64 2.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.85 150.19 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.692 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -172.73 89.5 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.33 -179.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -70.95 61.65 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.972 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -92.13 -55.66 3.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.646 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 65.66 -73.39 0.07 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER 44.12 31.41 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.35 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.322 -1.265 . . . . 0.0 112.576 179.93 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.63 163.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.985 0.421 . . . . 0.0 110.758 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -90.33 -45.5 8.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.06 127.19 50.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.015 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.33 110.22 2.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.218 . . . . 0.0 112.456 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.27 168.21 21.56 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.544 2.163 . . . . 0.0 112.291 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.59 142.87 54.98 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.98 0.419 . . . . 0.0 110.162 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -78.5 168.75 19.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.032 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.13 51.84 56.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.505 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.93 162.07 42.99 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.63 2.22 . . . . 0.0 112.312 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.65 124.01 10.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.718 2.279 . . . . 0.0 112.442 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -60.11 88.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.202 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.95 -52.38 0.45 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.243 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.62 169.03 13.53 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 122.667 -0.314 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.681 ' CB ' HD22 ' A' ' 28' ' ' LEU . 1.7 m-85 -77.52 -179.74 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.49 -166.4 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.18 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 15.9 m-70 -59.72 178.9 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.866 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -87.79 47.19 1.47 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.606 1.192 . . . . 0.0 110.731 -178.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.64 -71.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.013 0.435 . . . . 0.0 110.821 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 12.4 t0 40.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.077 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -59.57 89.96 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 57.0 173.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.261 0.351 . . . . 0.0 110.586 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 118.44 94.7 1.66 Allowed Glycine 0 CA--C 1.489 -1.535 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.354 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.8 p -50.36 -57.89 6.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.286 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -47.52 -55.4 9.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.8 m -48.56 156.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.344 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -168.26 69.43 0.17 Allowed Glycine 0 C--O 1.201 -1.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 15' ' ' PHE . 1.3 mt -78.32 -171.63 2.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.67 0.748 . . . . 0.0 110.972 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 74.49 0.59 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.954 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.54 -56.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 111.048 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -54.85 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.95 101.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.983 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 18' ' ' LYS . 26.7 m -113.25 133.61 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.336 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.74 63.5 0.29 Allowed 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.929 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.72 108.88 2.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -51.2 101.34 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.289 0.566 . . . . 0.0 111.401 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -76.07 82.26 2.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.8 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.263 179.89 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -83.64 100.82 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.525 0.202 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -117.89 71.18 0.81 Allowed 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 83.81 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.63 0 O-C-N 124.199 0.937 . . . . 0.0 110.473 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.24 110.13 2.58 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.345 2.03 . . . . 0.0 112.464 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.57 168.07 22.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.277 1.984 . . . . 0.0 112.352 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -80.22 160.91 25.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -85.31 170.18 13.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.023 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.75 90.76 1.61 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.054 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 58.6 Cg_endo -69.96 110.03 2.5 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 122.989 2.459 . . . . 0.0 112.023 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 53.7 Cg_endo -70.44 100.95 0.95 Allowed 'Trans proline' 0 CA--C 1.497 -1.365 0 C-N-CA 122.255 1.97 . . . . 0.0 112.584 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.49 31.29 20.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.942 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.97 -64.06 0.28 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.2 t 61.37 157.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.3 p90 -54.88 142.91 27.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.948 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.89 -167.21 0.17 Allowed Glycine 0 N--CA 1.419 -2.462 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.667 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 31' ' ' ASN . 31.9 m170 -60.67 173.03 0.79 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 121.658 0.742 . . . . 0.0 110.104 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HE3' HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -95.69 38.58 1.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.157 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.83 -27.69 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 28' ' ' LEU . 18.9 t70 -55.36 147.8 16.36 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 170.01 0.95 Allowed 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -44.89 164.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.671 0 O-C-N 124.498 1.124 . . . . 0.0 111.024 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.05 88.49 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.553 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 p -43.97 -59.02 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 111.327 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.17 -58.85 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -60.02 171.97 0.87 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.056 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.02 67.46 0.21 Allowed Glycine 0 C--O 1.198 -2.131 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.659 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 20' ' ' ASP . 6.2 mt -83.38 167.82 17.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.12 49.43 0.45 Allowed Glycine 0 C--N 1.291 -1.962 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.532 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.03 -63.98 1.27 Allowed 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.738 -0.272 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' HB2' ' CD2' ' A' ' 17' ' ' HIS . 8.8 m120 -58.98 144.48 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -60.56 142.36 55.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.657 HG11 ' HE3' ' A' ' 18' ' ' LYS . 4.5 m -120.73 -179.78 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.98 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t0 56.3 75.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -151.64 -46.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.696 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.7 -30.95 15.07 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.234 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -86.19 145.36 27.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.823 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.351 179.943 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.024 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 t0 60.45 104.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.98 -31.92 19.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.8 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.11 87.08 2.28 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.8 Cg_endo -70.33 110.11 2.59 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.677 2.251 . . . . 0.0 112.353 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 54.3 Cg_endo -69.95 150.61 67.29 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.361 2.041 . . . . 0.0 112.267 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -86.32 77.2 9.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.99 172.24 7.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 110.385 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.19 -61.03 7.78 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.555 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.39 158.82 56.04 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.845 2.363 . . . . 0.0 111.981 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.99 92.8 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.528 2.152 . . . . 0.0 112.053 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.59 30.91 20.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.996 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . -109.07 65.81 0.24 Allowed Glycine 0 C--O 1.214 -1.148 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.582 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' CZ ' ' A' ' 15' ' ' PHE . 27.1 p -56.21 -48.76 75.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.451 -0.441 . . . . 0.0 111.048 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -125.21 -178.8 4.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 110.378 178.37 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.47 168.22 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.134 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.19 177.94 0.76 Allowed 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.641 -0.279 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HD3' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -90.8 49.17 1.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 124.947 1.404 . . . . 0.0 110.872 -179.797 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.77 -45.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' HD11 ' A' ' 22' ' ' ILE . 5.0 t0 -82.57 123.32 29.11 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.21 77.67 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.861 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -130.04 172.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -158.54 72.83 0.23 Allowed Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.387 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -68.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.62 -66.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.091 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -76.42 172.23 13.29 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.244 -0.285 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.28 64.03 0.31 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.398 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.0 mt -57.21 167.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 47.07 1.04 Allowed Glycine 0 C--N 1.283 -2.416 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.675 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -93.92 -37.54 11.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.275 0.559 . . . . 0.0 111.705 179.197 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.24 127.19 30.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.025 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -58.94 126.91 29.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG11 ' HD3' ' A' ' 18' ' ' LYS . 4.8 m -118.86 134.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.97 56.45 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -93.69 -171.94 2.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.466 0.65 . . . . 0.0 110.41 179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -51.17 -30.41 16.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.373 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttm 60.5 110.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.016 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 CA-C-O 118.268 -1.295 . . . . 0.0 112.475 -179.767 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -176.42 146.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.477 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.88 31.79 2.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.46 109.82 2.24 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.637 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.82 110.0 2.46 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.36 168.21 21.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -60.3 161.61 7.01 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -75.98 172.1 13.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.031 0.832 . . . . 0.0 110.474 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.42 90.77 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.222 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 159.17 54.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.555 2.17 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.11 63.45 2.0 Allowed 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 122.638 2.225 . . . . 0.0 112.157 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -164.89 31.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.1 -83.11 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.586 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.1 m -60.28 174.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.31 -178.88 1.82 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.015 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.13 -177.76 1.04 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.94 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -61.7 177.06 0.45 Allowed 'General case' 0 C--O 1.211 -0.935 0 O-C-N 122.701 -0.294 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HD3' HG11 ' A' ' 33' ' ' VAL . 14.7 pttm -96.73 38.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.37 -26.31 3.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.3 144.6 19.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.065 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -58.87 170.88 0.75 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 pt -46.27 166.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.704 0 O-C-N 124.591 1.182 . . . . 0.0 110.729 -178.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.11 88.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.41 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 p -42.44 -58.47 2.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.754 0.312 . . . . 0.0 111.721 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -50.71 -58.41 5.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.043 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.9 m -61.25 172.19 1.15 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.076 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.09 68.81 0.17 Allowed Glycine 0 C--O 1.198 -2.105 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.732 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -76.0 168.88 19.23 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 122.663 1.22 . . . . 0.0 110.01 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 83.1 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.332 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.9 t -158.29 -46.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.475 0.637 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -59.99 -179.55 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 98.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG11 ' HD3' ' A' ' 18' ' ' LYS . 5.2 m -118.81 134.64 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 111.265 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.08 61.84 3.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.234 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -86.48 111.97 21.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.773 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -50.65 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.37 135.16 57.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.386 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.7 p -57.65 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 111.08 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -50.89 164.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.123 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.53 -178.07 0.25 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.634 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -65.03 175.44 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -90.81 49.3 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.02 -32.99 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.9 138.27 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.63 143.58 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.51 173.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.65 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -67.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -64.51 -67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.8 p -73.16 172.07 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.88 69.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.5 mt -60.78 169.06 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 59.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -31.37 56.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.82 151.0 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 t 60.65 156.67 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -54.65 157.27 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.21 157.88 17.52 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.046 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' ' ND2' ' A' ' 31' ' ' ASN . 5.1 m-70 -65.9 176.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.64 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp 74.9 96.18 0.07 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.284 1.04 . . . . 0.0 110.951 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 32.3 mt -50.07 -35.89 11.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.229 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 58.46 160.82 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.335 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -82.28 163.7 21.63 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.071 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.58 173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 125.132 1.52 . . . . 0.0 110.934 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -167.02 45.9 0.25 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.332 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -66.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.177 0.513 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -108.72 -51.87 2.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.272 0.558 . . . . 0.0 111.168 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -59.14 167.0 1.88 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.277 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -157.68 64.34 0.31 Allowed Glycine 0 C--O 1.206 -1.628 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.601 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 28' ' ' LEU . 2.4 mm? -83.1 -178.32 7.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.961 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 100.72 70.62 0.91 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.369 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 t -111.85 -63.33 1.43 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.475 ' ND2' ' CE1' ' A' ' 17' ' ' HIS . 1.5 m-80 -56.57 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.81 164.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 20.9 m-85 -59.07 -178.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.369 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -171.04 0.95 Allowed Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.654 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.06 -178.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.55 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 48.82 1.69 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.5 mt -89.4 -31.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.994 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 t70 54.82 105.31 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.599 0.714 . . . . 0.0 112.427 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.86 166.05 21.71 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.927 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -46.58 142.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.413 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 93.76 0.24 Allowed Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.773 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -46.78 -56.72 5.77 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.937 0.433 . . . . 0.0 111.554 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -44.85 -51.97 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.373 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.8 m -44.08 145.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.572 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -140.63 56.21 0.61 Allowed Glycine 0 C--O 1.221 -0.711 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.347 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.17 170.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.983 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.72 -32.86 2.96 Favored Glycine 0 C--N 1.311 -0.857 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.512 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.3 t -61.54 -37.41 83.68 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.344 -0.504 . . . . 0.0 111.24 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -58.05 149.29 23.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.183 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? . . . . . 0 N--CA 1.451 -0.38 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.503 0 N-CA-C 112.649 -0.18 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -166.93 176.24 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -59.69 171.96 0.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.55 173.76 2.37 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.95 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 28' ' ' LEU . 5.8 m-70 -61.3 175.93 0.51 Allowed 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HA ' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -90.73 48.68 1.56 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 124.597 1.186 . . . . 0.0 110.653 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.27 -46.47 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 120.927 0.394 . . . . 0.0 111.108 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 144.73 51.97 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 72.79 3.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.024 0.828 . . . . 0.0 111.118 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -131.19 173.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 O-C-N 125.005 1.441 . . . . 0.0 110.732 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.592 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -168.67 -40.69 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.519 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -59.74 -74.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -66.8 -66.53 0.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.416 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -90.14 172.11 9.05 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.243 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -152.07 53.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.507 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -52.43 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.124 0.488 . . . . 0.0 111.087 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 66.9 0.85 Allowed Glycine 0 C--N 1.286 -2.234 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.781 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -126.33 -53.38 1.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 110.848 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -58.78 128.02 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.581 -0.207 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.83 -170.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 0.0 110.717 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -52.67 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.007 179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.96 169.16 0.33 Allowed Glycine 0 CA--C 1.494 -1.262 0 CA-C-O 122.117 0.843 . . . . 0.0 111.839 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.413 ' O ' HD13 ' A' ' 28' ' ' LEU . 31.0 m-70 -65.13 176.91 1.14 Allowed 'General case' 0 C--O 1.208 -1.09 0 O-C-N 122.346 -0.502 . . . . 0.0 110.835 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 48.95 1.58 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.908 1.38 . . . . 0.0 110.731 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.52 -35.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' OD1' HD11 ' A' ' 22' ' ' ILE . 2.1 t0 -88.22 123.68 33.08 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.187 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.41 73.01 1.84 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.663 0.602 . . . . 0.0 110.948 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.1 mt -131.95 172.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.893 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -152.05 27.78 0.9 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.408 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -69.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.818 0.342 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -124.35 -61.67 1.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -61.34 172.11 1.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.136 0.174 . . . . 0.0 111.413 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.86 64.36 0.3 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.734 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.8 mt -55.25 170.78 0.19 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 111.044 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.27 83.91 0.93 Allowed Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.275 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.09 -53.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.057 0.456 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -59.09 131.63 51.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.977 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 52.63 177.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.508 ' HB2' HD23 ' A' ' 28' ' ' LEU . 2.6 p90 -48.68 140.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.787 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.99 177.69 0.92 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.518 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -93.11 131.72 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.215 0.531 . . . . 0.0 110.52 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' CB ' HD13 ' A' ' 28' ' ' LEU . 0.7 OUTLIER 166.92 99.26 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.997 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -34.68 -52.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 56.36 162.78 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.1 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 169.21 18.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.259 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -42.2 161.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.263 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.74 91.36 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.511 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.8 p -43.88 -58.45 2.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.632 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.69 -59.06 4.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.141 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 m -65.99 152.8 43.8 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -159.31 62.6 0.3 Allowed Glycine 0 C--O 1.211 -1.287 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.816 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 15' ' ' PHE . 56.3 mt -67.35 -174.75 0.41 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.41 72.46 1.16 Allowed Glycine 0 C--N 1.288 -2.087 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.63 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.3 t -71.03 -33.23 70.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.39 151.12 24.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 pttt . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.093 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.628 -0.189 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -70.23 -176.55 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.539 0.209 . . . . 0.0 111.186 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -47.39 151.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.973 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.11 -167.49 43.41 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.641 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -59.04 178.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.36 0.6 . . . . 0.0 110.997 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt 74.82 84.18 0.1 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.47 -32.59 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.371 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 28' ' ' LEU . 6.5 t70 59.5 159.96 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.114 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.98 163.17 18.15 Favored 'General case' 0 C--O 1.199 -1.566 0 C-N-CA 123.522 0.729 . . . . 0.0 111.273 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.67 173.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -149.25 46.56 0.66 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.664 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.1 p -58.67 -58.61 7.82 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.725 0.297 . . . . 0.0 110.933 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -123.07 -59.08 1.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 m -59.83 150.76 27.4 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.049 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -141.37 54.32 0.63 Allowed Glycine 0 N--CA 1.424 -2.14 0 O-C-N 124.071 0.857 . . . . 0.0 112.637 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.679 ' H ' HD22 ' A' ' 28' ' ' LEU . 1.1 mm? -60.56 179.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.981 0.419 . . . . 0.0 110.733 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 38.18 2.01 Favored Glycine 0 C--N 1.28 -2.528 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.644 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -74.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -75.51 157.35 34.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.016 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 176.04 0.53 Allowed 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -55.27 166.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -56.2 157.51 9.78 Favored Glycine 0 CA--C 1.497 -1.062 0 CA-C-O 121.891 0.717 . . . . 0.0 112.018 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -64.64 177.27 0.94 Allowed 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 tptp 75.57 96.82 0.07 Allowed 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.997 0.903 . . . . 0.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 20.0 mt -48.41 -31.42 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.302 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.32 99.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.765 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -52.32 149.34 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.6 173.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 109.09 93.33 2.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.419 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.334 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.13 -57.85 10.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -59.27 133.15 55.83 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.584 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -135.45 53.04 0.78 Allowed Glycine 0 C--O 1.204 -1.733 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.941 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 15' ' ' PHE . 2.6 mm? -73.5 -177.38 2.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.899 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 87.02 72.02 1.29 Allowed Glycine 0 C--N 1.284 -2.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.618 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.99 -75.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.639 0.257 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.36 -179.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.208 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 -174.25 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -55.84 164.16 1.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.725 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.79 161.92 5.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.793 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -61.58 178.49 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.749 0.309 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 77.04 97.33 0.07 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.3 mt -47.08 -42.36 6.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.711 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 46.71 94.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.436 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -56.3 89.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt 54.34 173.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.216 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -179.78 -82.28 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -82.18 0.65 Allowed 'General case' 0 C--O 1.213 -0.837 0 O-C-N 122.634 -0.333 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -120.22 -52.23 2.18 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 122.407 0.283 . . . . 0.0 110.772 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 172.78 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.585 0.354 . . . . 0.0 111.376 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -151.61 61.63 0.4 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.195 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 11.4 mt -52.66 170.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 15' ' ' PHE . . . 130.71 70.9 0.11 Allowed Glycine 0 C--N 1.289 -2.054 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.534 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 -47.26 2.68 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.701 0.286 . . . . 0.0 111.068 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -56.37 -179.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t 60.26 157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 4.2 p90 -51.67 161.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.145 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.22 -165.16 23.35 Favored Glycine 0 N--CA 1.418 -2.535 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.535 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 19' ' ' ILE . 32.8 m-70 -58.14 172.82 0.4 Allowed 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.527 0.203 . . . . 0.0 111.024 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 49.34 1.53 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 123.9 0.75 . . . . 0.0 111.017 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 17' ' ' HIS . 20.1 mt -69.89 -43.88 79.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.43 136.11 37.56 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.97 153.57 22.08 Favored 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 124.13 0.893 . . . . 0.0 111.172 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.78 173.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.435 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 149.6 92.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -67.67 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.21 -56.56 5.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.1 p -61.53 172.08 1.3 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 15' ' ' PHE . . . -166.2 68.3 0.19 Allowed Glycine 0 C--O 1.217 -0.956 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.45 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.4 mt -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.914 0.387 . . . . 0.0 110.845 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.61 55.48 0.58 Allowed Glycine 0 C--N 1.283 -2.393 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.55 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -109.02 -71.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.693 0.283 . . . . 0.0 110.791 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -66.24 152.38 45.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.879 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.11 172.1 7.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 9.8 m-85 -59.85 141.11 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.16 -151.71 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.59 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -56.57 173.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 13.3 pttp -91.56 49.63 1.61 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.585 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.42 -52.28 38.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.1 t70 -59.93 137.94 57.95 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -79.26 162.75 25.46 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.716 0.635 . . . . 0.0 110.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.55 174.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 O-C-N 123.969 0.793 . . . . 0.0 110.558 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -147.02 32.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.553 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -67.38 0.4 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.637 0.256 . . . . 0.0 110.88 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -88.78 -53.28 4.69 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.069 0.462 . . . . 0.0 111.225 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 t -70.08 172.45 7.94 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.514 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -151.15 60.4 0.41 Allowed Glycine 0 C--O 1.2 -1.978 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.623 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -60.26 -174.94 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.375 0.607 . . . . 0.0 110.406 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 68.38 0.92 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.767 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.91 -47.21 0.27 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 117.407 0.604 . . . . 0.0 112.425 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.21 -179.08 1.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.097 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.597 -179.562 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.208 0 N-CA-C 112.4 -0.28 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -122.65 -95.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.34 0.114 . . . . 0.0 110.721 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -122.07 144.55 48.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.98 -155.86 0.14 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 28' ' ' LEU . 7.4 m-70 -56.46 173.13 0.19 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 119.847 -0.12 . . . . 0.0 111.052 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 3.4 ptmt -103.76 39.03 1.69 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 125.349 1.656 . . . . 0.0 111.135 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 17' ' ' HIS . 10.3 mt -81.24 -46.24 20.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -60.31 138.03 58.03 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.06 119.73 9.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.318 0.58 . . . . 0.0 111.029 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mt -102.18 173.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 112.37 44.51 0.84 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.492 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.81 -68.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -125.9 -59.16 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -59.62 167.83 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.425 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.36 61.81 0.38 Allowed Glycine 0 C--O 1.2 -2.025 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.418 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 17' ' ' HIS . 18.8 mt -61.21 176.34 0.46 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.181 0.991 . . . . 0.0 110.233 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 27.23 3.25 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.572 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 15' ' ' PHE . 0.5 OUTLIER -102.34 -57.92 1.97 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.045 0.45 . . . . 0.0 111.542 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.35 -179.14 2.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t 60.78 156.7 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.4 p90 -55.27 -179.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.021 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.88 156.42 47.17 Favored Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.195 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -74.69 179.13 4.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.792 0.329 . . . . 0.0 111.131 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tttt 77.53 98.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.445 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.407 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 62.0 mt -40.15 -49.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.563 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CB ' HD12 ' A' ' 28' ' ' LEU . 5.4 t70 58.26 161.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 110.786 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.53 10.97 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -41.3 161.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 125.105 1.503 . . . . 0.0 111.512 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.36 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.117 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 p -40.61 -58.69 1.54 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.811 0.339 . . . . 0.0 111.821 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -50.06 -57.66 7.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.374 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 p -72.58 171.9 11.57 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -157.77 39.56 0.53 Allowed Glycine 0 C--O 1.216 -1.011 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.781 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -64.26 177.35 0.85 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 104.61 51.46 0.91 Allowed Glycine 0 C--N 1.283 -2.378 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.729 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -30.85 11.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -60.93 154.24 22.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 111.081 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.121 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.6 p -57.88 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -51.07 164.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.45 -178.0 0.23 Allowed Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -65.4 176.54 1.37 Allowed 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 119.859 -0.115 . . . . 0.0 110.782 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -92.08 48.96 1.47 Allowed 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 124.179 0.924 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.14 -32.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 138.62 35.2 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.69 143.48 27.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.929 0.768 . . . . 0.0 111.177 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.92 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.544 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.59 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.17 91.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.407 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -67.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -64.46 -66.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.8 p -75.27 171.95 13.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -170.05 69.78 0.14 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.354 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -60.31 169.48 1.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 59.09 0.13 Allowed Glycine 0 C--N 1.295 -1.738 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.849 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -31.51 54.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -97.04 151.08 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.001 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.966 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.46 -95.44 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.858 -0.201 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.45 152.76 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.0 110.695 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.36 179.22 1.31 Allowed Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.549 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.502 ' O ' HD13 ' A' ' 28' ' ' LEU . 37.9 m-70 -59.32 175.53 0.31 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.354 0.121 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 39.58 1.08 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.489 1.118 . . . . 0.0 110.962 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.568 HG22 HH12 ' A' ' 21' ' ' ARG . 1.7 mt -106.1 -20.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.221 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.19 109.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.568 HH12 HG22 ' A' ' 19' ' ' ILE . 3.0 mtm-85 -68.34 152.59 45.22 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.479 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.5 174.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 O-C-N 124.289 0.993 . . . . 0.0 110.401 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 133.62 94.75 0.54 Allowed Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.552 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 p -46.01 -59.9 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.616 0.208 . . . . 0.0 110.957 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.09 -73.6 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.942 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 t 55.6 171.61 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.184 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -160.54 29.38 0.34 Allowed Glycine 0 C--O 1.21 -1.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.198 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 17' ' ' HIS . 6.9 mt -73.39 172.46 11.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.775 0.798 . . . . 0.0 110.631 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.28 27.42 4.49 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.876 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -31.35 59.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.566 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -81.79 -179.14 7.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 mttm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 -179.841 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.41 -170.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -53.17 -178.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 163.95 0.62 Allowed Glycine 0 CA--C 1.496 -1.101 0 CA-C-O 122.162 0.868 . . . . 0.0 111.871 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.5 ' O ' HD13 ' A' ' 28' ' ' LEU . 34.2 m-70 -62.28 177.15 0.52 Allowed 'General case' 0 C--O 1.208 -1.106 0 O-C-N 122.418 -0.46 . . . . 0.0 111.143 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -91.04 48.63 1.54 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.564 1.165 . . . . 0.0 110.521 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.68 -37.7 9.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.8 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.64 144.65 41.59 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -93.04 162.72 13.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 123.564 0.54 . . . . 0.0 111.055 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.68 173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -144.61 65.82 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.62 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -66.96 0.45 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.634 0.73 . . . . 0.0 110.842 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -104.41 -56.85 2.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 m -76.44 172.81 12.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -148.19 59.32 0.46 Allowed Glycine 0 C--O 1.224 -0.497 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.308 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 17' ' ' HIS . 8.7 mt -56.07 170.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.864 0.364 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.03 80.6 0.69 Allowed Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.77 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -57.11 0.24 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.177 0.988 . . . . 0.0 110.968 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.92 172.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 -179.834 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.133 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 51.04 179.22 0.02 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.528 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.815 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -64.18 179.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.72 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.1 -163.85 0.07 OUTLIER Glycine 0 CA--C 1.492 -1.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.87 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 8.4 m-70 -56.56 -179.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.475 . . . . 0.0 111.013 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.64 48.23 1.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.835 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.41 -56.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 46.31 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.34 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.0 106.3 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.957 0.884 . . . . 0.0 111.824 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.85 173.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.125 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -99.9 42.55 1.95 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.451 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -79.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -126.83 -57.4 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -57.83 172.69 0.37 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.458 0.171 . . . . 0.0 111.397 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -164.95 67.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.328 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER -80.19 170.1 16.89 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 110.617 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.05 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.574 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -58.53 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.831 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.99 154.88 14.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tptm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.44 0 CA-C-O 120.333 -0.148 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.23 179.95 6.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -112.51 -179.41 3.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -172.85 0.17 Allowed Glycine 0 CA--C 1.499 -0.958 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.363 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 5.4 m-70 -57.47 -177.75 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.05 0.453 . . . . 0.0 111.108 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -85.35 46.55 1.3 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.266 -178.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.23 -64.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 t70 42.7 92.74 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 115.39 3.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.54 0.209 . . . . 0.0 111.19 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.81 173.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -100.11 43.62 1.75 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.347 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -56.92 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.528 0.204 . . . . 0.0 110.982 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -137.83 -64.11 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -49.43 172.67 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.64 64.09 0.31 Allowed Glycine 0 C--O 1.218 -0.852 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.142 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -60.48 168.31 2.19 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.919 0.866 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 18' ' ' LYS . . . 124.46 66.57 0.19 Allowed Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.094 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -66.52 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 0.0 110.812 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -65.09 135.71 55.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.201 -1.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.228 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.5 -164.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.93 166.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 110.991 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.02 -173.02 0.09 OUTLIER Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.224 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 9.2 m-70 -56.52 -178.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.301 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.439 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . 15.9 pttt -92.54 40.19 1.05 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.734 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.04 -52.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.1 t0 -61.46 95.07 0.05 OUTLIER 'General case' 0 C--O 1.188 -2.181 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.687 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.28 152.79 3.17 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 124.342 1.026 . . . . 0.0 111.708 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -92.96 173.03 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 145.42 -24.36 1.86 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.411 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.2 -79.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.152 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -139.87 -65.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.33 172.17 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 122.532 0.333 . . . . 0.0 111.753 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.77 69.78 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 20' ' ' ASP . 9.1 mt -62.35 169.39 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.932 0.396 . . . . 0.0 111.077 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' HA2' ' CA ' ' A' ' 18' ' ' LYS . . . 134.96 64.25 0.07 OUTLIER Glycine 0 C--N 1.296 -1.641 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.921 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -29.25 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.4 175.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.257 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -61.34 172.36 1.14 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.541 ' CB ' HD23 ' A' ' 28' ' ' LEU . 10.8 m-85 -60.01 -179.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.32 -152.81 0.02 OUTLIER Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.718 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.772 ' O ' HD13 ' A' ' 28' ' ' LEU . 36.1 m-70 -61.59 176.37 0.51 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 110.888 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.02 41.12 1.12 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.09 -66.27 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 120.787 0.327 . . . . 0.0 111.043 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.72 111.23 10.84 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -74.87 76.07 2.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.96 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.48 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -173.34 -85.0 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.406 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -81.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.625 0.25 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.71 -50.76 5.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.081 0.467 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -59.9 172.03 0.83 Allowed 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.62 70.03 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 17' ' ' HIS . 53.0 mt -59.59 178.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.3 42.6 0.18 Allowed Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.724 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.72 -58.64 2.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.85 150.19 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.692 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.4 tptt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.837 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.275 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.62 169.03 13.53 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 122.667 -0.314 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.681 ' CB ' HD22 ' A' ' 28' ' ' LEU . 1.7 m-85 -77.52 -179.74 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.49 -166.4 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.18 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 15.9 m-70 -59.72 178.9 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.866 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 47.19 1.47 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.606 1.192 . . . . 0.0 110.731 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.64 -71.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.013 0.435 . . . . 0.0 110.821 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 12.4 t0 40.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.077 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -59.57 89.96 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 57.0 173.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.261 0.351 . . . . 0.0 110.586 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 118.44 94.7 1.66 Allowed Glycine 0 CA--C 1.489 -1.535 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.354 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.8 p -50.36 -57.89 6.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.286 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -47.52 -55.4 9.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.8 m -48.56 156.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.344 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -168.26 69.43 0.17 Allowed Glycine 0 C--O 1.201 -1.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 15' ' ' PHE . 1.3 mt -78.32 -171.63 2.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.67 0.748 . . . . 0.0 110.972 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 74.49 0.59 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.954 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.54 -56.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 111.048 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -54.85 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.983 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.187 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.2 t 61.37 157.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.3 p90 -54.88 142.91 27.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.948 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.89 -167.21 0.17 Allowed Glycine 0 N--CA 1.419 -2.462 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.667 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 31' ' ' ASN . 60.3 m-70 -60.67 173.03 0.79 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 121.658 0.742 . . . . 0.0 110.104 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.69 38.58 1.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.157 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.83 -27.69 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 28' ' ' LEU . 18.9 t70 -55.36 147.8 16.36 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 170.01 0.95 Allowed 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -44.89 164.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.671 0 O-C-N 124.498 1.124 . . . . 0.0 111.024 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.05 88.49 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.553 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 p -43.97 -59.02 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 111.327 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.17 -58.85 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -60.02 171.97 0.87 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.056 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.02 67.46 0.21 Allowed Glycine 0 C--O 1.198 -2.131 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.659 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 20' ' ' ASP . 6.2 mt -83.38 167.82 17.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.12 49.43 0.45 Allowed Glycine 0 C--N 1.291 -1.962 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.532 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.03 -63.98 1.27 Allowed 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.738 -0.272 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 12.6 m-80 -58.98 144.48 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 179.942 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . . . . . . 0 C--O 1.214 -1.148 0 CA-C-O 120.975 0.208 . . . . 0.0 112.582 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' CZ ' ' A' ' 15' ' ' PHE . 27.1 p -56.21 -48.76 75.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.451 -0.441 . . . . 0.0 111.048 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -125.21 -178.8 4.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 110.378 178.37 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.47 168.22 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.134 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.19 177.94 0.76 Allowed 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.641 -0.279 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 49.17 1.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 124.947 1.404 . . . . 0.0 110.872 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.77 -45.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' HD11 ' A' ' 22' ' ' ILE . 5.0 t0 -82.57 123.32 29.11 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.21 77.67 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.861 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -130.04 172.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -158.54 72.83 0.23 Allowed Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.387 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -68.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.62 -66.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.091 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -76.42 172.23 13.29 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.244 -0.285 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.28 64.03 0.31 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.398 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.0 mt -57.21 167.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 47.07 1.04 Allowed Glycine 0 C--N 1.283 -2.416 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.675 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -93.92 -37.54 11.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.275 0.559 . . . . 0.0 111.705 179.197 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.24 127.19 30.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.025 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.007 179.997 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.1 m -60.28 174.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.31 -178.88 1.82 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.015 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.13 -177.76 1.04 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.94 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -61.7 177.06 0.45 Allowed 'General case' 0 C--O 1.211 -0.935 0 O-C-N 122.701 -0.294 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -96.73 38.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.585 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.37 -26.31 3.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.3 144.6 19.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.065 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -58.87 170.88 0.75 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 pt -46.27 166.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.704 0 O-C-N 124.591 1.182 . . . . 0.0 110.729 -178.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.11 88.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.41 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 p -42.44 -58.47 2.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.754 0.312 . . . . 0.0 111.721 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -50.71 -58.41 5.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.043 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.9 m -61.25 172.19 1.15 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.076 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.09 68.81 0.17 Allowed Glycine 0 C--O 1.198 -2.105 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.732 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -76.0 168.88 19.23 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 122.663 1.22 . . . . 0.0 110.01 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 83.1 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.332 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.9 t -158.29 -46.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.475 0.637 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -59.99 -179.55 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 68.49 -68.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -33.45 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.733 ' NZ ' HD11 ' A' ' 28' ' ' LEU . 0.7 OUTLIER -106.24 87.15 2.38 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.48 110.13 2.63 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.28 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.54 168.13 22.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.427 2.085 . . . . 0.0 112.279 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.39 163.39 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 178.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 111.369 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.06 109.22 1.76 Allowed Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.545 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.43 170.91 15.1 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.428 2.086 . . . . 0.0 112.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.98 63.34 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.139 . . . . 0.0 112.305 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.24 112.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.35 174.05 21.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.7 p -57.65 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 111.08 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -50.89 164.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.123 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.53 -178.07 0.25 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.634 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -65.03 175.44 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.766 ' NZ ' HG11 ' A' ' 33' ' ' VAL . 4.5 pttt -90.81 49.3 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.02 -32.99 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.9 138.27 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.63 143.58 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.51 173.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.65 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -67.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -64.51 -67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.8 p -73.16 172.07 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.88 69.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.415 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.733 HD11 ' NZ ' ' A' ' 4' ' ' LYS . 8.5 mt -60.78 169.06 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 59.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -31.37 56.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.82 151.0 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -93.11 161.99 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG11 ' NZ ' ' A' ' 18' ' ' LYS . 30.4 m -108.64 -177.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -86.91 54.01 3.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.93 -175.69 5.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -50.66 147.76 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.234 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -176.7 6.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.462 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 CA-C-O 120.984 0.214 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.96 -31.59 70.02 Favored 'General case' 0 C--O 1.196 -1.725 0 CA-C-O 121.15 0.5 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -88.76 -31.11 18.56 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.983 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.4 77.01 0.69 Allowed Pre-proline 0 C--O 1.217 -0.644 0 CA-C-O 122.739 1.257 . . . . 0.0 110.643 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' HB2' HG12 ' A' ' 33' ' ' VAL . 55.9 Cg_endo -70.92 110.12 2.71 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.717 2.278 . . . . 0.0 111.988 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 45.1 Cg_endo -68.76 149.27 72.9 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.962 1.775 . . . . 0.0 111.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tptm 59.7 161.53 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.071 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -85.92 172.39 10.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.582 0.551 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.04 108.78 0.93 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.902 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.11 110.83 3.15 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 121.693 1.595 . . . . 0.0 112.473 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.68 62.13 3.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.314 2.009 . . . . 0.0 112.44 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -165.48 -168.29 1.32 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.94 -63.51 5.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.695 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 t 60.65 156.67 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -54.65 157.27 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.21 157.88 17.52 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.046 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' ' ND2' ' A' ' 31' ' ' ASN . 5.1 m-70 -65.9 176.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.64 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp 74.9 96.18 0.07 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.284 1.04 . . . . 0.0 110.951 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 32.3 mt -50.07 -35.89 11.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.229 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 58.46 160.82 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.335 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -82.28 163.7 21.63 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.071 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.58 173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 125.132 1.52 . . . . 0.0 110.934 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -167.02 45.9 0.25 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.332 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -66.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.177 0.513 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -108.72 -51.87 2.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.272 0.558 . . . . 0.0 111.168 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -59.14 167.0 1.88 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.277 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -157.68 64.34 0.31 Allowed Glycine 0 C--O 1.206 -1.628 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.601 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 28' ' ' LEU . 2.4 mm? -83.1 -178.32 7.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.961 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 100.72 70.62 0.91 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.369 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 t -111.85 -63.33 1.43 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.475 ' ND2' ' CE1' ' A' ' 17' ' ' HIS . 1.5 m-80 -56.57 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt 59.87 73.6 0.48 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 5' ' ' PRO . 3.9 m -121.12 135.95 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.18 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -105.36 56.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -64.83 109.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 66.1 -73.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.045 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -175.15 -41.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.149 -1.361 . . . . 0.0 112.479 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 112.4 -0.28 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -153.9 80.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.37 . . . . 0.0 111.055 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.27 -31.61 70.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -106.35 86.92 2.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.39 110.25 2.64 Favored 'Trans proline' 0 C--O 1.202 -1.288 0 C-N-CA 122.835 2.357 . . . . 0.0 112.111 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.91 164.95 32.78 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.349 2.032 . . . . 0.0 112.304 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG3' ' CE1' ' A' ' 17' ' ' HIS . 3.0 mmmm -60.99 163.18 6.13 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 123.659 0.599 . . . . 0.0 110.922 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -96.79 170.14 9.38 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.65 -89.31 0.28 Allowed Glycine 0 N--CA 1.446 -0.633 0 O-C-N 125.064 1.477 . . . . 0.0 112.668 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.01 151.38 67.6 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 C-N-CA 122.021 1.814 . . . . 0.0 112.426 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.6 60.87 4.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.907 2.405 . . . . 0.0 112.364 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -179.62 -178.48 0.47 Allowed 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.691 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.43 76.16 0.24 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.482 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.81 164.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 20.9 m-85 -59.07 -178.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.369 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -171.04 0.95 Allowed Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.654 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.435 ' CE1' ' HG3' ' A' ' 7' ' ' LYS . 3.6 m-70 -56.06 -178.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.55 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 48.82 1.69 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.5 mt -89.4 -31.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.972 0.415 . . . . 0.0 110.994 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 t70 54.82 105.31 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.599 0.714 . . . . 0.0 112.427 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.86 166.05 21.71 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.927 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -46.58 142.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.413 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 93.76 0.24 Allowed Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.773 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -46.78 -56.72 5.77 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.937 0.433 . . . . 0.0 111.554 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -44.85 -51.97 9.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.373 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.8 m -44.08 145.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.572 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -140.63 56.21 0.61 Allowed Glycine 0 C--O 1.221 -0.711 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.347 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.17 170.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 110.983 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.72 -32.86 2.96 Favored Glycine 0 C--N 1.311 -0.857 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.512 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.3 t -61.54 -37.41 83.68 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.344 -0.504 . . . . 0.0 111.24 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -58.05 149.29 23.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.183 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -58.97 127.56 32.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.46 -176.36 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.94 61.76 0.19 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.091 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.27 -61.79 2.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -50.74 97.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -31.27 21.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.88 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.918 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.608 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.93 159.65 40.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.843 0.354 . . . . 0.0 110.919 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -162.92 93.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -59.13 109.25 1.75 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.09 110.22 2.76 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.586 2.191 . . . . 0.0 112.364 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 157.29 60.09 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.394 2.063 . . . . 0.0 112.184 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.64 164.17 3.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.86 174.52 5.84 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 124.61 1.194 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.14 -60.78 0.61 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.554 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.5 160.29 49.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.591 2.194 . . . . 0.0 112.401 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.09 122.39 8.98 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 C-N-CA 122.627 2.218 . . . . 0.0 111.532 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 p30 43.41 91.97 0.01 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.641 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.46 -143.41 44.3 Favored Glycine 0 C--O 1.208 -1.503 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.649 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -166.93 176.24 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -59.69 171.96 0.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.55 173.76 2.37 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.95 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 28' ' ' LEU . 5.8 m-70 -61.3 175.93 0.51 Allowed 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.024 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HA ' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -90.73 48.68 1.56 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 124.597 1.186 . . . . 0.0 110.653 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.27 -46.47 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-O 120.927 0.394 . . . . 0.0 111.108 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 144.73 51.97 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 72.79 3.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.024 0.828 . . . . 0.0 111.118 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -131.19 173.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 O-C-N 125.005 1.441 . . . . 0.0 110.732 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.592 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -168.67 -40.69 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.519 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -59.74 -74.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -66.8 -66.53 0.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.416 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -90.14 172.11 9.05 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.243 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -152.07 53.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.507 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -52.43 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.124 0.488 . . . . 0.0 111.087 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 66.9 0.85 Allowed Glycine 0 C--N 1.286 -2.234 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.781 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -126.33 -53.38 1.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 110.848 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -58.78 128.02 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -60.04 92.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.11 -175.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.083 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.4 61.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.39 118.6 31.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.807 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -51.09 -44.86 61.32 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.395 0.278 . . . . 0.0 111.393 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -31.46 71.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.932 0.396 . . . . 0.0 110.149 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.353 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -132.86 93.99 3.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.92 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -89.75 -36.02 15.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -106.65 86.56 2.31 Favored Pre-proline 0 CA--C 1.516 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.517 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.35 110.14 2.6 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.223 1.949 . . . . 0.0 112.371 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.57 167.92 22.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.401 2.068 . . . . 0.0 112.329 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -60.63 163.18 5.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -76.73 170.1 17.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.096 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.56 -90.68 0.22 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.44 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.96 157.77 58.91 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.434 2.089 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 84.17 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.999 2.466 . . . . 0.0 112.323 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.54 31.21 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.11 162.2 28.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.581 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -77.83 -170.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 0.0 110.717 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -52.67 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.007 179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.96 169.16 0.33 Allowed Glycine 0 CA--C 1.494 -1.262 0 CA-C-O 122.117 0.843 . . . . 0.0 111.839 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.413 ' O ' HD13 ' A' ' 28' ' ' LEU . 31.0 m-70 -65.13 176.91 1.14 Allowed 'General case' 0 C--O 1.208 -1.09 0 O-C-N 122.346 -0.502 . . . . 0.0 110.835 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.718 ' HD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -90.9 48.95 1.58 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.908 1.38 . . . . 0.0 110.731 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.52 -35.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' OD1' HD11 ' A' ' 22' ' ' ILE . 2.1 t0 -88.22 123.68 33.08 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.187 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.41 73.01 1.84 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.663 0.602 . . . . 0.0 110.948 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.1 mt -131.95 172.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.893 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -152.05 27.78 0.9 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.408 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -69.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.818 0.342 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -124.35 -61.67 1.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -61.34 172.11 1.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.136 0.174 . . . . 0.0 111.413 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.86 64.36 0.3 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.734 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.8 mt -55.25 170.78 0.19 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 111.044 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.27 83.91 0.93 Allowed Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.275 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -149.09 -53.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.057 0.456 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -59.09 131.63 51.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 132.06 52.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.977 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.718 HG11 ' HD2' ' A' ' 18' ' ' LYS . 27.8 m -107.13 -176.41 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.76 61.61 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.82 -172.25 2.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.631 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 65.83 -73.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.217 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.35 130.13 35.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.614 0 CA-C-O 117.659 -1.634 . . . . 0.0 112.355 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.62 150.23 38.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.74 -31.36 16.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.33 87.14 2.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 110.06 2.6 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.523 2.149 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 161.73 44.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.684 2.256 . . . . 0.0 112.293 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -62.07 163.33 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 172.34 12.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.763 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.62 -154.88 31.55 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.274 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.66 170.68 17.07 Favored 'Trans proline' 0 C--O 1.205 -1.164 0 C-N-CA 122.74 2.293 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.91 84.25 0.69 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.028 2.485 . . . . 0.0 111.938 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.75 130.41 34.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.756 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.9 -129.17 11.59 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 52.63 177.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.508 ' HB2' HD23 ' A' ' 28' ' ' LEU . 2.6 p90 -48.68 140.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.787 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.99 177.69 0.92 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.518 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.407 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -93.11 131.72 37.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.215 0.531 . . . . 0.0 110.52 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' CB ' HD13 ' A' ' 28' ' ' LEU . 0.7 OUTLIER 166.92 99.26 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.997 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -34.68 -52.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 56.36 162.78 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.1 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 169.21 18.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.259 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -42.2 161.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.263 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.74 91.36 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.511 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.8 p -43.88 -58.45 2.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 111.632 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.69 -59.06 4.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.141 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 m -65.99 152.8 43.8 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -159.31 62.6 0.3 Allowed Glycine 0 C--O 1.211 -1.287 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.816 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 15' ' ' PHE . 56.3 mt -67.35 -174.75 0.41 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.41 72.46 1.16 Allowed Glycine 0 C--N 1.288 -2.087 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.63 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.3 t -71.03 -33.23 70.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.39 151.12 24.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -59.08 124.29 19.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.093 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.52 HG11 ' C ' ' A' ' 38' ' ' GLY . 12.3 m -116.5 134.54 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -112.27 54.13 0.71 Allowed 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.243 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.89 -65.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.488 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.5 p30 -43.75 -52.23 6.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.732 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.39 -40.6 19.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.52 ' C ' HG11 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.602 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -103.04 -65.77 0.98 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.98 -46.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -107.03 87.98 3.38 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.079 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 55.9 Cg_endo -71.69 110.56 2.92 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 123.019 2.479 . . . . 0.0 112.477 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.9 Cg_endo -70.08 150.42 66.25 Favored 'Trans proline' 0 C--O 1.202 -1.305 0 C-N-CA 121.956 1.771 . . . . 0.0 112.332 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' CG ' HD11 ' A' ' 28' ' ' LEU . 7.6 tptt 61.3 111.52 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.707 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.73 169.42 9.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.04 -95.67 0.2 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.116 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.85 111.32 3.26 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.663 2.242 . . . . 0.0 111.842 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.98 56.35 5.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.494 2.129 . . . . 0.0 112.41 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 179.91 158.74 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.13 -177.03 2.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.1 p -70.23 -176.55 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.539 0.209 . . . . 0.0 111.186 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -47.39 151.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.973 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.11 -167.49 43.41 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.641 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -59.04 178.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.36 0.6 . . . . 0.0 110.997 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt 74.82 84.18 0.1 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.47 -32.59 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.371 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 28' ' ' LEU . 6.5 t70 59.5 159.96 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.114 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.98 163.17 18.15 Favored 'General case' 0 C--O 1.199 -1.566 0 C-N-CA 123.522 0.729 . . . . 0.0 111.273 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.67 173.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -149.25 46.56 0.66 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.664 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.1 p -58.67 -58.61 7.82 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.725 0.297 . . . . 0.0 110.933 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -123.07 -59.08 1.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.1 m -59.83 150.76 27.4 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.049 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -141.37 54.32 0.63 Allowed Glycine 0 N--CA 1.424 -2.14 0 O-C-N 124.071 0.857 . . . . 0.0 112.637 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.679 ' H ' HD22 ' A' ' 28' ' ' LEU . 1.1 mm? -60.56 179.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.981 0.419 . . . . 0.0 110.733 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 38.18 2.01 Favored Glycine 0 C--N 1.28 -2.528 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.644 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -74.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -75.51 157.35 34.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.016 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -102.04 152.58 20.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.72 134.83 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.04 61.82 3.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.548 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.41 97.57 0.58 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.041 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -50.72 155.0 1.22 Allowed 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? 59.99 85.69 0.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.82 0.343 . . . . 0.0 110.675 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.381 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.124 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.2 83.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 111.032 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -99.27 -48.59 4.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -106.71 81.2 0.84 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.257 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 110.01 2.57 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.583 2.189 . . . . 0.0 112.481 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.45 168.08 22.19 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.535 2.157 . . . . 0.0 112.394 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.12 163.29 39.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -80.66 172.22 14.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.242 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.24 -61.49 0.15 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.5 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.86 110.39 2.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.421 2.081 . . . . 0.0 112.437 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.75 62.11 3.02 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.61 2.206 . . . . 0.0 112.247 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 178.53 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.51 112.11 1.05 Allowed Glycine 0 C--N 1.321 -0.255 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.653 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 176.04 0.53 Allowed 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -55.27 166.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -56.2 157.51 9.78 Favored Glycine 0 CA--C 1.497 -1.062 0 CA-C-O 121.891 0.717 . . . . 0.0 112.018 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -64.64 177.27 0.94 Allowed 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 tptp 75.57 96.82 0.07 Allowed 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.997 0.903 . . . . 0.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 20.0 mt -48.41 -31.42 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.302 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.32 99.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.765 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -52.32 149.34 5.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.6 173.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 109.09 93.33 2.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.419 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.334 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.13 -57.85 10.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 m -59.27 133.15 55.83 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.584 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -135.45 53.04 0.78 Allowed Glycine 0 C--O 1.204 -1.733 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.941 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 15' ' ' PHE . 2.6 mm? -73.5 -177.38 2.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.899 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 87.02 72.02 1.29 Allowed Glycine 0 C--N 1.284 -2.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.618 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.99 -75.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.639 0.257 . . . . 0.0 110.723 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.36 -179.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 155.04 40.14 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.18 134.8 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.713 0.768 . . . . 0.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.09 61.07 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.67 -65.75 0.98 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -50.93 104.0 0.07 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.906 0.384 . . . . 0.0 111.491 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.06 135.78 52.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.671 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.796 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -175.94 -53.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.0 110.834 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.48 93.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.771 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 109.58 2.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.415 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 51.3 Cg_endo -69.65 110.35 2.51 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.272 1.982 . . . . 0.0 112.074 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.4 Cg_endo -69.2 150.04 71.19 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.477 2.118 . . . . 0.0 112.365 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -58.91 165.25 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.631 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 172.67 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.31 109.36 1.89 Allowed Glycine 0 C--N 1.317 -0.481 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.67 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.76 3.08 Favored 'Trans proline' 0 C--N 1.329 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.01 67.98 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.215 1.943 . . . . 0.0 112.286 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -177.48 116.81 0.09 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.687 0.755 . . . . 0.0 110.147 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.56 -112.42 4.02 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.413 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 -174.25 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -55.84 164.16 1.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.725 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.79 161.92 5.91 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.793 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -61.58 178.49 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.749 0.309 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 77.04 97.33 0.07 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.705 HD13 HG12 ' A' ' 33' ' ' VAL . 31.3 mt -47.08 -42.36 6.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.711 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 46.71 94.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.436 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -56.3 89.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt 54.34 173.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.216 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -179.78 -82.28 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -82.18 0.65 Allowed 'General case' 0 C--O 1.213 -0.837 0 O-C-N 122.634 -0.333 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -120.22 -52.23 2.18 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 122.407 0.283 . . . . 0.0 110.772 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 172.78 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.585 0.354 . . . . 0.0 111.376 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -151.61 61.63 0.4 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.195 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 11.4 mt -52.66 170.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 15' ' ' PHE . . . 130.71 70.9 0.11 Allowed Glycine 0 C--N 1.289 -2.054 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.534 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 -47.26 2.68 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.701 0.286 . . . . 0.0 111.068 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -56.37 -179.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 148.01 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.705 HG12 HD13 ' A' ' 19' ' ' ILE . 4.7 m -119.1 134.4 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.984 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.87 61.67 6.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -151.05 -47.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.01 151.35 1.96 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.141 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tttp 60.47 80.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.716 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.37 -78.76 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.55 -54.14 0.67 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.372 1.069 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.79 87.33 2.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.275 0.56 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.61 110.04 2.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.502 2.135 . . . . 0.0 112.403 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.31 168.24 21.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 112.201 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 151.75 25.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.802 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -94.06 172.28 8.32 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.633 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.71 150.4 20.53 Favored Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.064 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.1 163.8 36.36 Favored 'Trans proline' 0 C--O 1.204 -1.223 0 C-N-CA 122.995 2.463 . . . . 0.0 112.249 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.71 92.18 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.36 2.04 . . . . 0.0 112.412 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 p30 176.41 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.26 -178.73 16.0 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t 60.26 157.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 4.2 p90 -51.67 161.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.145 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.22 -165.16 23.35 Favored Glycine 0 N--CA 1.418 -2.535 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.535 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 19' ' ' ILE . 32.8 m-70 -58.14 172.82 0.4 Allowed 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 120.527 0.203 . . . . 0.0 111.024 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 49.34 1.53 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 123.9 0.75 . . . . 0.0 111.017 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 17' ' ' HIS . 20.1 mt -69.89 -43.88 79.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.43 136.11 37.56 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.97 153.57 22.08 Favored 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 124.13 0.893 . . . . 0.0 111.172 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.78 173.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.435 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 149.6 92.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.517 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -67.67 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.21 -56.56 5.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.1 p -61.53 172.08 1.3 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' ' CE1' ' A' ' 15' ' ' PHE . . . -166.2 68.3 0.19 Allowed Glycine 0 C--O 1.217 -0.956 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.45 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.4 mt -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.914 0.387 . . . . 0.0 110.845 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.61 55.48 0.58 Allowed Glycine 0 C--N 1.283 -2.393 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.55 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -109.02 -71.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.693 0.283 . . . . 0.0 110.791 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -66.24 152.38 45.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.81 161.58 32.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 m -118.96 134.6 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.406 . . . . 0.0 111.128 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.89 59.81 1.48 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.809 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.69 -45.99 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -50.68 176.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.76 71.09 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.888 0.475 . . . . 0.0 110.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.204 -1.331 . . . . 0.0 112.519 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -73.15 -33.78 65.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.692 0.282 . . . . 0.0 110.743 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -63.24 -49.57 73.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 110.688 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -59.51 109.98 2.38 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.949 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.15 110.71 2.7 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.103 1.869 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 168.33 21.77 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.392 2.061 . . . . 0.0 112.3 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HE2' HD12 ' A' ' 19' ' ' ILE . 43.5 tttm -60.64 162.48 6.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -79.27 170.37 16.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.402 0.62 . . . . 0.0 110.214 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.08 90.92 0.73 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.452 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.05 154.42 66.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.725 2.283 . . . . 0.0 112.55 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 83.79 0.7 Allowed 'Trans proline' 0 C--O 1.212 -0.788 0 C-N-CA 122.549 2.166 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -165.6 32.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.6 -87.34 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.11 172.1 7.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 9.8 m-85 -59.85 141.11 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.16 -151.71 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.59 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -56.57 173.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HD3' HG11 ' A' ' 33' ' ' VAL . 13.3 pttp -91.56 49.63 1.61 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.585 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.433 HD12 ' HE2' ' A' ' 7' ' ' LYS . 22.4 mt -68.42 -52.28 38.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.1 t70 -59.93 137.94 57.95 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -79.26 162.75 25.46 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.716 0.635 . . . . 0.0 110.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.55 174.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 O-C-N 123.969 0.793 . . . . 0.0 110.558 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -147.02 32.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.553 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -67.38 0.4 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.637 0.256 . . . . 0.0 110.88 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -88.78 -53.28 4.69 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.069 0.462 . . . . 0.0 111.225 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 t -70.08 172.45 7.94 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.514 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -151.15 60.4 0.41 Allowed Glycine 0 C--O 1.2 -1.978 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.623 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -60.26 -174.94 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.375 0.607 . . . . 0.0 110.406 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 68.38 0.92 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.767 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.91 -47.21 0.27 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 117.407 0.604 . . . . 0.0 112.425 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.21 -179.08 1.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.097 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -60.46 95.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.597 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG11 ' HD3' ' A' ' 18' ' ' LYS . 4.6 m -119.25 135.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -79.32 61.98 3.55 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.677 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.73 113.98 20.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -50.57 111.68 0.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.764 0.316 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -60.21 -33.0 71.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.014 -179.743 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.83 118.26 3.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.0 0.429 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -176.64 -55.5 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.75 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 86.89 2.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.811 0.339 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.4 Cg_endo -70.34 110.17 2.6 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.538 2.159 . . . . 0.0 112.358 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 56.0 Cg_endo -69.61 153.06 70.08 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.804 1.67 . . . . 0.0 113.54 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -150.78 76.69 1.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.935 0.398 . . . . 0.0 111.148 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -101.92 172.36 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.843 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.22 90.81 0.75 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 153.27 67.99 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.73 2.287 . . . . 0.0 112.268 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.01 62.39 2.48 Favored 'Trans proline' 0 CA--C 1.509 -0.756 0 C-N-CA 122.526 2.15 . . . . 0.0 112.028 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.89 109.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.835 0.35 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.82 118.27 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.4 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -122.65 -95.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.34 0.114 . . . . 0.0 110.721 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -122.07 144.55 48.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.98 -155.86 0.14 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.622 ' O ' HD22 ' A' ' 28' ' ' LEU . 7.4 m-70 -56.46 173.13 0.19 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 119.847 -0.12 . . . . 0.0 111.052 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 28' ' ' LEU . 3.4 ptmt -103.76 39.03 1.69 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 125.349 1.656 . . . . 0.0 111.135 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 17' ' ' HIS . 10.3 mt -81.24 -46.24 20.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -60.31 138.03 58.03 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.06 119.73 9.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.318 0.58 . . . . 0.0 111.029 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mt -102.18 173.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 112.37 44.51 0.84 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.492 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.81 -68.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -125.9 -59.16 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -59.62 167.83 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.425 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.36 61.81 0.38 Allowed Glycine 0 C--O 1.2 -2.025 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.418 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 17' ' ' HIS . 18.8 mt -61.21 176.34 0.46 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.181 0.991 . . . . 0.0 110.233 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 27.23 3.25 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.572 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 15' ' ' PHE . 0.5 OUTLIER -102.34 -57.92 1.97 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.045 0.45 . . . . 0.0 111.542 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.35 -179.14 2.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -176.16 79.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.14 135.67 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.238 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -106.59 56.58 0.65 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -172.22 2.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.752 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 t30 65.8 -73.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.005 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -176.16 -59.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.421 -179.838 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.421 -0.271 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -175.85 174.49 2.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 110.714 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.47 -48.24 82.61 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -59.35 109.63 2.07 Favored Pre-proline 0 C--N 1.318 -0.801 0 O-C-N 124.834 1.334 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 53.8 Cg_endo -70.14 110.46 2.64 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.257 1.971 . . . . 0.0 112.223 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 55.4 Cg_endo -69.61 150.52 69.23 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.589 2.193 . . . . 0.0 112.285 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.72 163.4 17.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.837 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 170.37 15.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.41 158.22 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.66 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.38 110.23 2.63 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 63.49 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.354 2.036 . . . . 0.0 112.147 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 60.26 109.61 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.69 -61.71 1.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t 60.78 156.7 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.4 p90 -55.27 -179.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.021 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.88 156.42 47.17 Favored Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.195 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -74.69 179.13 4.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.792 0.329 . . . . 0.0 111.131 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tttt 77.53 98.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.445 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.407 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 62.0 mt -40.15 -49.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.563 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CB ' HD12 ' A' ' 28' ' ' LEU . 5.4 t70 58.26 161.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 110.786 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 170.53 10.97 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -41.3 161.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 O-C-N 125.105 1.503 . . . . 0.0 111.512 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.36 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.117 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 p -40.61 -58.69 1.54 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.811 0.339 . . . . 0.0 111.821 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -50.06 -57.66 7.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.374 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 p -72.58 171.9 11.57 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -157.77 39.56 0.53 Allowed Glycine 0 C--O 1.216 -1.011 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.781 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -64.26 177.35 0.85 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . 104.61 51.46 0.91 Allowed Glycine 0 C--N 1.283 -2.378 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.729 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -30.85 11.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -60.93 154.24 22.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -176.78 79.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.74 -179.03 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.186 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.16 61.63 0.3 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.39 118.86 31.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.39 101.54 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.745 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt 60.59 95.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.653 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 68.49 -68.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.91 -33.39 59.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' NZ ' HD11 ' A' ' 28' ' ' LEU . 1.4 tmtt? -106.08 86.96 2.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.49 110.19 2.64 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.517 2.144 . . . . 0.0 112.243 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 167.91 22.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.429 2.086 . . . . 0.0 112.409 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -61.04 163.74 5.7 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.093 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 178.7 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.187 0.518 . . . . 0.0 111.52 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 109.08 1.7 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.538 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.28 171.51 13.81 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.318 2.012 . . . . 0.0 112.487 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.64 63.17 2.3 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 123.161 2.574 . . . . 0.0 112.293 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.25 112.97 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.781 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.15 172.09 19.15 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.461 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.6 p -57.88 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -51.07 164.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.45 -178.0 0.23 Allowed Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -65.4 176.54 1.37 Allowed 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 119.859 -0.115 . . . . 0.0 110.782 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.788 ' NZ ' HG11 ' A' ' 33' ' ' VAL . 4.4 pttt -92.08 48.96 1.47 Allowed 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 124.179 0.924 . . . . 0.0 110.479 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.4 mt -80.14 -32.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 138.62 35.2 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.69 143.48 27.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.929 0.768 . . . . 0.0 111.177 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.92 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.544 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.59 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 152.17 91.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.407 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -67.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -64.46 -66.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.8 p -75.27 171.95 13.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -170.05 69.78 0.14 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.354 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 8.7 mt -60.31 169.48 1.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 59.09 0.13 Allowed Glycine 0 C--N 1.295 -1.738 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.849 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -31.51 54.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -97.04 151.08 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.001 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -93.82 161.99 14.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.788 HG11 ' NZ ' ' A' ' 18' ' ' LYS . 30.8 m -108.77 -177.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -86.83 53.93 3.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.8 -175.85 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -50.68 146.67 5.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.236 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 -175.0 5.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.827 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.629 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.659 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -61.07 108.45 0.89 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.184 0.516 . . . . 0.0 110.847 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.83 71.58 0.82 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.35 109.57 2.03 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 122.308 0.243 . . . . 0.0 110.62 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 55.8 Cg_endo -70.02 110.08 2.52 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.557 2.171 . . . . 0.0 112.355 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 53.4 Cg_endo -69.39 168.02 22.27 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.269 1.979 . . . . 0.0 112.356 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.54 130.71 34.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 172.14 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.1 62.97 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.415 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.0 154.27 66.94 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.834 2.356 . . . . 0.0 111.963 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.97 63.59 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.145 1.897 . . . . 0.0 112.032 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 60.1 31.3 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.34 127.94 2.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.46 -95.44 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.858 -0.201 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.45 152.76 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.0 110.695 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.36 179.22 1.31 Allowed Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.549 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.502 ' O ' HD13 ' A' ' 28' ' ' LEU . 37.9 m-70 -59.32 175.53 0.31 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.354 0.121 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.77 ' HG2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.25 39.58 1.08 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.489 1.118 . . . . 0.0 110.962 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.568 HG22 HH12 ' A' ' 21' ' ' ARG . 1.7 mt -106.1 -20.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.221 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.19 109.98 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 111.265 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.568 HH12 HG22 ' A' ' 19' ' ' ILE . 3.0 mtm-85 -68.34 152.59 45.22 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.479 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.5 174.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 O-C-N 124.289 0.993 . . . . 0.0 110.401 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 133.62 94.75 0.54 Allowed Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.552 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 p -46.01 -59.9 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.616 0.208 . . . . 0.0 110.957 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.09 -73.6 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.942 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 t 55.6 171.61 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.184 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' PHE . . . -160.54 29.38 0.34 Allowed Glycine 0 C--O 1.21 -1.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.198 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 17' ' ' HIS . 6.9 mt -73.39 172.46 11.2 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.775 0.798 . . . . 0.0 110.631 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.28 27.42 4.49 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.876 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -31.35 59.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.01 0.433 . . . . 0.0 111.566 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -81.79 -179.14 7.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -60.72 118.13 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.77 HG12 ' HG2' ' A' ' 18' ' ' LYS . 4.9 m -118.81 134.73 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.98 62.49 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.99 173.98 8.8 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 122.724 0.409 . . . . 0.0 111.928 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.2 t30 66.1 -73.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.629 0.581 . . . . 0.0 110.831 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -80.54 121.76 26.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.741 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.64 88.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.94 -31.89 66.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -106.05 86.81 2.13 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.884 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.2 Cg_endo -70.51 110.17 2.64 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.748 2.299 . . . . 0.0 112.311 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.9 Cg_endo -69.49 168.23 21.81 Favored 'Trans proline' 0 C--O 1.208 -1.007 0 C-N-CA 122.553 2.169 . . . . 0.0 112.106 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -61.0 91.33 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.337 0 O-C-N 124.043 0.84 . . . . 0.0 110.011 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -75.42 172.11 13.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 52.34 7.46 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.596 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.9 158.65 56.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 112.288 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.22 63.81 2.06 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 122.199 1.933 . . . . 0.0 112.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 60.26 84.33 0.12 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.67 -165.0 36.64 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.602 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.41 -170.43 1.49 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -53.17 -178.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 163.95 0.62 Allowed Glycine 0 CA--C 1.496 -1.101 0 CA-C-O 122.162 0.868 . . . . 0.0 111.871 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.5 ' O ' HD13 ' A' ' 28' ' ' LEU . 34.2 m-70 -62.28 177.15 0.52 Allowed 'General case' 0 C--O 1.208 -1.106 0 O-C-N 122.418 -0.46 . . . . 0.0 111.143 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -91.04 48.63 1.54 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.564 1.165 . . . . 0.0 110.521 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.68 -37.7 9.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.8 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.64 144.65 41.59 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -93.04 162.72 13.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 123.564 0.54 . . . . 0.0 111.055 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.5 mt 54.68 173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -144.61 65.82 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.62 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -66.96 0.45 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.634 0.73 . . . . 0.0 110.842 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -104.41 -56.85 2.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 m -76.44 172.81 12.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -148.19 59.32 0.46 Allowed Glycine 0 C--O 1.224 -0.497 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.308 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 17' ' ' HIS . 8.7 mt -56.07 170.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.864 0.364 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.03 80.6 0.69 Allowed Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.77 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -57.11 0.24 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.177 0.988 . . . . 0.0 110.968 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -58.92 172.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.0 tttm 56.4 79.23 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.39 -179.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.14 61.31 0.2 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.36 -72.13 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.34 158.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.84 143.71 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.445 -1.197 . . . . 0.0 112.247 179.652 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.07 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.853 0.359 . . . . 0.0 111.043 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -33.02 72.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.629 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.14 86.87 2.19 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.765 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.38 110.17 2.62 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.37 167.97 22.4 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.639 2.226 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -61.21 163.02 6.72 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.008 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -76.25 170.45 16.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 124.258 0.974 . . . . 0.0 110.731 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.19 169.62 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.616 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 56.1 Cg_endo -70.54 110.31 2.68 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.462 2.108 . . . . 0.0 112.336 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 54.1 Cg_endo -69.98 152.32 68.14 Favored 'Trans proline' 0 CA--C 1.497 -1.371 0 C-N-CA 122.437 2.091 . . . . 0.0 111.948 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.58 -20.89 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.188 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.21 -129.82 3.69 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.443 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 51.04 179.22 0.02 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.528 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.815 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -64.18 179.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.72 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.1 -163.85 0.07 OUTLIER Glycine 0 CA--C 1.492 -1.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.87 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 8.4 m-70 -56.56 -179.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.475 . . . . 0.0 111.013 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.64 48.23 1.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.835 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.41 -56.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t0 46.31 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.34 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.0 106.3 10.95 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.957 0.884 . . . . 0.0 111.824 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.85 173.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.125 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -99.9 42.55 1.95 Allowed Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.451 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -79.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -126.83 -57.4 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -57.83 172.69 0.37 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.458 0.171 . . . . 0.0 111.397 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 15' ' ' PHE . . . -164.95 67.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.328 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER -80.19 170.1 16.89 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.652 0.739 . . . . 0.0 110.617 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.05 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.574 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -58.53 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.831 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.99 154.88 14.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -176.48 110.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -101.16 -173.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.8 62.79 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.78 112.46 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -49.65 175.53 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.103 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -176.53 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.999 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.495 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.662 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -156.04 -175.59 5.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 110.934 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -109.77 -31.27 7.5 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 87.49 2.39 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.944 0.402 . . . . 0.0 110.321 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 52.7 Cg_endo -69.54 110.03 2.41 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.588 2.192 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.5 Cg_endo -69.36 168.42 21.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.536 2.157 . . . . 0.0 112.202 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -60.1 164.15 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -59.78 173.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.06 108.73 1.04 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.467 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 73.2 Cg_endo -73.25 110.81 3.14 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.294 1.996 . . . . 0.0 111.867 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 57.2 Cg_endo -69.31 62.99 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.739 2.293 . . . . 0.0 112.603 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -168.71 -177.38 3.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.52 112.45 4.31 Favored Glycine 0 C--O 1.209 -1.44 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.23 179.95 6.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -112.51 -179.41 3.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -172.85 0.17 Allowed Glycine 0 CA--C 1.499 -0.958 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.363 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 5.4 m-70 -57.47 -177.75 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.05 0.453 . . . . 0.0 111.108 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CA ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -85.35 46.55 1.3 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.266 -178.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.23 -64.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 t70 42.7 92.74 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 115.39 3.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.54 0.209 . . . . 0.0 111.19 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 54.81 173.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.009 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -100.11 43.62 1.75 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.347 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -56.92 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.528 0.204 . . . . 0.0 110.982 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -137.83 -64.11 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -49.43 172.67 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.64 64.09 0.31 Allowed Glycine 0 C--O 1.218 -0.852 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.142 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.3 mt -60.48 168.31 2.19 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 121.919 0.866 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 18' ' ' LYS . . . 124.46 66.57 0.19 Allowed Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.094 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -66.52 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 0.0 110.812 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -65.09 135.71 55.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.363 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 161.75 4.35 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.9 -179.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.269 0.557 . . . . 0.0 111.073 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.85 61.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.182 0.515 . . . . 0.0 111.323 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -145.25 -47.26 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.941 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -49.97 158.45 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.283 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.72 -79.43 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.027 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.328 0 CA-C-O 118.196 -1.336 . . . . 0.0 112.652 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.63 -0.188 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.24 -69.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.729 0.3 . . . . 0.0 111.186 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.7 -31.56 71.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.09 87.23 2.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.939 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.0 Cg_endo -70.44 109.94 2.57 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.621 2.214 . . . . 0.0 112.274 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 52.7 Cg_endo -69.66 168.24 22.0 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.37 2.046 . . . . 0.0 112.223 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 129.05 37.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.844 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -75.11 172.05 13.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.69 -83.24 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.276 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 168.45 21.92 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.35 77.92 0.9 Allowed 'Trans proline' 0 CA--C 1.498 -1.282 0 C-N-CA 122.586 2.191 . . . . 0.0 111.929 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.47 112.93 0.08 Allowed 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.922 0.391 . . . . 0.0 110.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.72 -88.04 0.21 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.52 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.5 -164.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.93 166.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 110.991 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.02 -173.02 0.09 OUTLIER Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.224 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 9.2 m-70 -56.52 -178.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.301 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.439 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . 15.9 pttt -92.54 40.19 1.05 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.734 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.04 -52.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.1 t0 -61.46 95.07 0.05 OUTLIER 'General case' 0 C--O 1.188 -2.181 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.687 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.28 152.79 3.17 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 124.342 1.026 . . . . 0.0 111.708 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -92.96 173.03 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 145.42 -24.36 1.86 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.411 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.2 -79.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.152 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -139.87 -65.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.33 172.17 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 122.532 0.333 . . . . 0.0 111.753 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.77 69.78 0.14 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 20' ' ' ASP . 9.1 mt -62.35 169.39 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.932 0.396 . . . . 0.0 111.077 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' HA2' ' CA ' ' A' ' 18' ' ' LYS . . . 134.96 64.25 0.07 OUTLIER Glycine 0 C--N 1.296 -1.641 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.921 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -29.25 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.4 175.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.257 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 161.65 7.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.06 135.0 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.22 59.98 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -32.89 14.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.828 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.76 172.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 132.93 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.301 0 CA-C-O 118.551 -1.138 . . . . 0.0 112.696 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.1 -69.81 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.076 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -118.04 71.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -59.21 109.89 2.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 110.27 2.54 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.196 1.93 . . . . 0.0 112.279 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.45 152.23 70.91 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.491 2.127 . . . . 0.0 112.345 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -70.99 148.0 48.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.739 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -75.55 172.31 12.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.036 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.71 -87.41 0.45 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.25 154.59 65.65 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.463 2.109 . . . . 0.0 112.334 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.8 84.48 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.196 . . . . 0.0 112.433 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 45.44 -168.74 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.284 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.77 -151.97 36.42 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 p -61.34 172.36 1.14 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.541 ' CB ' HD23 ' A' ' 28' ' ' LEU . 10.8 m-85 -60.01 -179.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.32 -152.81 0.02 OUTLIER Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.718 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.772 ' O ' HD13 ' A' ' 28' ' ' LEU . 36.1 m-70 -61.59 176.37 0.51 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 110.888 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.02 41.12 1.12 Allowed 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mt -73.09 -66.27 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 120.787 0.327 . . . . 0.0 111.043 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.72 111.23 10.84 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -74.87 76.07 2.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.96 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.3 mt 54.48 173.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -173.34 -85.0 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.406 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -81.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.625 0.25 . . . . 0.0 110.775 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.71 -50.76 5.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.081 0.467 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -59.9 172.03 0.83 Allowed 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.62 70.03 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 17' ' ' HIS . 53.0 mt -59.59 178.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.3 42.6 0.18 Allowed Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.724 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.72 -58.64 2.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.793 0.33 . . . . 0.0 110.882 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.85 150.19 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.692 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -172.73 89.5 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.33 -179.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -70.95 61.65 0.27 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.972 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -92.13 -55.66 3.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.646 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 65.66 -73.39 0.07 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.829 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER 44.12 31.41 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.35 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.322 -1.265 . . . . 0.0 112.576 179.93 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.63 163.9 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.985 0.421 . . . . 0.0 110.758 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -90.33 -45.5 8.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.06 127.19 50.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.015 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.33 110.22 2.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.218 . . . . 0.0 112.456 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.27 168.21 21.56 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.544 2.163 . . . . 0.0 112.291 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.59 142.87 54.98 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.98 0.419 . . . . 0.0 110.162 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -78.5 168.75 19.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.032 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.13 51.84 56.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.505 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.93 162.07 42.99 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.63 2.22 . . . . 0.0 112.312 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.65 124.01 10.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.718 2.279 . . . . 0.0 112.442 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -60.11 88.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.202 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.95 -52.38 0.45 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.243 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.62 169.03 13.53 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 122.667 -0.314 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.681 ' CB ' HD22 ' A' ' 28' ' ' LEU . 1.7 m-85 -77.52 -179.74 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.49 -166.4 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.18 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LEU . 15.9 m-70 -59.72 178.9 0.14 Allowed 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.866 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -87.79 47.19 1.47 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.606 1.192 . . . . 0.0 110.731 -178.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.64 -71.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.013 0.435 . . . . 0.0 110.821 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 12.4 t0 40.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.077 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -59.57 89.96 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.4 mt 57.0 173.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 123.261 0.351 . . . . 0.0 110.586 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 118.44 94.7 1.66 Allowed Glycine 0 CA--C 1.489 -1.535 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.354 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.8 p -50.36 -57.89 6.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.286 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -47.52 -55.4 9.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.8 m -48.56 156.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.344 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 15' ' ' PHE . . . -168.26 69.43 0.17 Allowed Glycine 0 C--O 1.201 -1.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 15' ' ' PHE . 1.3 mt -78.32 -171.63 2.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.67 0.748 . . . . 0.0 110.972 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 74.49 0.59 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.954 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.54 -56.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 111.048 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -54.85 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.95 101.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.983 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 18' ' ' LYS . 26.7 m -113.25 133.61 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.336 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.74 63.5 0.29 Allowed 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.929 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.72 108.88 2.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -51.2 101.34 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.289 0.566 . . . . 0.0 111.401 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -76.07 82.26 2.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.8 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.263 179.89 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -83.64 100.82 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.525 0.202 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -117.89 71.18 0.81 Allowed 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 83.81 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.63 0 O-C-N 124.199 0.937 . . . . 0.0 110.473 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.24 110.13 2.58 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.345 2.03 . . . . 0.0 112.464 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.57 168.07 22.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.277 1.984 . . . . 0.0 112.352 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -80.22 160.91 25.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -85.31 170.18 13.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.023 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.75 90.76 1.61 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.054 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 58.6 Cg_endo -69.96 110.03 2.5 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 122.989 2.459 . . . . 0.0 112.023 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 53.7 Cg_endo -70.44 100.95 0.95 Allowed 'Trans proline' 0 CA--C 1.497 -1.365 0 C-N-CA 122.255 1.97 . . . . 0.0 112.584 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.49 31.29 20.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.942 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.97 -64.06 0.28 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.2 t 61.37 157.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 2.3 p90 -54.88 142.91 27.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.948 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.89 -167.21 0.17 Allowed Glycine 0 N--CA 1.419 -2.462 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.667 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CE1' ' HB2' ' A' ' 31' ' ' ASN . 60.3 m-70 -60.67 173.03 0.79 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 121.658 0.742 . . . . 0.0 110.104 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HE3' HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -95.69 38.58 1.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.157 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.83 -27.69 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' HB3' HD12 ' A' ' 28' ' ' LEU . 18.9 t70 -55.36 147.8 16.36 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.05 170.01 0.95 Allowed 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -44.89 164.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.671 0 O-C-N 124.498 1.124 . . . . 0.0 111.024 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.05 88.49 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.553 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 p -43.97 -59.02 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 111.327 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.17 -58.85 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.95 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -60.02 171.97 0.87 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.056 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.02 67.46 0.21 Allowed Glycine 0 C--O 1.198 -2.131 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.659 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 20' ' ' ASP . 6.2 mt -83.38 167.82 17.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.12 49.43 0.45 Allowed Glycine 0 C--N 1.291 -1.962 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.532 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.03 -63.98 1.27 Allowed 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.738 -0.272 . . . . 0.0 110.844 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 12.6 m-80 -58.98 144.48 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -60.56 142.36 55.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.043 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.657 HG11 ' HE3' ' A' ' 18' ' ' LYS . 4.5 m -120.73 -179.78 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.98 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t0 56.3 75.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -151.64 -46.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.696 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.7 -30.95 15.07 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.234 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -86.19 145.36 27.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.823 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.351 179.943 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.024 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 t0 60.45 104.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.98 -31.92 19.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.8 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.11 87.08 2.28 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 56.8 Cg_endo -70.33 110.11 2.59 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.677 2.251 . . . . 0.0 112.353 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 54.3 Cg_endo -69.95 150.61 67.29 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.361 2.041 . . . . 0.0 112.267 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -86.32 77.2 9.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.99 172.24 7.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 110.385 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.19 -61.03 7.78 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.555 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.39 158.82 56.04 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.845 2.363 . . . . 0.0 111.981 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.99 92.8 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.528 2.152 . . . . 0.0 112.053 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 60.59 30.91 20.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.996 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . -109.07 65.81 0.24 Allowed Glycine 0 C--O 1.214 -1.148 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.582 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' CZ ' ' A' ' 15' ' ' PHE . 27.1 p -56.21 -48.76 75.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.451 -0.441 . . . . 0.0 111.048 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -125.21 -178.8 4.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 110.378 178.37 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.47 168.22 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.134 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.19 177.94 0.76 Allowed 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.641 -0.279 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HD3' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -90.8 49.17 1.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 124.947 1.404 . . . . 0.0 110.872 -179.797 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.77 -45.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' HD11 ' A' ' 22' ' ' ILE . 5.0 t0 -82.57 123.32 29.11 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.21 77.67 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.861 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.2 mt -130.04 172.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 22' ' ' ILE . . . -158.54 72.83 0.23 Allowed Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.387 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.48 -68.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.62 -66.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.091 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 t -76.42 172.23 13.29 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.244 -0.285 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -157.28 64.03 0.31 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.398 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 6.0 mt -57.21 167.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 47.07 1.04 Allowed Glycine 0 C--N 1.283 -2.416 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.675 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -93.92 -37.54 11.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.275 0.559 . . . . 0.0 111.705 179.197 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.24 127.19 30.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.025 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -58.94 126.91 29.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG11 ' HD3' ' A' ' 18' ' ' LYS . 4.8 m -118.86 134.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.97 56.45 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -93.69 -171.94 2.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.466 0.65 . . . . 0.0 110.41 179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -51.17 -30.41 16.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.373 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttm 60.5 110.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.016 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 CA-C-O 118.268 -1.295 . . . . 0.0 112.475 -179.767 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -176.42 146.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.477 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.88 31.79 2.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.46 109.82 2.24 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.637 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.82 110.0 2.46 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.36 168.21 21.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -60.3 161.61 7.01 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -75.98 172.1 13.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.031 0.832 . . . . 0.0 110.474 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.42 90.77 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.222 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.15 159.17 54.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.555 2.17 . . . . 0.0 112.222 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.11 63.45 2.0 Allowed 'Trans proline' 0 C--O 1.213 -0.772 0 C-N-CA 122.638 2.225 . . . . 0.0 112.157 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -164.89 31.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.1 -83.11 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.586 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.1 m -60.28 174.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.31 -178.88 1.82 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.015 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.13 -177.76 1.04 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.94 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -61.7 177.06 0.45 Allowed 'General case' 0 C--O 1.211 -0.935 0 O-C-N 122.701 -0.294 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HD3' HG11 ' A' ' 33' ' ' VAL . 14.7 pttm -96.73 38.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.37 -26.31 3.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.3 144.6 19.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.065 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -58.87 170.88 0.75 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 pt -46.27 166.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.704 0 O-C-N 124.591 1.182 . . . . 0.0 110.729 -178.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.11 88.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.41 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 p -42.44 -58.47 2.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.754 0.312 . . . . 0.0 111.721 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -50.71 -58.41 5.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.043 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.9 m -61.25 172.19 1.15 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.076 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.09 68.81 0.17 Allowed Glycine 0 C--O 1.198 -2.105 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.732 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -76.0 168.88 19.23 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 122.663 1.22 . . . . 0.0 110.01 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 83.1 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.332 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.9 t -158.29 -46.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.475 0.637 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -59.99 -179.55 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 98.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.017 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG11 ' HD3' ' A' ' 18' ' ' LYS . 5.2 m -118.81 134.64 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 111.265 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.08 61.84 3.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.234 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -86.48 111.97 21.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.773 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -50.65 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.37 135.16 57.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.386 179.849 . . . . . . . . 0 0 . 1 stop_ save_